EOS Med Chem is serving more than 100 Pharma companies, we have the original Drug Discovery Compounds, Like Impurity, small molecule and inhibitor.
Impurity we keep stock more than 80000, most in stock, we are World Sole Original Supplier, Each impurity we could supply: Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA.
EOS Med Chem Quotation include: Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, COA, MSDS.
Contact:
EOS Med Chem, Medicinal Chemical is Big
執大象，天下往，往而無害，安平泰
Ms Nina
Youtube: https://youtu.be/r5cJdXKNXHk
Tel: 0086-531-69905422
SALE OFFICE: 16F, China Overseas Plaza, Jinan City, China
epi-Sancycline (>70%), CAS: 906364-48-5, stock: 1.6g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₂₂N₂O₇.
epi-Sancycline-d6 Hydrochloride, CAS: /, stock: 6.6g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₁₆D₆N₂O₇.
α-Apo-oxytetracycline, CAS: 18695-01-7, stock: 8.6g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₂₂N₂O₈.
β-Apo-oxytetracycline, CAS: 18751-99-0, stock: 9.5g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₂₂N₂O₈.
Lymecycline (85%), CAS: 992-21-2, stock: 9g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₉H₃₈N₄O₁₀.
Lymecycline-d8 (>80%), CAS: /, stock: 7.1g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₉H₃₀D₈N₄O₁₀.
Meclocycline, CAS: 2013-58-3, stock: 2.8g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₂₁ClN₂O₈.
Methacycline, CAS: 914-00-1, stock: 6g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₂₂N₂O₈.
Methacycline Hydrochloride, CAS: 3963-95-9, stock: 3g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₂₃ClN₂O₈.
Minocycline Amino Ethyl Derivative, CAS: 4756-93-8, stock: 9.9g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₂₇N₃O₇.
Minocycline Hydrochloride, CAS: 13614-98-7, stock: 3.9g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₂₈ClN₃O₇.
Minocycline-d7 (Major), CAS: /, stock: 7.4g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₂₀D₇N₃O₇.
N-Des(dimethyl)-4-epi-tetracycline (~70%), CAS: 53864-51-0, stock: 8.8g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₀N₂O₈.
N-Des(dimethyl)tetracycline 4-Hydroxyimine, CAS: 1771-28-4, stock: 2.3g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₁₈N₂O₉.
N-Methylol Minocycline (~90%), CAS: 1075240-33-3, stock: 5.5g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₂₉N₃O₈.
Oxytetracycline Dihydrate, CAS: 6153-64-6, stock: 1.1g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₂₈N₂O₁₁.
Oxytetracycline Hydrochloride, CAS: 2058-46-0, stock: 6.2g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₂₅ClN₂O₉.
Pipacycline, CAS: 1110-80-1, stock: 1.8g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₉H₃₈N₄O₉.
Pyrazolo Minocycline Tri-TFA Salt, >80%, CAS: /, stock: 3.4g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₂₇N₅O₅ (C₆H₃F₉O₆).
Rolitetracycline (Technical Grade), CAS: 751-97-3, stock: 7.8g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₇H₃₃N₃O₈.
Sancycline, CAS: 808-26-4, stock: 2.6g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₂₂N₂O₇.
Sancycline Hydrochloride, CAS: 6625-20-3, stock: 3.5g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₂₃ClN₂O₇.
Sancycline-d6 Hydrochloride, CAS: /, stock: 7.2g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₁₆D₆N₂O₇.
Sarecycline Hydrochloride, CAS: 1035979-44-2, stock: 1.4g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₃₀ClN₃O₈.
Tetracycline, CAS: 60-54-8, stock: 2.1g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₂₄N₂O₈.
Tetracycline 10-O-b-D-Galactopyranoside, CAS: 319426-63-6, stock: 5.7g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₈H₃₄N₂O₁₃.
Tetracycline Hydrate, CAS: 305833-60-7, stock: 9.5g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₂₄N₂O₈ • H ₂O.
Tetracycline Hydrochloride, CAS: 64-75-5, stock: 5.7g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₂₅ClN₂O₈.
Tetracycline Phosphate complex, CAS: 1336-20-5, stock: 6.1g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₂₇N₂O₁₂P.
Tetracycline-d6 (80%), CAS: /, stock: 9.9g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₁₈D₆N₂O₈.
Tigecycline (open C-ring D-ring) Quinone Trifluoroacetic Acid Salt, CAS: /, stock: 2.3g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₆H₃₂N₄O₈ • x( C₂HF₃O₂).
Tigecycline Pentacyclic Analog, Technical Grade, CAS: 1268494-40-1, stock: 8.2g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₇H₃₂N₄O₉.
Viridicatumtoxin, CAS: 39277-41-3, stock: 4.6g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₀H₃₁NO₁₀.
3-(Benzyloxy)propyl-d6 4-Toluenesulfonate, CAS: /, stock: 2.8g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₄D₆O₄S.
3-Benzyloxy-1-propanol-d6, CAS: 1219124-64-7, stock: 6.4g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₈D₆O₂.
O-Benzyl Ternidazole-d6, CAS: /, stock: 3.8g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₁D₆N₃O₃.
Ternidazole Hydrochloride, CAS: 70028-95-4, stock: 5.4g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₁₂ClN₃O₃.
Ternidazole-d6 Hydrochloride, CAS: 1346599-62-9, stock: 2.8g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₆D₆ClN₃O₃.
(R)-Thioterpineol, CAS: 83150-78-1, stock: 1.9g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₈S.
(S)-α-Terpineol, CAS: 10482-56-1, stock: 7.3g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₈O.
Dihydro-α-terpineol, CAS: 498-81-7, stock: 6.4g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₂₀O.
α-Terpinenol, CAS: 98-55-5, stock: 4.7g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₈O.
α-Terpineol-d3 (Propyl Methyl-d3), CAS: 203633-12-9, stock: 3.2g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₅D₃O.
rac Terpinen-4-ol, CAS: 562-74-3, stock: 9.5g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₈O.
rac Terpinen-4-ol-d7, CAS: 1189483-12-2, stock: 1.1g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₁D₇O.
Terpineol (>90%), CAS: 8000-41-7, stock: 6.7g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₈O.
Terizidone, CAS: 25683-71-0, stock: 2g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₄N₄O₄.
Terizidone-15N2,d6 (Major), CAS: /, stock: 1.4g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₈D₆N₂¹⁵N₂O₄.
2-Cyano-3-hydroxy-N-(4-methylphenyl)-2-butenamide, CAS: 1385789-70-7, stock: 5.6g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₂N₂O₂.
4-Hydroxy-Teriflunomide, CAS: 1058722-45-4, stock: 5.3g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₉F₃N₂O₃.
A 77-1726, CAS: 163451-81-8, stock: 6.2g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₉F₃N₂O₂.
A77 1726 (E/Z) Mixture, CAS: 108605-62-5, stock: 7.2g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₉F₃N₂O₂.
A77 1726-d4, CAS: 1185240-22-5, stock: 6.7g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₅D₄F₃N₂O₂.
(-)-Norgestrel-d6, CAS: /, stock: 2.7g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₂₂D₆O₂.
(17α)-17-Hydroxy-3-oxo-19-norpregna-5(10),9(11)-diene-21-nitrile, CAS: 106111-42-6, stock: 6.4g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₅NO₂.
(17α)-3,3-[1,2-Ethanediylbis(oxy)]-17-hydroxy-19-norpregna-5(10),9(11)-diene-21-nitrile, CAS: 190662-30-7, stock: 7.9g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₂₉NO₃.
(17β)-17-(Benzoyloxy)-4-oxaandrost-5-en-3-one, CAS: 71996-13-9, stock: 6.7g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₃₀O₄.
(17β)-17-Hydroxy-17-methylestr-5(10)-en-3-one, CAS: 2741-75-5, stock: 1.8g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₂₈O₂.
(17β)-2’H-Androsta-2,4-dieno[3,2-c]pyrazol-17-ol, CAS: 929042-39-7, stock: 6.7g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₈N₂O.
(17β)-4-Chloro-17-(hydroxymethyl)-17-methyl-18-norandrosta-1,4,13-trien-3-one, CAS: 1372695-69-6, stock: 4.2g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₅ClO₂.
(2α,3α,5α,17β)-2,3-Epoxy-17-methylandrostan-17-ol, CAS: 968-54-7, stock: 4.2g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₃₂O₂.
(3bR,3cS,5aS,6R,8aS,8bS,10aR)-N-(tert-Butyl)-3b,5a-dimethyl-2-oxohexadecahydro-1H-indeno[5,4-f]oxireno[2,3-c]quinoline-6-carboxamide, CAS: /, stock: 5.5g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₃₆N₂O₃.
(3α,5β)-3-(Acetyloxy)pregnan-20-one, CAS: 1491-77-6, stock: 9.9g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₃₆O₃.
(3α,17α)-4-Chloro-3-hydroxy-17-methyl-18-Norandrosta-4,13-diene-17-methanol, CAS: 1372695-75-4, stock: 6.8g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₉ClO₂.
(3α,5β,17α)-4-Chloro-3-hydroxy-17-methyl-18-norandrost-13-ene-17-methanol, CAS: 1372695-73-2, stock: 6.5g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₃₁ClO₂.
(3α,5β,17β)-4-Chloro-3-hydroxy-17-methyl-18-norandrost-13-ene-17-methanol, CAS: 1372695-72-1, stock: 4.8g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₃₁ClO₂.
(3α,5β,17β)-4-Chloro-3-hydroxy-17-methyl-18-Norandrosta-1,13-diene-17-methanol, CAS: 1372695-71-0, stock: 3.6g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₉ClO₂.
(3α,17β)-4-Chloro-3-hydroxy-17-methyl-18-norandrosta-4,13-diene-17-methanol, CAS: 1372695-74-3, stock: 2.1g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₉ClO₂.
(3α,5β,16α,17α)-4-Chloro-17-methyl-18-androstane-3,16,17-triol, CAS: /, stock: 1.5g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₃₃ClO₃.
D-Cys(4)-Terlipressin Trifluoroacetic Acid Salt, CAS: /, stock: 5.1g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅₂H₇₄N₁₆O₁₅S₂ • x(C ₂HF₃O₂).
(3β,15α,17β)-15,17-Bis-O-(tert-butyldimethylsilyloxy) Androst-5-en-3-ol, CAS: 65429-25-6, stock: 5.1g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₁H₅₈O₃Si₂.
(3β,15α,17β)-15,17-Bis-O-(tert-butyldimethylsilyloxy) Androst-5-en-3-ol 3-O-Acetate, CAS: 65429-24-5, stock: 1.4g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₃H₆₀O₄Si₂.
D-Gln(7)-Terlipressin Trifluoroacetic Acid Salt, CAS: /, stock: 7.5g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅₂H₇₄N₁₆O₁₅S₂ • x( C₂HF₃O₂).
Terlipressin Diacetate Salt, CAS: 1884420-36-3, stock: 8.2g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅₆H₈₂N₁₆O₁₉S₂.
Terlipressin-d2 Diacetate Salt, CAS: /, stock: 2.2g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅₆H₈₀D₂N₁₆O₁₉S₂.
Terlipressin-Phe(d5) Diacetate Salt, CAS: /, stock: 1.6g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅₆H₇₇D₅N₁₆O₁₉S₂.
(3β,5α,17β)-17-Methyl-androst-1-ene-3,17-diol-d3, CAS: /, stock: 5.5g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₉D₃O₂.
(3β,5α,6β,15α,17β)-17-tert-Butyldimethylsilyloxy-6-methoxy-3,5-cycloandrostan-15-ol, CAS: 61252-35-5, stock: 7.7g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₆H₄₆O₃Si.
(5α)-Androst-9(11)-ene-3,17-dione, CAS: 15375-19-6, stock: 8.3g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₂₆O₂.
(5α)-Androstane-3,6,17-trione, CAS: 02/05/2243, stock: 5.6g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₂₆O₃.
(5β)-Androst-9(11)-ene-3,17-dione, CAS: 1093397-63-7, stock: 3.2g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₂₆O₂.
(6aS,7S,9aR)-2,5,6,6a,7,8,9,9a-Octahydro-6a-methyl-2-oxo-1H-indeno[5,4-f]quinoline-7-carboxylic Acid Methyl Ester, CAS: 166896-66-8, stock: 8.5g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₂₁NO₃.
11α-Hydroxyandrosta-1,4-dien-3,17-dione, CAS: 7801-18-5, stock: 7g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₂₄O₃.
11β-Hydroxytestosterone 11-Glucuronide, CAS: /, stock: 6.2g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₃₆O₉.
11β-Hydroxytestosterone 11-Sulphate, CAS: /, stock: 9.7g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₂₈O₆S.
11β-Hydroxytestosterone 17-Glucuronide, CAS: /, stock: 7.4g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₃₆O₉.
11β-Hydroxytestosterone 17-Sulphate, CAS: 41195-69-1, stock: 5.9g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₂₈O₆S.
11β-Methoxy Dienogest, CAS: /, stock: 7.3g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₂₇NO₃.
17-epi-Testosterone, CAS: 481-30-1, stock: 3.9g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₂₈O₂.
17-epi-Testosterone Enanthate, CAS: 219296-36-3, stock: 7.5g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₆H₄₀O₃.
17-epi-Testosterone-d3, CAS: 171199-96-5, stock: 4.7g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₂₅D₃O₂.
17-Hydroxypregn-4-en-3-one, CAS: 1235-97-8, stock: 4.7g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₃₂O₂.
17-Methyl-5β-androstane-3α,17β-diol, CAS: 641-84-9, stock: 9.7g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₃₄O₂.
17-O-Acetyl AndrostanoloneDiscontinued, see A637615, CAS: 1164-91-6, stock: 9.5g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₃₂O₃.
17-O-tert-Butyldimethylsilyl 5,14-Androstadiene-3β,17β-diol, CAS: 61252-32-2, stock: 4g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₄₂O₂Si.
17α-Cyanomethyl-19-nortestosterone, CAS: 67473-36-3, stock: 7.8g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₇NO₂.
17α-Hydroxy-5α-androstan-3-one, CAS: 571-24-4, stock: 4.4g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₃₀O₂.
17α-Methyl-4-[(phenylthio)methyl]testosterone, CAS: 71507-77-2, stock: 8.5g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₇H₃₆O₂S.
17β-Acetoxy-2α-bromo-5α-androstanone, CAS: 6173-35-9, stock: 6.8g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₃₁BrO₃.
17β-Hydroxy-17α-methyl-5β-androstan-3-one, CAS: 3275-58-9, stock: 9.9g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₃₂O₂.
17β-Hydroxy-4-androstene-3,11-dione Glucuronide Sodium Salt, CAS: /, stock: 8.7g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₃₃NaO₉.
(+)-α-Dihydrotetrabenazine, CAS: 85081-18-1, stock: 7.1g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₂₉NO₃.
17β-Hydroxy-4-androstene-3,11-dione Sulphate Sodium Salt, CAS: /, stock: 5.4g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₂₅NaO₆S.
17β-Methyl epi-Testosterone, CAS: 2607-14-9, stock: 8.3g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₃₀O₂.
(+)-α-Dihydrotetrabenazine-13C2D6, CAS: /, stock: 5.3g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇¹³C₂H₂₃D₆NO₃.
(+)-β-Dihydrotetrabenazine, CAS: 924854-60-4, stock: 1.9g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₂₉NO₃.
17β-Methyl epi-Testosterone-d5, CAS: /, stock: 4.9g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₅D₅O₂.
(+)-β-Dihydrotetrabenazine-13C2D6, CAS: /, stock: 1.8g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇¹³C₂H₂₃D₆NO₃.
(-)-Tetrabenazine (>75% ee), CAS: 1026016-84-1, stock: 2.4g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₂₇NO₃.
(-)-Tetrabenazine-d3 (>75% ee), CAS: /, stock: 9.6g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₂₄D₃NO₃.
(11bR)-3-Isobutyl-1-10-methoxy-2,3,4,6,7,11b-hexahydro-1H-pyrido[2,1-a]isoquinoline-2,9-diol, CAS: 1795790-34-9, stock: 2.7g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₂₇NO₃.
(2-Acetyl-4-methylpentyl)trimethylammonium Iodide, CAS: 1069-62-1, stock: 2.6g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₂₄INO.
(2R,3R,11bR)-Dihydrotetrabenazine D-Val, CAS: /, stock: 3.6g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₃₈N₂O₄.
(2R,3R,11bS)-Dihydrotetrabenazine, CAS: 862377-29-5, stock: 5.5g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₂₉NO₃.
(2R,3R,11bS)-Dihydrotetrabenazine D-Val, CAS: /, stock: 3.1g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₃₈N₂O₄.
(2R,3R,11bS)-Dihydrotetrabenazine L-Val, CAS: /, stock: 7.2g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₃₈N₂O₄.
(2R,3S,11bR)-Dihydrotetrabenazine, CAS: 862377-31-9, stock: 5.6g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₂₉NO₃.
(2R,3S,11bR)-Dihydrotetrabenazine D-Val, CAS: /, stock: 7.4g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₃₈N₂O₄.
(2R,3S,11bR)-Dihydrotetrabenazine D-Val, CAS: /, stock: 7.4g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₃₈N₂O₄.
(2R,3S,11bR)-Dihydrotetrabenazine-L-Val, CAS: /, stock: 7.3g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₃₈N₂O₄.
(2R,3S,11bS)-Dihydrotetrabenazine, CAS: 924854-62-6, stock: 6.6g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₂₉NO₃.
(2R,3S,11bS)-Dihydrotetrabenazine L-Val, CAS: /, stock: 7.7g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₃₈N₂O₄.
2-Chloro-4-fluoro-3-methylbenzonitrile, CAS: 796600-15-2, stock: 1.3g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₅ClFN.
(2R,3S,11bS)-Dihydrotetrabenazine-d6, CAS: 1583277-33-1, stock: 4.2g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₂₃D₆NO₃.
(2S,3R,11bR)-Dihydrotetrabenazine D-Val, CAS: /, stock: 3.7g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₃₈N₂O₄.
2-Chlorocypionic Acid, CAS: /, stock: 4.6g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₁₃ClO₂.
2-Hydroxymethylene Ethisterone, CAS: 02/02/2787, stock: 1.1g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₂₈O₃.
(2S,3R,11bR)-Dihydrotetrabenazine L-Val, CAS: /, stock: 3.7g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₃₈N₂O₄.
(2S,3R,11bS)-Dihydrotetrabenazine, CAS: 8862377-33-1, stock: 4.1g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₂₉NO₃.
2-Hydroxymethylene Ethisterone-13C3, CAS: /, stock: 3.7g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉¹³C₃H₂₈O₃.
2-Methyl-5α-androst-2-en-17-one, CAS: 32300-87-1, stock: 8g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₃₀O.
(2S,3R,11bS)-Dihydrotetrabenazine D-Val, CAS: /, stock: 8.8g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₃₈N₂O₄.
(2S,3R,11bS)-Dihydrotetrabenazine-L-Val, CAS: /, stock: 5.4g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₃₈N₂O₄.
20α-Acetoxy-4-pregnen-3-one, CAS: 06/09/5035, stock: 9.4g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₃₄O₃.
(2S,3S,11bR)-Dihydrotetrabenazine, CAS: 862377-27-3, stock: 6.4g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₂₉NO₃.
(2S,3S,11bR)-Dihydrotetrabenazine D-Val, CAS: /, stock: 3.5g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₃₈N₂O₄.
(2S,3S,11bR)-Dihydrotetrabenazine L-Val, CAS: /, stock: 8.7g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₃₈N₂O₄.
(2S,3S,11bS)-Dihydrotetrabenazine, CAS: 164104-49-8, stock: 9.2g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₂₉NO₃.
(2S,3S,11bS)-Dihydrotetrabenazine D-Val, CAS: /, stock: 3.8g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₃₈N₂O₄.
(2S,3S,11bS)-Dihydrotetrabenazine L-Val, CAS: /, stock: 5.7g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₃₈N₂O₄.
(2S,3S,11bS)-Dihydrotetrabenazine-d6, CAS: 1583277-31-9, stock: 2.7g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₂₃D₆NO₃.
(3R,11bR)-Tetrabenazine, CAS: 1026016-83-0, stock: 8.1g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₂₇NO₃.
(3R,11bR)-Tetrabenazine-d3, CAS: /, stock: 9.8g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₂₅D₃NO₃.
3,17-Bis-O-(tert-Butyldimethylsilyl) 5,14-Androstadiene-3β,17β-diol, CAS: /, stock: 9.9g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₁H₅₆O₂Si₂.
3,17-Di-O-acetyl Androsta-5,14,16-triene-3β,17-diol, CAS: 34635-42-2, stock: 3.6g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₃₀O₄.
1,11b-Dedihydrotetrabenazine, CAS: 100322-43-8, stock: 4.9g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₂₅NO₃.
1,11b-Dedihydrotetrabenazine-d6, CAS: /, stock: 10g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₁₉D₆NO₃.
1,3,4,11b-Detetrahydrotetrabenazine Chloride, CAS: 1555366-92-1, stock: 8g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₂₄ClNO₃.
1,3,4,11b-Detetrahydrotetrabenazine Chloride-d6, CAS: /, stock: 3.3g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₁₈D₆ClNO₃.
3-Ethoxy-androsta-3,5-dien-17-ol-d3, CAS: /, stock: 5.5g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₂₉D₃O₂.
1,3,4,6,7,11b-Hexahydro-1-isobutyl-9,10-dimethoxy-2H-benzo[a]quinolizin-2-one, CAS: 99672-64-7, stock: 4.5g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₂₇NO₃.
1,3,4,6,7,11b-Hexahydro-1-isobutyl-9,10-dimethoxy-2H-benzo[a]quinolizin-2-one-d7, CAS: /, stock: 8g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₂₀D₇NO₃.
1,3,4,6,7,11b-Hexahydro-9-hydroxy-10-methoxy-3-(2-methylpropyl)-2H-benzo[a]quinolizin-2-one, CAS: 149183-89-1, stock: 7.2g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₂₅NO₃.
3,4-Dihydro-7,8-dimethoxyisoquinoline, CAS: 75877-72-4, stock: 5.5g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₃NO₂.
3-Methoxy-17-methylestra-2,5(10)-dien-17β-ol, CAS: 19590-65-9, stock: 7.4g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₃₀O₂.
3-Methoxy-17α-methylestra-1,3,5(10)trien-17β-ol, CAS: 15236-73-4, stock: 5g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₈O₂.
3-Des(2-methylpropyl)-3-n-Butyl Tetrabenazine, CAS: 19328-35-9, stock: 7.9g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₂₇NO₃.
3-Des(2-methylpropyl)-3-n-Butyl Tetrabenazine-d9, CAS: /, stock: 6.9g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₁₈D₉NO₃.
3-O-Acetyl 5,14-Androstadiene-3β,17β-diol, CAS: 61252-30-0, stock: 9.5g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₃₀O₃.
3-O-Acetyl-17-O-tert-butyldimethylsilyl 5,14-Androstadiene-3β,17β-diol, CAS: 61252-31-1, stock: 1.9g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₇H₄₄O₃Si.
3-[(Dimethylamino)methyl]2-octanone, CAS: /, stock: 1.6g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₂₃NO.
5-Methyl-3-methylene-2-hexanone, CAS: 1187-87-7, stock: 4.3g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₁₄O.
3-Oxo-4-aza-11a-methoxy-5α-αndrost-1-ene-17β-carboxylic Acid Methyl Ester, CAS: 1026013-15-9, stock: 6g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₃₁NO₄.
6,7-Dimethoxy-3,4-dihydroisoquinoline Hydrochloride Hydrate, CAS: 20232-39-7, stock: 2.2g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₄ClNO₂ •xH₂O.
cis (2,3)-Dihydro Tetrabenazine, CAS: 113627-25-1, stock: 5g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₂₉NO₃.
3-Oxo-4-azaandrosta-1,5,7-triene-17-carboxylic Acid Methyl Ester, CAS: 166896-63-5, stock: 7.9g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₅NO₃.
cis (2,3)-Dihydro Tetrabenazine-d6, CAS: /, stock: 4.3g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₂₃D₆NO₃.
cis-Dihydrotetrabenazine Glucuronide, CAS: /, stock: 4.5g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₃₇NO₉.
3α,17α-Dimethylandrostane-3β,17β-diol, CAS: 896717-01-4, stock: 3.6g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₃₆O₂.
cis-Dihydrotetrabenazine Glucuronide-d6, CAS: /, stock: 1.4g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₃₁D₆NO₉.
Hydroxy Tetrabenazine - Mixture of cis and trans Isomers, CAS: 3466-75-9, stock: 3.7g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₂₉NO₃.
2-(Bromomethyl)-2-(2,4-dichlorophenyl)-1,3-dioxolane-4-methanol (Mixture of diastereomers), CAS: 68751-57-5, stock: 8.7g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₁BrCl₂O₃.
3α,17β-Androst-5-enediol, CAS: 16895-59-3, stock: 3.5g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₃₀O₂.
N-(3,4-Dimethoxyphenethyl)formamide, CAS: 14301-36-1, stock: 9.2g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₅NO₃.
Phenyl-piperidin-2-yl-methanol, CAS: 23702-98-9, stock: 3.8g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₇NO.
cis-[2-Bromomethyl-2-(2,4-dichlorophenyl)-1,3-dioxolan-4-yl]methyl Benzoate, CAS: 61397-56-6, stock: 2.1g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₁₅BrCl₂O₄.
N4-Triazolyl Terconazole, CAS: /, stock: 5.9g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₆H₃₁Cl₂N₅O₃.
3α,17β-Androst-5-enediol 3-(p-Nitrobenzoate), CAS: /, stock: 4.3g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₆H₃₃NO₅.
rac-(2,3)-Dihydro Tetrabenazine [Cis/Trans Mixture], CAS: /, stock: 5.3g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₂₉NO₃.
rac-(2,3)-Dihydro Tetrabenazine-13C2,D6 [Cis/Trans Mixture], CAS: /, stock: 1.4g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇¹³C₂H₂₃D₆NO₃.
rel-(2S,4S)-Terconazole, CAS: 1486497-66-8, stock: 2.2g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₆H₃₁Cl₂N₅O₃.
Terconazole, CAS: 67915-31-5, stock: 7.2g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₆H₃₁Cl₂N₅O₃.
Tetrabenazine, CAS: 58-46-8, stock: 9.6g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₂₇NO₃.
Terconazole-d4, CAS: 1398065-50-3, stock: 8.2g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₆H₂₇D₄Cl₂N₅O₃.
Terconazole-d8, CAS: /, stock: 8.5g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₆H₂₃D₈Cl₂N₅O₃.
Tetrabenazine, CAS: 718635-93-9, stock: 8.2g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₂₇NO₃.
Tetrabenazine-d6, CAS: 1392826-25-3, stock: 1.6g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₂₁D₆NO₃.
trans-[2-Bromomethyl-2-(2,4-dichlorophenyl)-1,3-dioxolan-4-yl]methyl Benzoate, CAS: 61397-57-7, stock: 5.2g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₁₅BrCl₂O₄.
3β,4β-Dihydroxyandrost-5-en-17-one, CAS: 63518-24-1, stock: 4.5g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₂₈O₃.
trans (2,3)-Dihydro Tetrabenazine, CAS: 171598-74-6, stock: 7.5g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₂₉NO₃.
trans (2,3)-Dihydro Tetrabenazine-d6, CAS: /, stock: 1.8g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₂₃D₆NO₃.
trans-Dihydrotetrabenazine Glucuronide, CAS: /, stock: 2.3g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₃₇NO₉.
trans-Dihydrotetrabenazine Glucuronide-d6, CAS: /, stock: 2.7g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₃₁D₆NO₉.
3β-Methoxy-5,14-androstadiene-17β-ol, CAS: /, stock: 2.2g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₃₀O₂.
trans-Tetrabenazine, CAS: 1381929-92-5, stock: 7.1g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₂₇NO₃.
4,17α-Dimethyl-2-hydroxymethylene Testosterone, CAS: 38539-99-0, stock: 7.1g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₃₂O₃.
4,17α-Dimethyltestosterone, CAS: 28626-76-8, stock: 7.9g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₃₂O₂.
4,5-Epoxy-19-nortestosterone, CAS: 52153-24-9, stock: 2.4g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₂₆O₃.
4-Chloro-6β,17β-dihydroxy-17α-methyl-1,4-androstadien-3-one-d3, CAS: /, stock: 4.5g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₄D₃ClO₃.
4-Fluoro-19-nortestosterone, CAS: 1881-31-8, stock: 4.1g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₂₅FO₂.
5,6,7,8-Dehydro Finasteride, CAS: /, stock: 5g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₃₂N₂O₂.
5α-Androst-15-ene-3,17-dione, CAS: 127380-69-2, stock: 2.7g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₂₆O₂.
5α-Androstan-3β,17α-diol, CAS: 01/11/5856, stock: 1.1g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₃₂O₂.
(1-Benzylpiperidin-4-yl)diphenyl-d10-methanol, CAS: /, stock: 2.6g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₁₇D₁₀NO.
(3E)-4-[4-(1,1-Dimethylethyl)phenyl]-3-buten-1-ol, CAS: 1228105-37-0, stock: 9.6g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₂₀O.
(Decarboxy)-1-Oxo Fexofenadine-d10 Methanol, CAS: /, stock: 9.5g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₂H₂₉D₁₀NO₃.
(R)-Fexofenadine, CAS: 139965-10-9, stock: 2.2g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₂H₃₉NO₄.
(S)-Fexofenadine, CAS: 139965-11-0, stock: 6.8g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₂H₃₉NO₄.
5α-Methyl Androstanediol, CAS: /, stock: 3.8g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₃₄O₂.
(Z)-4-[4-[4-(Hydroxydiphenylmethyl)-1-piperidinyl]-1-buten-1-yl]-α,α-dimethyl-benzeneacetic Acid, CAS: /, stock: 6.2g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₂H₃₇NO₃.
(Z)-4-[4-[4-(Hydroxydiphenylmethyl)-1-piperidinyl]-1-buten-1-yl]-α,α-dimethyl-benzeneacetic Acid-d6, CAS: /, stock: 4.8g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₂H₃₁D₆NO₃.
2-Dechloro-2-Hydroxy Terbuthylazine Sulfate, CAS: /, stock: 8g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₁₉N₅O₅S.
5α-Methyl-d3 Androstanediol, CAS: /, stock: 8.3g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₃₁D₃O₂.
1-(4-(4-(tert-Butyl)phenyl)-4-hydroxybutyl)-4-piperidinecarboxylic Acid Ethyl Ester, CAS: 100499-85-2, stock: 8.9g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₃₅NO₃.
1-(4-(4-(tert-Butyl)phenyl)-4-hydroxybutyl)piperidine-4-carboxylic Acid, CAS: /, stock: 5.6g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₃₁NO₃.
2-Dechloro-2-Hydroxy Terbuthylazine Sulfate-d9, CAS: /, stock: 4.1g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₁₀D₉N₅O₅S.
4-Amino-6-[(1,1-dimethylethyl)amino]-1,3,5-triazin-2(1H)-one, CAS: 66753-06-8, stock: 9.7g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₁₃N₅O.
1-Dehydroxy Terfenadine, CAS: 147158-67-6, stock: 9.2g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₂H₄₁NO.
6-[(1,1-Dimethylethyl)amino]-4-(ethylamino)-1,3,5-triazin-2(1H)-one, CAS: 66753-07-9, stock: 8.9g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₁₇N₅O.
Bis(ethylamino)-tert-butylamino-s-triazine, CAS: 35651-07-1, stock: 8.7g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₂₂N₆.
1-Oxo Fexofenadine Methyl Ester, CAS: 154477-55-1, stock: 9.9g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₃H₃₉NO₄.
1-Oxo Fexofenadine-d10 Methyl Ester, CAS: /, stock: 5.3g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₃H₂₉D₁₀NO₄.
Bis(ethylamino)-tert-butylamino-s-triazine-d9, CAS: /, stock: 1.1g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₃D₉N₆.
Bis(tert-butylamino)chloro-s-triazine, CAS: 39605-42-0, stock: 1.2g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₂₀ClN₅.
5β-Androstane-3α,17α-diol, CAS: 5856-10-0, stock: 6.9g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₃₂O₂.
2-(4-(1-Hydroxy-4-(4-(hydroxydiphenylmethyl)piperidin-1-yl)butyl)phenyl)propanoic Acid, CAS: 185066-33-5, stock: 3.9g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₁H₃₇NO₄.
2-(4-(4-(4-(3-Benzoylphenyl)piperidin-1-yl)-1-hydroxybutyl)phenyl)-2-methylpropanoic acid, CAS: /, stock: 8.1g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₂H₃₇NO₄.
Bis(tert-butylamino)chloro-s-triazine-d18, CAS: /, stock: 6.2g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₂D₁₈ClN₅.
Desethyl Terbuthylazine, CAS: 30125-63-4, stock: 6.8g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₁₂ClN₅.
2-(4-(4-(4-(Diphenylmethylene)piperidin-1-yl)butanoyl)phenyl)-2-methylpropanoic Acid Methyl Ester, CAS: 1025909-08-3, stock: 3.2g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₃H₃₇NO₃.
Desethyl Terbuthylazine-d9, CAS: 1219798-52-3, stock: 2.3g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₃D₉ClN₅.
Terbuthylazine, CAS: 5915-41-3, stock: 8.2g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₁₆ClN₅.
3-(Cyclopropylcarbonyl)-α,α-dimethylbenzeneacetic Acid, CAS: 162096-56-2, stock: 7.5g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₆O₃.
4-(Cyclopropylcarbonyl)-α,α-dimethylbenzeneacetic Acid, CAS: 162096-54-0, stock: 4.1g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₆O₃.
Terbuthylazine-(ethyl-d5), CAS: 222986-60-9, stock: 3.4g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₁₁D₅ClN₅.
Terbuthylazine-13C4, CAS: /, stock: 7.6g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅¹³C₄H₁₆ClN₅.
4-Chlorophenethyl Bromide, CAS: 6529-53-9, stock: 4g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₈BrCl.
4-[4-(Methanesulfonyloxy)-1-butynyl]-α,α-di(methyl)benzeneacetic Acid, Methyl Ester, CAS: 154825-94-2, stock: 9.6g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₂₀O₅S.
Terbuthylazine-d9, CAS: 1346602-52-5, stock: 7.2g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₇D₉ClN₅.
4-[4-[4-(Diphenylmethylene)-1-piperidinyl]-1-hydroxybutyl]-α,α-dimethyl-benzeneacetic Acid, CAS: 1187954-57-9, stock: 5.1g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₂H₃₇NO₃.
4-[4-[4-(Hydroxydiphenylmethyl)-1-piperidinyl]-1-butyn-1-yl]-α,α-dimethyl-benzeneacetic Acid, CAS: 832088-68-3, stock: 3.9g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₂H₃₅NO₃.
4-[4-[4-(Hydroxydiphenylmethyl)-1-piperidinyl]-1-butyn-1-yl]-α,α-dimethyl-benzeneacetic Acid-d6, CAS: /, stock: 9.8g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₂H₂₉D₆NO₃.
Dehydroxy Terfenadine, CAS: 1632048-95-3, stock: 4g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₂H₄₁NO.
Dehydroxydehydro Terfenadine, CAS: 104953-06-2, stock: 5.4g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₂H₃₉NO.
6,7-Dehydro Norethindrone Acetate, CAS: 106765-04-2, stock: 6.9g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₂₆O₃.
Fexofenadine, CAS: 83799-24-0, stock: 4g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₂H₃₉NO₄.
Fexofenadine 1-Methyl Ether Methyl Ester, CAS: /, stock: 8.8g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₄H₄₃NO₄.
Fexofenadine Hydrochloride, CAS: 153439-40-8, stock: 7.7g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₂H₄₀ClNO₄.
Fexofenadine N-Oxide, CAS: 1422515-52-3, stock: 9.2g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₂H₃₉NO₅.
Fexofenadine-d10 Hydrochloride, CAS: 1215821-44-5, stock: 6.3g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₂H₃₀D₁₀ClNO₄.
Fexofenadine-d10 Methyl Ester, CAS: /, stock: 9.2g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₃H₃₁D₁₀NO₄.
Fexofenadine-d6, CAS: 548783-71-7, stock: 4.8g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₂H₃₃D₆NO₄.
6-Dehydrotestosterone Acetate, CAS: 2352-19-4, stock: 9g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₂₈O₃.
Fexofenadinone, CAS: 76811-98-8, stock: 9.3g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₂H₃₇NO₄.
Fexofenadinone Hydrochloride, CAS: /, stock: 6.4g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₂H₃₇NO₄ • (HCl)x.
Fexofenadinone-d10, CAS: /, stock: 6.8g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₂H₂₇D₁₀NO₄.
meta-Fexofenadine Hydrochloride, CAS: /, stock: 1.1g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₂H₄₀ClNO₄.
6-Methylenetestosterone, CAS: 3347-73-7, stock: 9.7g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₈O₂.
6α-Chloro Testosterone, CAS: 847674-32-2, stock: 5.3g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₂₇ClO₂.
Terfenadone, CAS: 43076-30-8, stock: 9.6g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₂H₃₉NO₂.
6β-Hydroperoxy Testosterone, CAS: 99371-91-2, stock: 3.8g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₂₈O₄.
7H-Dodecafluoroheptanoic Acid, CAS: 1546-95-8, stock: 9.6g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₂F₁₂O₂.
9,10-Dehydro-19-nortestosterone, CAS: 6218-29-7, stock: 4.4g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₂₄O₂.
Abietic Acid, 75%, CAS: 514-10-3, stock: 3.7g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₃₀O₂.
Abietic Acid, >95%, CAS: 514-10-3, stock: 6.6g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₃₀O₂.
Androst-4-ene-3β,17α-diol-d3, CAS: /, stock: 3g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₂₇D₃O₂.
Bovine T(Testosterone) ELISA Kit (96T), CAS: /, stock: 4.9g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
Clostebol Propionate, CAS: 2162-44-9, stock: 2.1g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₃₁ClO₃.
CP-100263 Dihydrochloride Hydrate, CAS: 872726-33-5, stock: 3g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₂₆Cl₂N₂O • xH ₂O.
Cypionic Acid, CAS: 140-77-2, stock: 10g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₁₄O₂.
D-(-)-Norgestrel, CAS: 797-63-7, stock: 3.6g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₂₈O₂.
D-(-)-Norgestrel 17-Acetate, CAS: 13732-69-9, stock: 8.2g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₃₀O₃.
D-(-)-Norgestrel 17-Acetate-d3, CAS: /, stock: 8.7g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₂₇D₃O₃.
D-(-)-Norgestrel β-D-Glucuronide, CAS: /, stock: 5.6g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₇H₃₆O₈.
D-(-)-Norgestrel β-D-Glucuronide Methyl Ester, CAS: /, stock: 4.9g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₈H₃₈O₈.
D-(-)-Norgestrel Tri-O-acetyl β-D-Glucuronide Methyl Ester, CAS: /, stock: 5.1g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₄H₄₄O₁₁.
D-(-)-Norgestrel-d6 17-Acetate, CAS: /, stock: 1.2g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₂₄D₆O₃.
D-(-)-Norgestrel-d7, CAS: /, stock: 5.8g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₂₁D₇O₂.
Dienogest, CAS: 65928-58-7, stock: 4.4g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₅NO₂.
Dienogest-d8 (major), CAS: /, stock: 1.1g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₁₇D₈NO₂.
Dihydroabietyl Alcohol, CAS: 18175-73-0, stock: 6.4g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₃₄O.
Dihydrotestosterone Derivative with Linker, CAS: /, stock: 8.4g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄₃H₆₀ClN₅O₇.
Dimethisterone, CAS: 79-64-1, stock: 3.6g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₃₂O₂.
Dimethisterone-d3, CAS: /, stock: 4.6g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₂₉D₃O₂.
Dimethoxy 17-epi-Dienogest, CAS: /, stock: 5.2g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₃₁NO₃.
Dimethoxy Dienogest, CAS: 102193-41-9, stock: 6.3g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₃₁NO₃.
Drostanolone Enanthate, CAS: 13425-31-5, stock: 4.7g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₇H₄₄O₃.
epi Dienogest, CAS: /, stock: 9.7g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₅NO₂.
Epitestosterone Sulfate Triethylamine Salt, CAS: 182296-42-0, stock: 4.8g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₄₃NO₅S.
Epitestosterone Sulfate-d3 Triethylamine Salt, CAS: 182296-44-2, stock: 4.3g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₄₀D₃NO₅S.
Estra-5(10),9(11)-diene-3,17-dione Cyclic 3,17-Bis(1,2-ethanediyl acetal), CAS: 57905-07-4, stock: 3.5g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₃₀O₄.
Ethisterone, CAS: 434-03-7, stock: 6.4g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₂₈O₂.
Ethisterone-13C2, CAS: /, stock: 4.3g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉¹³C₂H₂₈O₂.
Finasteride, CAS: 98319-26-7, stock: 6.1g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₃₆N₂O₂.
Finasteride 2-(2-Methylpropanol)amide, CAS: 116285-36-0, stock: 7.8g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₃₆N₂O₃.
Finasteride-d9, CAS: 1131342-85-2, stock: 5.7g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₂₇D₉N₂O₂.
Geranyl Linalool, CAS: 1113-21-9, stock: 7.6g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₃₄O.
Geranyl Linalool O-β-D-Glucoside, CAS: /, stock: 6g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₆H₄₄O₆.
Gestonorone, CAS: 2137-18-0, stock: 7.4g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₈O₃.
Gestonorone Capronate, CAS: 1253-28-7, stock: 9.1g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₆H₃₈O₄.
Heptanoic Acid, CAS: 111-14-8, stock: 9.7g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₁₄O₂.
Human HSD17B3 (Testosterone 17-beta-dehydrogenase 3) ELISA Kit (96T), CAS: /, stock: 1.3g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
Human Testosterone ELISA Kit (96T), CAS: /, stock: 9.2g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
Iron Triabietate, CAS: 1280215-93-1, stock: 1.8g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₃₀O₂ • 1/3 Fe.
Lynestrenol, CAS: 52-76-6, stock: 3.4g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₈O.
Mouse Hsd17b3 (Testosterone 17-beta-dehydrogenase 3) ELISA Kit (96T), CAS: /, stock: 7.2g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
Mouse Testosterone ELISA Kit (96T), CAS: /, stock: 9.1g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
N-Des(1,1-dimethylethyl) N-Cyclohexyl Finasteride, CAS: 133216-45-2, stock: 1.7g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₃₈N₂O₂.
N-Des(1,1-dimethylethyl) N-Cyclohexyl Finasteride-d11, CAS: /, stock: 9.1g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₂₇D₁₁N₂O₂.
Norethandrolone-d4, CAS: /, stock: 5.2g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₆D₄O₂.
Norethindrone, CAS: 68-22-4, stock: 5.7g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₆O₂.
Norethindrone Acetate, CAS: 51-98-9, stock: 3g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₂₈O₃.
Norethindrone-2,2,4,6,6,10-d6, CAS: /, stock: 3.4g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₀D₆O₂.
Norethindrone-d7 (Major), CAS: /, stock: 2.5g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₁₉D₇O₂.
Norethisterone Enanthate, CAS: 3836-23-5, stock: 8.9g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₇H₃₈O₃.
Norvinisterone, CAS: 6795-60-4, stock: 5.6g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₈O₂.
Norvinisterone-d2, CAS: /, stock: 1.9g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₆D₂O₂.
NSC 54709, CAS: 26013-82-1, stock: 2.7g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₃₅NO₂.
Phosphoric Acid Diethyl Ester, CAS: 598-02-7, stock: 3.8g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄H₁₁O₄P.
Prenortestosterone, CAS: 1089-78-7, stock: 2.7g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₂₆O₂.
Rat Hsd17b3 (Testosterone 17-beta-dehydrogenase 3) ELISA Kit (96T), CAS: /, stock: 8.8g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
Rat T(Testosterone) ELISA Kit (96T), CAS: /, stock: 3.8g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
Testosterone 17β-Carboxylic Acid, CAS: 302-97-6, stock: 1.2g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₈O₃.
Testosterone 2-Undecanoylundecanoate, CAS: /, stock: 1.2g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄₁H₆₈O₄.
Testosterone p-Toluenesulfonate, CAS: 1255-57-8, stock: 1.7g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₆H₃₄O₄S.
Testosterone Tridecanoate-d3, CAS: /, stock: 9.4g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₂H₄₉D₃O₃.
Testosterone-16,16,17-d3 17-Phenylpropionate, CAS: 876054-55-6, stock: 1.6g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₈H₃₃D₃O₃.
Testosterone-d3 17β-Hemisuccinate, CAS: 521-15-3, stock: 3.6g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₂₉D₃O₅.
Topterone, CAS: 60607-35-4, stock: 9.9g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₃₄O₂.
1-(3,5-Dihydroxyphenyl)-2-[(1,1-dimethylethyl)(phenylmethyl)amino]ethanone Hydrobromide, CAS: 1797117-23-7, stock: 6.5g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₂₄BrNO₃.
1-(3,5-Dihydroxyphenyl)-2-[(1,1-dimethylethyl)(phenylmethyl)amino]ethanone-d9 Hydrobromide, CAS: /, stock: 9.6g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₁₅D₉BrNO₃.
Tridecanoic Acid, CAS: 638-53-9, stock: 7.2g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₂₆O₂.
Tridecanoic Acid Chloride, CAS: 17746-06-4, stock: 7.3g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₂₅ClO.
1-(3,5-Dihydroxyphenyl)-2-[(1,1-dimethylethyl)amino]-ethanone Hydrochloride, CAS: 1246815-70-2, stock: 4.1g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₈ClNO₃.
Tridecanoic Acid Ethyl Ester, CAS: 28267-29-0, stock: 1.2g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₃₀O₂.
Tridecanoic Acid Ethyl-d5 Ester, CAS: /, stock: 4.9g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₂₅D₅O₂.
1-Deshydroxy 1-Oxo Terbutaline Sulfate, CAS: /, stock: 5g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₃₄N₂O₆•H₂SO₄.
2-(1,1-Dimethylethyl)-1,2,3,4-tetrahydro-4,6,8-Isoquinolinetriol Hemisulfate Hydrate, CAS: /, stock: 9g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: 2(C₁₃H₁₉NO₃) • H₂SO₄ • x(H ₂O).
Tridecanoic-d25 Acid, CAS: 202529-03-1, stock: 2.1g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃HD₂₅O₂.
Universal DHT(Dihydrotestosterone) ELISA Kit (96T), CAS: /, stock: 4.8g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
Universal T(Testosterone) ELISA Kit (96T), CAS: /, stock: 8.1g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
Bambuterol Hydrochloride, CAS: 81732-46-9, stock: 3.4g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₃₀ClN₃O₅.
Bambuterol-d9 Hydrochloride, CAS: 1794810-59-5, stock: 8.1g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₂₁D₉ClN₃O₅.
Hydroxymethyl Clenbuterol, CAS: 38339-18-3, stock: 2.9g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₈Cl₂N₂O₂.
Hydroxymethyl Clenbuterol-d6, CAS: 1346601-00-0, stock: 2.4g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₂D₆Cl₂N₂O₂.
Terbutaline, CAS: 23031-25-6, stock: 5.8g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₉NO₃.
Terbutaline 3,5-Dibenzyl Ether, CAS: 28924-25-6, stock: 6.5g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₆H₃₁NO₃.
Terbutaline Hemisulfate Salt, CAS: 23031-32-5, stock: 4.3g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₉NO₃ 0.5 H ₂SO₄.
Terbutaline Sulfate, CAS: 71324-19-1, stock: 7.2g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₉NO₆S.
Terbutaline-d9, CAS: 1189658-09-0, stock: 4.4g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₀D₉NO₃.
Terbutaline-d9 3,5-Dibenzyl Ether, CAS: 1189428-81-6, stock: 1.6g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₆H₂₂D₉NO₃.
Tulobuterol, CAS: 41570-61-0, stock: 8.4g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₈ClNO.
Tulobuterol Hydrochloride, CAS: 56776-01-3, stock: 6.3g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₉Cl₂NO.
Tulobuterol-d9 Hydrochloride, CAS: 1325559-14-5, stock: 1.7g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₀D₉Cl₂NO.
[3,5-Bis(phenylmethoxy)phenyl]oxirane, CAS: 50841-47-9, stock: 7.4g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₂₀O₃.
1,4-Bis[(tetrahydro-2-furanyl)carbonyl]-piperazine, CAS: 547730-06-3, stock: 9.1g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₂₂N₂O₄.
1,4-Di-2-furoyl-piperazine, CAS: 31350-27-3, stock: 4.7g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₄N₂O₄.
1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-(5-hydroxy-1-oxopentyl)-piperazine, CAS: 109678-71-9, stock: 6.8g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₂₇N₅O₄.
1-(Tetrahydro-2-furoyl)-piperazine, CAS: 63074-07-7, stock: 3.1g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₁₆N₂O₂.
1-[4-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-1-piperazinyl]-2-hydroxy-1-pentanone, CAS: 152551-75-2, stock: 1.4g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₂₇N₅O₄.
1-[4-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-1-piperazinyl]-2-hydroxy-1-pentanone-d8, CAS: /, stock: 3.6g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₁₉D₈N₅O₄.
1-[4-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-1-piperazinyl]-5-hydroxy-1-pentanone Hydrochloride, CAS: /, stock: 3.8g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₂₈ClN₅O₄.
1-[4-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-1-piperazinyl]-5-hydroxy-1-pentanone-d8, CAS: /, stock: 7.3g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₁₉D₈N₅O₄.
2,2’-(1,4-Piperazinediyl)bis[6,7-dimethoxy-4-quinazolinamine](Terazosin Impurity), CAS: 102839-00-9, stock: 8.2g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₂₈N₈O₄.
2,4-Dichloro-6,7-dimethoxyquinazoline, CAS: 27631-29-4, stock: 7.9g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₈Cl₂N₂O₂.
2-Furanyl-1-piperazinylmethanone, CAS: 40172-95-0, stock: 1.9g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₁₂N₂O₂.
2-Piperazinyl-4-amino-6,7-dimethoxyquinazoline, CAS: 60547-97-9, stock: 1.4g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₉N₅O₂.
4-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-1-piperazinecarboxaldehyde Hydrochloride, CAS: 84050-21-5, stock: 1.2g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₂₀ClN₅O₃.
5-Hydroxy-1-(1-piperazinyl)-1-pentanone, CAS: /, stock: 9.9g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₁₈N₂O₂.
6,7-Dimethoxy-2,4-quinazolinediamine, CAS: 60547-96-8, stock: 5.5g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₂N₄O₂.
6,7-Dimethoxy-2-(4-(tetrahydrofuran-2-carbonyl)piperazin-1-yl)quinazolin-4(1H)-one, CAS: 1177261-73-2, stock: 7.9g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₂₄N₄O₅.
N-Des((tetrahydrofuran-2-yl)methanone)) Terazosin Dihydrochloride, CAS: 60548-08-5, stock: 1.5g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₉N₅O₂•2[HCl].
Prazosin Hydrochloride, CAS: 19237-84-4, stock: 5.1g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₂₂ClN₅O₄.
Prazosin Hydrochloride (1.0 mg/mL in Methanol), CAS: 19237-84-4, stock: 9.7g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₂₂ClN₅O₄.
Terazosin (piperazine D8), CAS: 1006718-20-2, stock: 3.9g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₁₇D₈N₅O₄.
Terazosin Dimer Impurity Dihydrochloride, CAS: 1486464-41-8, stock: 2.8g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₂₈N₈O₄•2[HCl].
Terazosin Hydrochloride, CAS: 63074-08-8, stock: 9.5g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₂₆ClN₅O₄.
Terazosin Hydrochloride Dihydrate, CAS: 70024-40-7, stock: 8.7g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₃₀ClN₅O₆.
[4-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-1-piperazinyl][(5S)-tetrahydro-5-methyl-2-furanyl]methanone, CAS: 1177261-85-6, stock: 5.6g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₇N₅O₄.
[4-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-1-piperazinyl][(5S)-tetrahydro-5-methyl-2-furanyl]methanone-d8, CAS: /, stock: 5.5g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₁₉D₈N₅O₄.
[4-(4-Amino-6-hydroxy-7-methoxy-2-quinazolinyl)-1-piperazinyl](tetrahydro-2-furanyl)methanone, CAS: 105356-89-6, stock: 2.6g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₂₃N₅O₄.
[4-(4-Amino-6-hydroxy-7-methoxy-2-quinazolinyl)-1-piperazinyl](tetrahydro-2-furanyl)methanone-d8, CAS: /, stock: 3.6g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₁₅D₈N₅O₄.
[4-(4-Amino-7-hydroxy-6-methoxy-2-quinazolinyl)-1-piperazinyl](tetrahydro-2-furanyl)methanone, CAS: 105356-90-9, stock: 2g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₂₃N₅O₄.
[4-(4-Amino-7-hydroxy-6-methoxy-2-quinazolinyl)-1-piperazinyl](tetrahydro-2-furanyl)methanone-d8, CAS: /, stock: 6.8g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₁₅D₈N₅O₄.
(5E,9E,13E)-Teprenone, CAS: 3796-63-2, stock: 5.6g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₃₈O.
(5Z,9Z,13E)-Geranylgeranylacetone, CAS: 3879-24-1, stock: 2.1g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₃₈O.
(5Z,9Z,13Z)-Geranylgeranylacetone, CAS: 3796-67-6, stock: 5.1g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₃₈O.
6,10,14,18-Tetramethyl-5,9,13,17-nonadecatertaen-2-ol, CAS: 109826-68-8, stock: 7.5g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₄₀O.
Teprenone, CAS: 6809-52-5, stock: 4.6g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₃₈O.
1-Bromobutane, CAS: 109-65-9, stock: 7.3g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄H₉Br.
1-Bromobutane-d3, CAS: 55724-42-0, stock: 2.1g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄H₆D₃Br.
1-Bromobutane-d9, CAS: 98195-36-9, stock: 10g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄D₉Br.
4,4’-Methylenebis[N,N-dimethylcyclohexanamine], CAS: 13474-64-1, stock: 4g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₃₄N₂.
Mebezonium Iodide, CAS: 7681-78-9, stock: 6.4g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₄₀I₂N₂.
2,2,6,6-Tetramethylpiperidine-1,4-diol, CAS: 03/10/3637, stock: 1.1g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₁₉NO₂.
4-Hydroxy-2,2,6,6-tetramethyl-1-piperidinyloxy, CAS: 2226-96-2, stock: 2g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₁₈NO₂.
4-Hydroxy-TEMPO Benzoate, Free Radical, CAS: 3225-26-1, stock: 2.3g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₂₂NO₃.
(2R,6R)-6-Amino-5-oxo-2-(2-thienyl)perhydro-1,4-thiazepine, CAS: 110221-27-7, stock: 4.2g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₁₂N₂OS₂.
(2S,6R)-6-Amino-5-oxo-2-(2-thienyl)perhydro-1,4-thiazepine, CAS: 110221-26-6, stock: 5.2g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₁₂N₂OS₂.
Temocapril Hydrochloride, CAS: 110221-44-8, stock: 4.1g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₂₉ClN₂O₅S₂.
Temocapril-d5, CAS: 1356840-03-3, stock: 9.5g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₂₃D₅N₂O₅S₂.
Temocaprilat, CAS: 110221-53-9, stock: 5.1g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₂₄N₂O₅S₂.
3-Amino-2-(formylamino)-3-iminopropanamide, CAS: 100191-43-3, stock: 6.5g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄H₈N₄O₂.
3-Amino-3-imino-2-(2-phenyldiazenyl)propanamide Hydrochloride, CAS: 6285-64-9, stock: 2.8g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₁₂ClN₅O.
3-Amino-3-imino-2-(2-phenyldiazenyl)propanamide-d5 Hydrochloride, CAS: /, stock: 6.5g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉D₅H₇ClN₅O.
3-Methyl-d3-1,1-diphenylurea, CAS: 208107-10-2, stock: 4.2g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₁D₃N₂O.
5-Amino-N1-methyl-1H-imidazole-1,4-dicarboxamide, CAS: 188612-53-5, stock: 9.5g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₉N₅O₂.
5-Aminoimidazole-4-carboxamide, CAS: 360-97-4, stock: 6.7g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄H₆N₄O.
5-Aminoimidazole-4-carboxamide Hydrochloride, CAS: 72-40-2, stock: 7g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄H₇ClN₄O.
5-Aminoimidazole-4-carboxamide Lactose Adduct, CAS: /, stock: 6.5g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₂₆N₄O₁₁.
5-Aminoimidazole-4-carboxamide Lactose Adduct-13C2,15N, CAS: /, stock: 1.6g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄¹³C₂H₂₆N₃¹⁵NO₁₁.
5-Aminoimidazole-4-carboxamide-13C2,15N Hydrochloride Salt, CAS: 1246816-45-4, stock: 8g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂¹³C₂H₇ClN₃¹⁵NO.
5-Aminoimidazole-4-carboxamide-15N2 Hydrochloride (>90%), CAS: /, stock: 3.7g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄H₇ClN₂¹⁵N₂O.
5-Diazoimidazole-4-carboxamide, CAS: 7008-85-7, stock: 8.3g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄H₃N₅O.
5-Nitro-1H-imidazole-4-carboxamide-15N2, CAS: /, stock: 6.7g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄H₄N₂¹⁵N₂O₃.
8-Descarboxamido-8-cyano Temozolomide, CAS: 114601-31-9, stock: 3.6g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₄N₆O.
ABT 888, CAS: 912444-00-9, stock: 6g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₆N₄O.
AM-TS23, CAS: 1489285-17-7, stock: 2.5g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₂N₂O₃S₃.
Cyanotemozolomide, CAS: 287964-59-4, stock: 1.5g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₄N₆O₄.
Dimethyl Aminoterephthalate, CAS: 5372-81-6, stock: 1.7g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₁NO₄.
Lomeguatrib, CAS: 192441-08-0, stock: 8g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₈BrN₅OS.
MTIC, CAS: 3413-72-7, stock: 5.5g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅H₈N₆O.
MTIC-d3, CAS: 1185242-69-6, stock: 2g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅H₅D₃N₆O.
N,N-Diphenylcarbamyl Chloride, CAS: 83-01-2, stock: 6g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₀ClNO.
N-Succinimidyl N-Methylcarbamate, CAS: 18342-66-0, stock: 2.6g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₈N₂O₄.
N’-Methyl-N,N-diphenylurea, CAS: 13114-72-2, stock: 8.7g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₄N₂O.
Regadenoson, CAS: 313348-27-5, stock: 6g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₈N₈O₅.
Temozolomide, CAS: 85622-93-1, stock: 2.7g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₆N₆O₂.
Temozolomide Acid, CAS: 113942-30-6, stock: 6g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₅N₅O₃.
Temozolomide-d3, CAS: 208107-14-6, stock: 7g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₃D₃N₆O₂.
(2E,4E)-4-(4,4-Dimethyl-2-pentyn-1-ylidene)-2-pentenedioic Acid 1,5-Dimethyl Ester, CAS: 1176744-66-3, stock: 7.3g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₈O₄.
(2E,4E)-4-(4,4-Dimethylpent-2-yn-1-yl)pent-2-ene-1,5-diol, CAS: 1176744-51-6, stock: 8.2g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₈O₂.
(2E,4E/Z)-1-Chloro-4-(chloromethyl)-8,8-dimethyl-2,4-nonadien-6-yne, CAS: /, stock: 8.9g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₆Cl₂.
1-Bromo-6,6-dimethyl-2-hepten-4-yne(Mixture of cis-trans isomers), CAS: 126764-15-6, stock: 4.3g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₁₃Br.
1-Chloro-6,6-dimethyl-2-heptene-4-yne (90:10 E:Z), CAS: 126764-17-8, stock: 6.9g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₁₃Cl.
2,2-Dichloro-3,3-dimethylbutane, CAS: 594-84-3, stock: 7.8g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₁₂Cl₂.
2,2-Dimethyl-3-butynoic Acid Methyl Ester, CAS: 95924-34-8, stock: 6.5g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₁₀O₂.
4,4-Dimethyl-2-pentynal, CAS: 2579-21-7, stock: 4.7g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₁₀O.
Carboxyterbinafine Methyl Ester, CAS: 1076199-76-2, stock: 4.8g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₂₅NO₂.
cis-Terbinafine, CAS: 78628-81-6, stock: 5g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₂₅N.
cis-Terbinafine Hydrochloride, CAS: 176168-78-8, stock: 5.6g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₂₆ClN.
Hydroxy Terbinafine Benzoate, CAS: 1076198-30-5, stock: 4.7g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₈H₂₉NO₂.
Methyl-1-naphthalenemethylamine, CAS: 14489-75-9, stock: 3g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₃N.
Terbinafine, CAS: 91161-71-6, stock: 5.5g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₂₅N.
Terbinafine N-oxide, CAS: /, stock: 4.1g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₂₅NO.
(4-Borono-3-fluorophenyl)-carbamic Acid C-(Phenylmethyl) Ester, CAS: 874290-59-2, stock: 7.7g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₂BFO₄.
(4-Bromo-3-fluorophenyl)carbamic Acid Benzyl Ester, CAS: 510729-01-8, stock: 6.7g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₁BrFNO₂.
(5S)-3-(3-Fluorophenyl)-5-(hydroxymethyl)-2-pxazolidinone, CAS: 919081-42-8, stock: 7.2g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₀FNO₃.
(5S)-3-(4-Bromo-3-fluorophenyl)-5-hydroxymethyloxazolidin-2-one, CAS: 1369530-77-7, stock: 9.1g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₉BrFNO₃.
5-Bromo-2-(1-methyl-1H-tetrazol-5-yl)pyridine, CAS: 380380-63-2, stock: 3.3g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₆BrN₅.
5-Bromo-2-(1-methyl-1H-tetrazol-5-yl)pyridine-d3, CAS: /, stock: 7.9g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₅D₃BrN₅.
5-Bromo-2-(2-methyl-2H-tetrazol-5-yl)pyridine, CAS: 380380-64-3, stock: 1.8g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₆BrN₅.
5-Bromo-2-(2-methyl-2H-tetrazol-5-yl)pyridine-d3, CAS: /, stock: 7.7g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₃D₃BrN₅.
bis-Tedizolidyl Phosphate Diester, CAS: 1256966-02-5, stock: 5.1g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₄H₂₉F₂N₁₂O₈P.
Desfluoro Tedizolid, CAS: /, stock: 3g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₆N₆O₃.
Desfluoro Tedizolid Phosphate Ester, CAS: /, stock: 1.4g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₇N₆O₆P.
Deshydroxy-chloro Tedizolid, CAS: 1239662-46-4, stock: 3.9g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₄ClFN₆O₂.
ent-Tedizolid, CAS: 1431699-67-0, stock: 7.5g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₅FN₆O₃.
ent-Tedizolid Phosphate, CAS: 1835340-19-6, stock: 5.4g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₆FN₆O₆P.
N,O-Descarbonyl Tedizolid, CAS: /, stock: 8.1g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₁₇FN₆O₂.
N,O-Descarbonyl Tedizolid Phosphate Ester, CAS: /, stock: 4.9g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₁₈FN₆O₅P.
N-[3-Fluoro-4-[6-(2-methyl-2H-tetrazol-5-yl)-3-pyridinyl]phenyl]carbamic Acid Phenylmethyl Ester, CAS: 1220910-89-3, stock: 2.8g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₁₇FN₆O₂.
N-[3-Fluoro-4-[6-(2-methyl-2H-tetrazol-5-yl)-3-pyridinyl]phenyl]carbamic Acid Phenylmethyl Ester-d3, CAS: /, stock: 4.1g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₁₄D₃FN₆O₂.
Tedizolid, CAS: 856866-72-3, stock: 1g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₅FN₆O₃.
Tedizolid Phosphate, CAS: 856867-55-5, stock: 1.6g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₆FN₆O₆P.
Tedizolid Phosphate Dimer, CAS: 1220910-90-6, stock: 2.3g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₄H₃₀F₂N₁₂O₁₁P₂.
Tedizolid Phosphate-d3, CAS: /, stock: 6.9g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₃D₃FN₆O₆P.
Tedizolid Pyrophosphate Ester, CAS: 1239662-48-6, stock: 8.8g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₇FN₆O₉P₂.
Tedizolid-(d1,d2,d3) Deuterium Mixture, CAS: /, stock: 7.8g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₂D₃FN₆O₃.
[2-(2-Methyl-2H-tetrazol-5-yl)pyridin-5-yl] Dimer, CAS: /, stock: 1.5g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₂N₁₀.
(R)-Telaprevir, CAS: 923270-50-2, stock: 2.9g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₆H₅₃N₇O₆.
(R)-Telaprevir-d4, CAS: /, stock: 4.7g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₆H₄₉D₄N₇O₆.
cis-1,2-Cyclopentanedicarboxylic Anhydride, CAS: 35878-28-5, stock: 9.9g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₈O₃.
Des[N-[(1S)-1-[2-(cyclopropylamino)-2-oxoacetyl]butyl]carboxamido] 1-Carboxy Telaprevir, CAS: 402958-98-9, stock: 2.4g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₇H₃₉N₅O₅.
Des[N-[(1S)-1-[2-(cyclopropylamino)-2-oxoacetyl]butyl]carboxamido] 1-tert-Butyloxycarbonyl Telaprevir, CAS: 926276-19-9, stock: 2.4g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₁H₄₇N₅O₅.
Hydroxy Telaprevir-d4 (Mixture of Diastereomers), CAS: /, stock: 1.1g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₆H₅₁D₄N₇O₆.
Telaprevir, CAS: 402957-28-2, stock: 9.7g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₆H₅₃N₇O₆.
Telaprevir-d4, CAS: 402957-28-2, stock: 3.1g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₆H₄₉D₄N₇O₆.
3’5’-Di-toluoyl-L-thymidine-d3 (α/β mixture), CAS: /, stock: 8.2g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₆H₂₃D₃N₂O₇.
Telbivudine, CAS: 3424-98-4, stock: 4.6g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₄N₂O₅.
Telbivudine-d3, CAS: /, stock: 7.8g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₁D₃N₂O₅.
2-Methylthieno[2,3-d]isothiazol-3(2H)-one 1,1-Dioxide, CAS: 94040-09-2, stock: 3g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₅NO₃S₂.
3-[(Methylamino)sulfonyl]-2-thiophenecarboxylic Acid, CAS: 64527-92-0, stock: 7.3g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₇NO₄S₂.
4-Methoxy Lornoxicam, CAS: /, stock: 9.6g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₂ClN₃O₄S₂.
Lornoxicam, CAS: 70374-39-9, stock: 1.9g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₀ClN₃O₄S₂.
Lornoxicam-d3, CAS: /, stock: 3.9g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₇D₃ClN₃O₄S₂.
Lornoxicam-d4, CAS: 1216527-48-8, stock: 7.9g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₆D₄ClN₃O₄S₂.
Methyl 4-Hydroxy-2-methyl-2H-Thieno[2,3-e]-1,2-thiazine-3-carboxylic Acid 1,1-Dioxide Ester, CAS: 59804-25-0, stock: 3g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₉NO₅S₂.
Methyl 6-chloro-4-hydroxy-2H-thieno[2,3-e][1,2]thiazine-3-carboxylate 1,1-Dioxide, CAS: 906522-88-1, stock: 4.1g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₆ClNO₅S₂.
N-(2-Pyridyl)oxamic Acid, CAS: 13120-39-3, stock: 4.7g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₆N₂O₃.
N-Methylthiophene-2-carboxamide, CAS: 39880-77-8, stock: 5.8g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₇NOS.
Tenoxicam, CAS: 59804-37-4, stock: 7g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₁N₃O₄S₂.
Tenoxicam-d4, CAS: 1329834-60-7, stock: 9.1g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₇D₄N₃O₄S₂.
(1E)-1-(4-Chlorophenyl)-4,4-dimethyl-1-penten-3-one-D9, CAS: /, stock: 8.8g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₆D₉ClO.
1-(4-Chloro-3-methoxyphenyl)-4,4-dimethylpentan-3-one, CAS: 1539797-51-7, stock: 7.5g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₉ClO₂.
1-(4-Chlorophenyl)-4,4-dimethyl-3-pentanone-D9, CAS: /, stock: 5.8g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₈D₉ClO.
1-Bromo-4-(4-chlorophenyl)butan-2-one, CAS: 143327-55-3, stock: 3.1g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₀BrClO.
2-(tert-Butyl)-2-(4-chloro-3-methoxyphenethyl)oxirane, CAS: /, stock: 7.7g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₂₁ClO₂.
3-((1H-1,2,4-Triazol-1-yl)methyl)-1-(4-chloro-3-methoxyphenyl)-4,4-dimethylpentan-3-ol, CAS: /, stock: 4.5g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₂₄ClN₃O₂.
3-(4-Chloro-3-methoxyphenethyl)-4,4-dimethylpent-1-en-3-ol, CAS: /, stock: 8.9g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₂₃ClO₂.
4-(4-Chlorophenyl)-1-(1H-1,2,4-triazol-1-yl)butan-2-one, CAS: /, stock: 9.8g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₂ClN₃O.
4-(4-Chlorophenyl)-1-(4H-1,2,4-triazol-4-yl)butan-2-one, CAS: /, stock: 1.4g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₂ClN₃O.
4-(Bromomethyl)-1-chloro-2-methoxybenzene, CAS: 103347-14-4, stock: 1.7g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₈BrClO.
5-(3-((1H-1,2,4-Triazol-1-yl)methyl)-3-hydroxy-4,4-dimethylpentyl)-2-chlorophenol, CAS: /, stock: 2.2g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₂₂ClN₃O₂.
5-(4-Chlorophenyl)-2,2-dimethyl-3-(1H-1,2,4-triazol-1-ylmethyl)-1,3-pentanediol, CAS: 212267-64-6, stock: 1.7g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₂₂ClN₃O₂.
Methyl 3-((1H-1,2,4-Triazol-1-yl)methyl)-5-(4-chlorophenyl)-3-hydroxy-2,2-dimethylpentanoate, CAS: /, stock: 1.2g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₂₂ClN₃O₃.
Pinacol-d12, CAS: 75160-24-6, stock: 7.8g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₂D₁₂O₂.
Tebuconazole, CAS: 107534-96-3, stock: 9.6g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₂₂ClN₃O.
Tebuconazole-d9, CAS: 1246818-83-6, stock: 1.8g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₁₃D₉ClN₃O.
Tebuconazole-d9 (0.5mg/mL in Acetonitrile), CAS: 1246818-83-6, stock: 7.3g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₁₃D₉ClN₃O.
Dalbavancin, CAS: 171500-79-1, stock: 7.3g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈₈H₁₀₀Cl₂N₁₀O₂₈.
L-α-Acetoxypropionyl Chloride, CAS: 36394-75-9, stock: 3.1g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅H₇ClO₃.
N1-(3-Dimethylaminopropyl)-N4-(3-aminopropyl)piperazine, CAS: 131705-39-0, stock: 9g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₂₈N₄.
Teicoplanin A2 (Mixture of 2-1, 2-2, 2-3, 2-4 and 2-5), CAS: 61036-64-4, stock: 8.7g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: N/A.
Teicoplanin A2 (Mixture of 2-1, 2-3, 2-4 and 2-5) Deuterated, CAS: /, stock: 3.1g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: NA.
4,7-seco-Tebipenemoic Acid Methyl Ester Pivoxil, CAS: 1391053-29-4, stock: 9.6g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₃₅N₃O₇S₂.
4,7-seco-Tebipenemoic Acid Pivoxil, CAS: 1380688-27-6, stock: 6.6g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₃₃N₃O₇S₂.
Δ2,3(Δ3,4)-4,7-seco-Tebipenemoic Acid, CAS: /, stock: 7.6g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₂₂N₃O₅S₂.
(+)-Taxifolin, CAS: 17654-26-1, stock: 7.3g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₂O₇.
(+)-trans Taxifolin, CAS: 480-18-2, stock: 5.7g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₂O₇.
(+/-)-trans Taxifolin, CAS: 24198-97-8, stock: 9.9g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₂O₇.
(+/-)-trans Taxifolin-d3, CAS: /, stock: 5.8g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₉D₃O₇.
(2R,3R)-2-[3,4-Bis(phenylmethoxy)phenyl]-2,3-dihydro-3,5,7-tris(phenylmethoxy)-4H-1-benzopyran-4-one, CAS: 574749-31-8, stock: 5.8g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅₀H₄₂O₇.
(2R,3R,4S)-2-[3,4-Bis(phenylmethoxy)phenyl]-3,4-dihydro-3,5,7-tris(phenylmethoxy)-2H-1-benzopyran-4-ol 4-Acetate, CAS: 478241-14-4, stock: 4.8g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅₂H₄₆O₈.
(2R,3S,4S)-2-[3,4-Bis(phenylmethoxy)phenyl]-3,4-dihydro-3,5,7-tris(phenylmethoxy)-2H-1-benzopyran-4-ol, CAS: 574749-29-4, stock: 10g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅₀H₄₄O₇.
3-[3,4-Bis(ethoxymethoxy)phenyl]-1-[2,4,6-tris(ethoxymethoxy)phenyl]-2-propen-1-one, CAS: 1076199-13-7, stock: 9.4g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₀H₄₂O₁₁.
3-[3,4-Bis(ethoxymethoxy)phenyl]-1-[2-hydroxy-4,6-bis(ethoxymethoxy)phenyl]-2-propen-1-one, CAS: 1076199-11-5, stock: 9.6g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₇H₃₆O₁₀.
Astilbin, CAS: 29838-67-3, stock: 2.7g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₂₂O₁₁.
cis-Dihydroquercetin, CAS: 114761-89-6, stock: 7.8g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₂O₇.
Silymarin (>80%), CAS: 65666-07-1, stock: 7.4g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: N/A.
[3-[3,4-Bis(ethoxymethoxy)phenyl]oxiranyl][2,4,6-tris(ethoxymethoxy)phenyl]methanone, CAS: 1076199-12-6, stock: 4.3g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₀H₄₂O₁₂.
(2S)-Benzhydryl 3-methyl-7-oxo-3-((Z)-triaz-1-en-1-ylmethyl)-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate 4,4-dioxide-15N, CAS: /, stock: 2.4g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₂₀N₃¹⁵NO₅S.
(2S,4S,5R)-3,3-Dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic Acid 4-Oxide Phenylmethyl Ester-d2, CAS: /, stock: 9.2g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₅D₂NO₄S.
(2S,5R)-3,3-dimethyl-7-oxo-4-oxide-4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylic Acid Diphenylmethyl Ester, CAS: 87579-78-0, stock: 1.5g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₂₁NO₄S.
(2S,5R)-3-(Azidomethyl)-3-methyl-7-oxo-4,4-dioxide-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic Acid Diphenylmethyl Ester, CAS: /, stock: 2.9g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₂₀N₄O₅S.
(2S,5R)-6,6-Dibromo-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid 4-Oxide Phenylmethyl Ester, CAS: 153833-41-1, stock: 7.9g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₅Br₂NO₄S.
(2S,5R,6S)-6-bromo-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid Diphenylmethyl Ester, CAS: 74189-25-6, stock: 8.9g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₂₀BrNO₃S.
(6R)-3-Methyl-8-oxo-5,5-dioxide-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid Diphenylmethyl Ester, CAS: 370588-49-1, stock: 4.5g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₁₉NO₅S.
(αR,2R)-2-(2-Benzothiazolyldithio)-α-(1-methylethenyl)-4-oxo-1-azetidineacetic Acid Diphenylmethyl Ester, CAS: 87579-79-1, stock: 6.9g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₈H₂₄N₂O₃S₃.
2-(2-Benzothiazolyldithio)-α-(1-methylethenyl)-4-oxo-1-azetidineacetic Acid Diphenylmethyl Ester, CAS: /, stock: 1.3g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₈H₂₄N₂O₃S₃.
2-[2-(Hydroxyimino)ethylidene]hydrazide Acetic Acid, CAS: 161228-22-4, stock: 7.9g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄H₇N₃O₂.
2S,3S,5R)-(Azidomethyl)-3-methyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic Acid 4,4-Dioxide Diphenylmethyl Ester, CAS: /, stock: 1.7g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₂₀N₄O₅S.
3-(Chloromethyl)-3-methyl-7-oxo-4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylic Acid Diphenylmethyl Ester, CAS: /, stock: 2.8g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₂₀ClNO₃S.
3-Azido-3-methyl-8-oxo-5,5-dioxide-5-thia-1-azabicyclo[4.2.0]octane-2-carboxylic Acid Diphenylmethyl Ester-15N, CAS: /, stock: 7.3g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₂₀N₃¹⁵NO₅S.
6-Bromo-3,3-dimethyl-7-oxo-4-oxide-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic Acid Diphenylmethyl Ester, CAS: 80353-26-0, stock: 9.7g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₂₀BrNO₄S.
6α-Bromopenicillanic Acid, CAS: 24138-28-1, stock: 6.6g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₁₀BrNO₃S.
Benzyl 6,6-Dibromopenicillanate, CAS: 35564-99-9, stock: 5.8g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₅Br₂NO₃S.
Descarboxy Tazobactam, CAS: /, stock: 5.9g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₁₂N₄O₃S.
Penicillanic Acid Benzyl Ester-d2, CAS: /, stock: 3.3g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₅D₂NO₃S.
Penicillanic Acid Sodium Salt-d2, CAS: /, stock: 9.1g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₈D₂NNaO₃S.
Potassium Azide-15N, CAS: 58524-53-1, stock: 2.2g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: KN₂¹⁵N.
Tazobactam, CAS: 89786-04-9, stock: 7.2g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₂N₄O₅S.
Tazobactam Diphenylmethyl Ester-15N3, CAS: /, stock: 8.9g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₂₂N¹⁵N₃O₅S.
Tazobactam Ethyl Ester, CAS: /, stock: 2.7g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₆N₄O₅S.
Tazobactam Impurity A, CAS: 1628710-72-4, stock: 5g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₂₂N₄O₄S.
Tazobactam Sodium Salt, CAS: 89785-84-2, stock: 8g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₁NaN₄O₅S.
Tazobactam Sodium Salt-13C2,15N1Please see T010103. Replaces T010102 when stock is depleted, CAS: /, stock: 4.2g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈¹³C₂H₁₁N₃¹⁵NNaO₅S.
Tazobactam Sodium Salt-15N3, CAS: /, stock: 2.2g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₁N¹⁵N₃NaO₅S.
Tazobactam-d4, CAS: /, stock: 3g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₈D₄N₄O₅S.
((((((R)-1-(6-(3,5-Bis(9-((R)-2-(phosphorylmethoxy)propyl)-9H-purin-6-yl)-1,3,5-triazinan-1-yl)-9H-purin-9-yl)propan-2-yl)oxy)methyl)phosphoryl)hexakis(oxy))hexakis(methylene) Hexaisopropyl Hexacarbonate, CAS: /, stock: 1.1g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆₀H₉₀N₁₅O₃₀P₃.
Tazobactam-d4 Sodium Salt, CAS: /, stock: 7g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₇D₄N₄NaO₅S.
[2R-(2α,3β,6α)]-3-Azido-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]octane-2-carboxylic Acid 5,5-Dioxide Diphenylmethyl Ester, CAS: 104862-31-9, stock: 2.1g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₂₀N₄O₅S.
(R)-(((1-(6-Amino-9H-purin-9-yl)propan-2-yl)oxy)methyl)phosphonic Acid Methyl Ester Trimethylamine, CAS: /, stock: 1.2g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₃₁N₆O₄P.
(R)-9-[2-(Diethylphosphonomethoxy)propyl] Adenine, CAS: 180587-75-1, stock: 8.7g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₂₂N₅O₄P.
[2S-(2α,3β,5α)]-3-(Azidomethyl)-3-methyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic Acid Diphenylmethyl Ester-15N3, CAS: /, stock: 7.8g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₂₀N₃¹⁵NO₃S.
[2S-(2α,3β,5α)]-3-(Chloromethyl)-3-methyl-7-oxo-4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylic Acid Diphenylmethyl Ester, CAS: 85573-73-5, stock: 5.6g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₂₀ClNO₃S.
(R)-9-[2-(Hydroxypropyl] Adenine(Desphosphoryl Tenofovir), CAS: 14047-28-0, stock: 5.9g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₁₁N₅O.
(R)-Diphenyl (((1-(6-amino-9H-purin-9-yl)propan-2-yl)oxy)methyl)phosphonate, CAS: 342631-41-8, stock: 7.6g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₂₂N₅O₄P.
(S)-9-[2-(Hydroxypropyl] Adenine, CAS: 14047-27-9, stock: 5g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₁₁N₅O.
(S)-Isopropyl 2-(((R)-((((R)-1-(6-amino-9H-purin-9-yl)propan-2-yl)oxy)methyl)(phenoxy)phosphoryl)amino)propanoate, CAS: /, stock: 4.1g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₂₉N₆O₅P.
(S)-Tenofovir, CAS: 147127-19-3, stock: 3.7g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₁₄N₅O₄P.
(S)-Tenofovir Disoproxil Fumarate, CAS: 1432630-26-6, stock: 1.8g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₃₄N₅O₁₄P.
2-O-tert-Butyldimethylsilylemtricitabine Tenofovir Disoproxil Dimer, CAS: /, stock: 9.5g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₄H₅₄FN₈O₁₃PSSi.
2-O-tert-Butyldimethylsilylemtricitabine Tenofovir Monosoproxil Dimer, CAS: /, stock: 3g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₉H₄₆FN₈O₁₀PSSi.
6-(2,2,2-Trifluoroacetamido)tenofovir 1-Methyl-1H-imidazol-3-ium-d6, CAS: /, stock: 9.2g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₁D₆F₃N₇O₄P.
6-(2,2,2-Trifluoroacetamido)tenofovir 2,2,2-Trifluoroacetic Anhydride-d6, CAS: /, stock: 7.5g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₆D₆F₆N₅O₆P.
6N-Bromomethyl Tenofovir Disoproxil, CAS: /, stock: 3.5g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₃₁BrN₅O₁₀P.
6N-Methoxymethyl Tenofovir Disoproxil, CAS: /, stock: 1.9g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₃₄N₅O₁₁P.
9-Propenyladenine, CAS: 4121-40-8, stock: 8.6g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₉N₅.
9-[2-(Hydroxypropyl-d6] Adenine, CAS: 1020719-54-3, stock: 8.6g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₅D₆N₅O.
Atripla, CAS: 731772-50-2, stock: 3.2g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄₅H₅₃ClF₄N₉O₁₉PS.
Chloromethyl Isopropyl Carbonate, CAS: 35180-01-9, stock: 5.1g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅H₉ClO₃.
Desmethyl Tenofovir Disoproxil Fumarate, CAS: /, stock: 9.6g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₃₂N₅O₁₄P.
Desmethyl Tenofovir Disoproxil-d4 Fumarate, CAS: /, stock: 6.2g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₂₈D₄N₅O₁₄P.
Desphenyl Tenofovir Alafenamide Ammonium Salt, CAS: /, stock: 1.1g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₂₈N₇O₅P.
Desphenyl Tenofovir Alafenamide-d7 Ammonium Salt, CAS: /, stock: 5.8g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₂₁D₇N₇O₅P.
Diethyl p-Toluenesulfonyloxymethylphosphonate, CAS: 31618-90-3, stock: 9.6g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₉O₆PS.
Diethylaminocarboxymethyl POC Tenofovir (Mixture of Diastereomers), CAS: 1246812-23-6, stock: 4.2g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₃₃N₆O₉P.
Emtricitabine Tenofovir Disoproxil Dihydrochloride (>90%), CAS: /, stock: 2.9g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₈H₄₀FN₈O₁₃PS · 2(HCl).
Emtricitabine Tenofovir Monosoproxil, CAS: /, stock: 5.1g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₃₂FN₈O₁₀PS.
Isopropyl Tenofovir, CAS: 1346597-36-1, stock: 4.9g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₂₀N₅O₄P.
Lamivudine Tenofovir Monosoproxil Methane, CAS: /, stock: 9.2g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₃₃N₈O₁₀PS.
MOC-POC Tenofovir Fumarate Salt(Mixture of Diastereomers), CAS: /, stock: 9.4g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₃₀N₅O₁₄P.
Mono-POC Ethyl Tenofovir (Mixture of Diastereomers), CAS: 1796539-92-8, stock: 4.8g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₂₆N₅O₇P.
Mono-POC Isopropyl Tenofovir(Mixture of Diastereomers), CAS: 1246812-40-7, stock: 5.9g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₂₈N₅O₇P.
Mono-POC Methyl Tenofovir (Mixture of Diastereomers), CAS: 1246812-16-7, stock: 6.7g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₂₄N₅O₇P.
Mono-POC Tenofovir, CAS: 211364-69-1, stock: 3.5g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₂₂N₅O₇P.
Mono-POC Tenofovir 6-Isopropyl Carbamate(Mixture of Diastereomers), CAS: 1244022-56-7, stock: 2.4g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₂₈N₅O₉P.
N-2-Propen-1-yl-9H-purin-6-amine Hydrobromide, CAS: 1797133-49-3, stock: 8.7g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₁₀BrN₅.
N6,O-Ditrifluoroacetyl Tenofovir, CAS: /, stock: 8.4g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₂F₆N₅O₆P.
N6-Trifluoroacetyl Tenofovir Phospho(N-methylimidazolide) TEA Salt, CAS: /, stock: 6.9g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₈F₃N₇O₄P⁻.
nPOC-POC Tenofovir(Mixture of Diastereomers), CAS: 1217542-13-6, stock: 8.4g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₃₀N₅O₁₀P.
nPOC-POC Tenofovir Fumarate(Mixture of Diastereomers), CAS: /, stock: 5.8g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₃₄N₅O₁₄P.
P-[[(1S)-2-(6-Amino-9H-purin-9-yl)-1-methylethoxy]methyl]-phosphonic Acid Monoethyl Ester, CAS: 1255525-18-8, stock: 4.3g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₈N₅O₄P.
rac Tenofovir-13C5, CAS: /, stock: 6.1g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄¹³C₅H₁₄N₅O₄P.
rac Tenofovir-d6, CAS: 1020719-94-1, stock: 1.1g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₈D₆N₅O₄P.
rac Tenofovir-d6 Diphosphate Triethylamine Salt (mixture of diastereomers), CAS: /, stock: 6.1g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₁₀D₆N₅O₁₀P₃ •x(C₆H₁₅N).
Tenofovir, CAS: 147127-20-6, stock: 5.5g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₁₄N₅O₄P.
Tenofovir (1.0 mg/mL in Water), CAS: 147127-20-6, stock: 8.4g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₁₄N₅O₄P.
Tenofovir Dibenzyloxy Isopropyl Carbamate, CAS: 1391052-09-7, stock: 1.5g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₇H₃₂N₅O₆P.
Tenofovir Dimer Triethylammonium Salt, CAS: /, stock: 3g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₀H₅₆N₁₂O₇P₂.
Tenofovir Diphosphate Triethylamine Salt (mixture of diastereomers), CAS: /, stock: 4.3g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₁₆N₅O₁₀P₃ •x(C₆H₁₅N).
Tenofovir Disoproxil, CAS: 201341-05-1, stock: 4.8g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₃₀N₅O₁₀P.
Tenofovir Disoproxil Dimer, CAS: 1093279-76-5, stock: 3.9g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₉H₆₀N₁₀O₂₀P₂.
Tenofovir Disoproxil Fumarate, CAS: 202138-50-9, stock: 6.3g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₃₄N₅O₁₄P.
Tenofovir Disoproxil Isopropoxycarbonyl, CAS: 1244022-54-5, stock: 4.9g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₃₆N₅O₁₂P.
Tenofovir Disoproxil-d6 Fumarate, CAS: /, stock: 5g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₂₄D₆N₅O₁₀P•C₄H₄O₄.
Tenofovir Exalidex, CAS: 911208-73-6, stock: 8.3g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₈H₅₂N₅O₅P.
Tenofovir Isopropyl Carbamate, CAS: 1391053-20-5, stock: 3.3g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₂₀N₅O₆P.
Tenofovir Isopropyl Ethyl Diester, CAS: 1422284-16-9, stock: 9.7g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₂₈N₅O₁₀P.
Tenofovir Monohydrate, CAS: 206184-49-8, stock: 5.7g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₁₄N₅O₄P • (H ₂O).
Tenofovir Monoisoproxil Dimer Ammonium Sodium Salt (>85%), CAS: /, stock: 6.7g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₉H₄₄N₁₀O₁₄P₂ • x(Na) • x(NH ₃).
Tenofovir Monomethyl Ester, CAS: 1796539-83-7, stock: 8.2g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₆N₅O₄P.
Tenofovir N-Isopropyl Derivative, CAS: /, stock: 7g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₂₀N₅O₄P.
Tenofovir Phosphate Diammonia Salt, >90%, CAS: /, stock: 4.6g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₂₁N₇O₇P₂.
Tenofovir Phosphate Diammonia Salt-13C5, CAS: /, stock: 5.9g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄¹³C₅H₁₅N₅O₇P₂ • 2( H₃N).
Tenofovir-d5, CAS: /, stock: 5g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₉D₅N₅O₄P.
Tri-POC Tenofovir Dimer (>90%), CAS: 1093279-77-6, stock: 3.1g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₄H₅₂N₁₀O₁₇P₂.
[(R)-2-(Phenylphosphonomethoxy)propyl]adenine-d5, CAS: /, stock: 4.6g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₃D₅N₅O₄P.
[2-(6-Amino-9H-purin-9-yl)-1-methylethoxy]methyl]-4-morpholinylphosphinic Acid, CAS: 308367-90-0, stock: 4.7g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₂₃N₆O₄P.
[[(1R)-2-(6-Amino-9H-purin-9-yl)-1-methylethoxy]methyl]monophenylester, CAS: 379270-35-6, stock: 2.1g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₈N₅O₄P.
1-Allyl-catellagic Acid Diethyl Ether, CAS: 216374-59-3, stock: 3.8g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₁₄O₆.
10-O-Allyl-3,8-deshydroxy-9-O-methyl Luteic Acid Methyl Ester, CAS: 1173188-31-2, stock: 2.4g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₁₈O₇.
(+)-Diacetyl-D-tartaric Acid, CAS: 66749-60-8, stock: 7.2g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₁₀O₈.
(+)-Dibenzoyl-D-Tartaric Acid Monohydrate, CAS: 80822-15-7, stock: 5.5g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₁₄O₈ • H₂O.
(+)-Diisopropyl L-Tartrate, CAS: 2217-15-4, stock: 8.8g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₈O₆.
(+)-Dimethyl L-Tartrate, CAS: 608-68-4, stock: 2g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₁₀O₆.
(+)-Dipivaloyl-D-tartaric Acid, CAS: 76769-55-6, stock: 8.5g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₂₂O₈.
(+)-O,O’-Di-p-toluoyl-D-tartaric Acid, CAS: 32634-68-7, stock: 4.9g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₁₈O₈.
(-)-Dibenzoyl-L-Tartaric Acid Monohydrate, CAS: 62708-56-9, stock: 2.7g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₁₄O₈ • H₂O.
(-)-Dimethyl 2,3-O-isopropylidene-L-tartrate, CAS: 37031-29-1, stock: 9.1g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₁₄O₆.
(-)-Dipivaloyl-L-tartaric Acid, CAS: 65259-81-6, stock: 5.4g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₂₂O₈.
(-)-Nicotine (+)-O,O’-Di-p-toluoyl-D-tartaric Acid, CAS: 68935-25-1, stock: 6.6g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₄N₂ • ( C₂₀H₁₈O₈).
(-)-O,O’-Di-p-toluoyl-L-tartaric Acid, CAS: 32634-66-5, stock: 5.6g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₁₈O₈.
(1S,2R)-Norephedrine Tartaric Acid Dibenzoate, CAS: /, stock: 5.5g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₇H₂₇NO₉.
(2R,3S)-3-Methylmalic Acid, CAS: 152204-30-3, stock: 8.7g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅H₈O₅.
(2S)-2-Amino-2,3-dimethyl-butanenitrile L-(+)-Tartaric Acid, CAS: 100594-33-0, stock: 9.7g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₈N₂O₆.
(3R,4R)-2,5-dioxotetrahydrofuran-3,4-diyl Dibenzoate, CAS: 64339-95-3, stock: 7.3g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₁₂O₇.
(5R,11S,13S)-rel-(+)-5,6,7,8,9,10,11,12-Octahydro-3-methoxy-5-methyl-5,11-methanobenzocyclodecen-13-amine L-Tartaric Acid, CAS: 58383-83-8, stock: 1.7g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₃₁NO₇.
(±)-Tartaric Acid, CAS: 133-37-9, stock: 1.1g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄H₆O₆.
(R)-5,6-Dehydro Pregabalin (-)-O,O’-Di-p-toluoyl-L-tartaric Acid, CAS: /, stock: 8.8g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₁₅NO₂ • C₂₀H₁₈O₈.
(R,R)-Tartaric Acid Monomethyl Ester Diacetate, CAS: 23294-83-9, stock: 5.7g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₁₂O₈.
(4-Hydroxy-2-bromomethylphenyl)boronic Acid, CAS: /, stock: 9.5g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₈BBrO₃.
(S)-1,2,3,4-Tetrahydro-5-methoxy-N-propyl-2-naphthalenamine Di-p-toluoyl-D-tartaric Acid Salt, CAS: /, stock: 7.4g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₄H₃₉NO₉.
(S)-1,2,3,4-Tetrahydro-5-methoxy-N-propyl-2-naphthalenamine Di-p-toluoyl-L-tartaric Acid Salt, CAS: /, stock: 8.6g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₄H₃₉NO₉.
2-Bromomethyl-4-aminophenylboronic Acid, CAS: /, stock: 6.5g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₉BBrNO₂.
4-Amino-2-methylphenylboronic Acid, CAS: 216060-08-1, stock: 3.8g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₁₀BNO₂.
(S)-4-[4-(Dimethylamino)-1-(4-fluorophenyl)-1-hydroxybutyl]-3-(hydroxymethyl)-benzonitrile Di-p-toluoyl-D-tartrate Salt (2:1), CAS: 128173-53-5, stock: 7.3g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆₀H₆₄F₂N₄O₁₂.
(S)-5,6-Dehydro Pregabalin (-)-O,O’-Di-p-toluoyl-L-tartaric Acid, CAS: /, stock: 2.8g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₁₅NO₂ • C₂₀H₁₈O₈.
4-Fluoro-1,3-dihydro-1-hydroxy-2,1-benzoxaborole, CAS: 174671-88-6, stock: 2.4g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₆BFO₂.
4-Fluoro-2-(hydroxymethyl)phenol, CAS: 2357-33-7, stock: 7.5g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₇FO₂.
1,1-Diphenyldiazomethane (>90%), CAS: 883-40-9, stock: 5.3g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₀N₂.
5-[(Z)-2-(1-hydroxy-1,3-dihydro-2,1-benzoxaborol-5-yl)diazen-1-yl]-1,3-dihydro-2,1-benzoxaborol-1-ol, CAS: /, stock: 2.8g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₂B₂N₂O₄.
Bis(4-fluoro-2-bromomethylphenyl)borinic Acid, CAS: /, stock: 6.6g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₁BBr₂F₂O.
2,3-O-Isopropylidene-D-tartaric Acid, Dimethyl Ester, CAS: 37031-30-4, stock: 7.1g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₁₄O₆.
2-Dimethylaminoethanol Bitartrate, CAS: 5988-51-2, stock: 2.5g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₁₇NO₇.
Bis(4-fluoro-2-methylphenyl)borinic Acid, CAS: /, stock: 2.8g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₃BF₂O.
Tavaborole (>90%), CAS: 174671-46-6, stock: 8.5g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₆BFO₂.
3R-(+)-3-(3-Methanesulfonyl-phenyl)-piperidine Tartaric Acid Salt, CAS: /, stock: 1.4g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₂₃NO₈S.
[2-Bromomethyl)-4-[(Z)-2-[3-(bromomethyl)-4-dihydroxyboranyl)phenyl]diazen-1-yl]phenyl]boronic Acid, CAS: /, stock: 6.5g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₄B₂Br₂N₂O₄.
3S-(-)-3-[3-(Methanesulfonyl)phenyl]piperidine Tartaric Acid Salt, CAS: 504398-38-3, stock: 9.4g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₂₃NO₈S.
4-(1-(2,4-Dimethylphenyl)ethyl)-1H-imidazole L(+)-Tartaric Acid, CAS: /, stock: 8.8g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₆N₂ • C ₄H₆O₆.
4-(1-(2,5-Dimethylphenyl)ethyl)-1H-imidazole L(+)-Tartaric Acid, CAS: /, stock: 4.9g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₆N₂ • C ₄H₆O₆.
4-(1-(2,6-Dimethylphenyl)ethyl)-1H-imidazole L(+)-Tartaric Acid, CAS: /, stock: 9.7g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₆N₂ • C ₄H₆O₆.
4-(1-(3,4-Dimethylphenyl)ethyl)-1H-imidazole L(+)-Tartaric Acid, CAS: /, stock: 2.7g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
Ammonium Tartrate Dibasic, CAS: 3164-29-2, stock: 5.3g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄H₁₂N₂O₆ • 2NH ₃.
Chicoric Acid, CAS: 6537-80-0, stock: 1.7g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₁₈O₁₂.
D-(-)-Diisopropyl Tartrate, CAS: 62961-64-2, stock: 2.8g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₈O₆.
D-(-)-Tartaric Acid, CAS: 147-71-7, stock: 1.4g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄H₆O₆.
Di-O-acetyl-L-tartaric Anhydride, CAS: 6283-74-5, stock: 3.3g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₈O₇.
Di-O-benzoyl L-Tartaric Acid, CAS: 2743-38-6, stock: 7g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₁₄O₈.
Di-O-benzoyl-D-tartaric Acid, CAS: 17026-42-5, stock: 4.2g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₁₄O₈.
Di-p-anisoyl-l-tartaric acid, CAS: 50583-51-2, stock: 10g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₁₈O₁₀.
Di-p-toluoyl-D-tartaric Acid Monohydrate, CAS: 71607-31-3, stock: 5.2g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₀O₉.
Dibenzyl Dipyridamole Tartaric Acid Ester Ammonium Salt, CAS: /, stock: 9.8g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄₂H₅₆N₈O₉ • x(NH ₃).
Dibutyl L-Tartrate, CAS: 15763-01-6, stock: 1.9g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₂₂O₆.
Dibutyl L-Tartrate-D18, CAS: /, stock: 5.9g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₄D₁₈O₆.
Diethyl D-(-)-Tartrate, CAS: 13811-71-7, stock: 2.6g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₁₄O₆.
Diethyl L-(+)-Tartrate, CAS: 87-91-2, stock: 3.4g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₁₄O₆.
Diethyl L-(+)-Tartrate-13C4, CAS: /, stock: 5.7g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄¹³C₄H₁₄O₆.
Diethyl L-(+)-Tartrate-13C8, CAS: /, stock: 7.4g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: ¹³C₈H₁₄O₆.
Dipyridamole Ditartaric Acid Diester Diammonium Salt (>90%), CAS: /, stock: 5.3g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₂H₅₄N₁₀O₁₄.
Dipyridamole Tartaric Acid Ester Ammonium Salt (~80%), CAS: /, stock: 9.8g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₈H₄₇N₉O₉.
Duloxetine-d3 Di-p-toluoyl-L-tartaric Acid Salt, CAS: /, stock: 8.1g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₈H₃₄D₃NO₉S.
L-(+)-Tartaric Acid, CAS: 87-69-4, stock: 5.5g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄H₆O₆.
Mesotartaric Acid, CAS: 147-73-9, stock: 3.9g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄H₆O₆.
Mesotartaric Acid Monohydrate, CAS: /, stock: 6.7g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄H₆O₆ • H ₂O.
Methylsuccinic Acid, CAS: 498-21-5, stock: 9.5g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅H₈O₄.
Mirtazapine L-Tartaric Acid, CAS: 1705597-66-5, stock: 2.7g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₂₅N₃O₆.
N,N,N’,N’-Tetramethyl-D-tartaramide, CAS: 63126-52-3, stock: 3.1g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₁₆N₂O₄.
N-L-Tartaryl Linagliptin, CAS: /, stock: 6.4g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₉H₃₂N₈O₇.
Octahydroindoline-2-carboxylic Acid Benzyl Ester (-)-Dibenzoyl-L-tartaric Acid, CAS: /, stock: 7.5g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₄H₃₅NO₁₀.
rac Fenfluramine Di-O-benzoyl-L-tartaric Acid, CAS: 895166-16-2, stock: 9.7g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₀H₃₀F₃NO₈.
Rochelle’s Salt, CAS: 6381-59-5, stock: 2.2g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄H₄KNaO₆•4[H₂O].
Sodium Bitartrate Monohydrate, CAS: 6131-98-2, stock: 7.2g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄H₅NaO₆ • H ₂O.
Sodium L-(+)-Tartaric Acid Dihydrate, CAS: 6106-24-7, stock: 6.2g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄H₄Na₂O₆.
Sodium L-(+)-Tartrate, CAS: 868-18-8, stock: 3.2g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄H₄Na₂O₆.
Tartaric Acid Isopropyl Ester, CAS: 116601-09-3, stock: 2.7g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₁₂O₆.
Tartaric Acid Methyl Ester, CAS: 3333-46-8, stock: 6.3g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅H₈O₆.
Tolterodine L-Tartrate, CAS: 124937-52-6, stock: 8.4g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₆H₃₇NO₇.
(αR,βR)-β-Ethyl-3-methoxy-α-methylbenzenepropanoyl Chloride, CAS: /, stock: 5.7g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₇ClO₂.
(R,Z)-3-(5-(Dimethylamino)-4-methylpent-2-en-3-yl)phenol Hydrochloride, CAS: 197144-93-7, stock: 7.9g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₂₁NO • (HCl).
3-(Dimethylamino)-1-(3-benzyloxyphenyl)-2S-methyl-1-propanone Dibenzoyl Tartrate, CAS: 1004315-81-4, stock: 1.9g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₇H₃₇NO₁₀.
3’-O-Benzyl-(1R)-hydroxy Tapentadol, CAS: 1004315-82-5, stock: 3.5g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₂₉NO₂.
m-Anisyllithium, CAS: 31600-88-1, stock: 9.8g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₇LiO.
O-Methyl Tapentadol Hydrochloride, CAS: 175591-17-0, stock: 4.7g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₂₅NO•HCl.
rac-3-(Dimethylamino)-1-(3-benzyloxyphenyl)-2-methyl-1-propanone, CAS: 41489-62-7, stock: 1.2g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₂₃NO₂.
Tapentadol-d5 O-β-D-Glucuronide, CAS: /, stock: 5.1g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₆D₅NO₇.
Tapentadol-d5 O-Sulfate, CAS: 1346598-84-2, stock: 5.9g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₈D₅NO₄S.
trans-2-Pentenoic Acid Chloride, CAS: 33698-85-0, stock: 7.4g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅H₇ClO.
Ethyl 6-(2-Chloro-2-(4,4-dimethylthiochroman-6-yl)vinyl)nicotinate, CAS: /, stock: 7.3g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₂₄ClNO₂S.
Tazarotene, CAS: 118292-40-3, stock: 8.9g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₂₁NO₂S.
Tazarotene Sulfone, CAS: 1262228-27-2, stock: 4g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₂₁NO₄S.
Tazarotene Sulfone-d8, CAS: /, stock: 6.2g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₁₃D₈NO₄S.
Tazarotene Sulfoxide, CAS: 864841-56-5, stock: 9.3g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₂₁NO₃S.
Tazarotene Sulfoxide-d8, CAS: /, stock: 1.7g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₁₃D₈NO₃S.
Tazarotene-d8, CAS: 1246815-76-8, stock: 7.7g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₁₃D₈NO₂S.
Tazarotenic Acid, CAS: 118292-41-4, stock: 5.1g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₁₇NO₂S.
Tazarotenic Acid Methyl Ester, CAS: 1332579-70-0, stock: 8g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₁₉NO₂S.
Tazarotenic Acid-d8, CAS: /, stock: 2g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₉D₈NO₂S.
2-Hydrazinoethanesulfonamide, CAS: 1039961-64-2, stock: 2.2g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂H₉N₃O₂S.
Taurinamide Hydrochloride, CAS: 89756-60-5, stock: 2.5g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂H₉ClN₂O₂S.
Taurinamide-D4, CAS: /, stock: 3.1g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃H₄D₄N₂O₂S.
Taurolidine, CAS: 19388-87-5, stock: 7.4g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₁₆N₄O₄S₂.
Taurolidine-D6, CAS: /, stock: 1.9g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₁₀D₆N₄O₄S₂.
Taurultam, CAS: 38668-01-8, stock: 8.5g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃H₈N₂O₂S.
Taurultam-D4, CAS: /, stock: 8.8g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃H₄D₄N₂O₂S.
4-Hydrazinobenzenesulfonic Acid, CAS: 98-71-5, stock: 5.4g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₈N₂O₃S.
Sulfanilic Acid-d4, CAS: 1235219-21-2, stock: 9.8g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₃D₄NO₃S.
2-(1-Piperazinyl)pyrimidine-d8, CAS: 1309283-31-5, stock: 7.8g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₄D₈N₄.
2-Chloro-5-hydroxypyrimidine, CAS: 4983-28-2, stock: 9g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄H₃ClN₂O.
Tandospirone Hydrochloride, CAS: 99095-10-0, stock: 3.4g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₂₉N₅O₂ • HCl.
tert-Butyl 4-(2-Pyrimidinyl)-1-piperazinecarboxylate-D8, CAS: /, stock: 4.2g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₂D₈N₄O₂.
1-Cyclohexyl-3-(4-hydroxyphenyl)urea, CAS: 38652-23-2, stock: 5.7g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₈N₂O₂.
N-Cyclohexyl-N’-[2-(tert-butyl)amino-3-hydroxypropoxy]phenylurea, CAS: 391053-61-4, stock: 4.3g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₃₃N₃O₃.
N-Cyclohexyl-N’-[2-(tert-butyl)amino-3-hydroxypropoxy]phenylurea-d5, CAS: 1329835-86-0, stock: 4.1g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₈D₅N₃O₃.
N-Cyclohexyl-N’-[4-(2,3-epoxypropoxy)phenyl]urea, CAS: 38649-72-8, stock: 8.2g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₂₂N₂O₃.
N-Cyclohexyl-N’-[4-(2,3-epoxypropoxy)phenyl]urea-d5, CAS: 1329613-05-9, stock: 3.3g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₁₇D₅N₂O₃.
rac Talinolol-d5, CAS: 1215343-94-4, stock: 8.4g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₈D₅N₃O₃.
rac-Talinolol, CAS: 57460-41-0, stock: 9.2g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₃₃N₃O₃.
(3,3,4,4,4-d5)-(E/Z)-1-[4-(2-Chloroethoxy)phenyl]-1-[4-hydroxyphenyl]-2-phenyl-1-butene, CAS: 1020719-27-0, stock: 5.7g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₁₈D₅ClO₂.
(4-(2-(Dimethylamino)ethoxy)phenyl)(4-((4-(2-(dimethylamino)ethoxy)phenyl)(phenyl)methyl)phenyl)methanone, CAS: /, stock: 6.1g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₄H₃₈N₂O₃.
(4-(4,4-Dimethyl-4,5-dihydrooxazol-2-yl)phenyl)(4-(2-(dimethylamino)ethoxy)phenyl)(phenyl)methanol, CAS: /, stock: 5.5g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₈H₃₂N₂O₃.
(7α)-21-[4-[(Diethylamino)methyl]-2-methoxyphenoxy]-7-methyl-19-norpregna-1,3,5(10)-trien-3-ol 2-Hydroxy-1,2,3-propanetricarboxylate Salt (1:1), CAS: 229634-98-4, stock: 5.2g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₃H₄₇NO₃ •C₆H₈O₇.
(E)-1-(4-Hydroxyphenyl)-1-[4-(trimethylacetoxy)phenyl]-2-phenylbut-1-ene, CAS: 177748-17-3, stock: 3.7g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₇H₂₈O₃.
(E)-1-[4-[2-(N,N-Dimethylamino)ethoxy]phenyl]-1-[4-(trimethylacetoxy)phenyl]-2-phenylbut-1-ene, CAS: 177748-19-5, stock: 1.3g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₁H₃₇NO₃.
(E)-3-Hydroxy Tamoxifen, CAS: 82413-20-5, stock: 4.1g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₆H₂₉NO₂.
(E)-3-Hydroxy Tamoxifen O-β-D-Glucuronide, CAS: 165460-33-3, stock: 2.9g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₂H₃₇NO₈.
(E)-3-Hydroxy Tamoxifen-d5, CAS: 1185245-32-2, stock: 2.3g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₆H₂₄D₅NO₂.
(E)-4-Acetoxy Tamoxifen, CAS: 76117-70-9, stock: 6.2g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₈H₃₁NO₃.
(E)-4-Alloxycarboxyl Tamoxifen, CAS: 1287191-58-5, stock: 7.5g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₀H₃₃NO₄.
(E)-4-Hydroxy Tamoxifen O-β-D-Glucuronide, CAS: 152764-51-7, stock: 2.6g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₂H₃₇NO₈.
(E)-4-Hydroxy Tamoxifen-d5, CAS: /, stock: 8.6g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₆H₂₄D₅NO₂.
(E)-4-Hydroxy-N-desmethyl Tamoxifen, CAS: 114828-90-9, stock: 1.7g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₂₇NO₂.
(E)-4’-Hydroxy Tamoxifen, CAS: 82413-21-6, stock: 3.3g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₆H₂₉NO₂.
(E)-α-Hydroxy Tamoxifen, CAS: 97151-02-5, stock: 2.5g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₆H₂₉NO₂.
(E)-N,N-Didesmethyl-4-hydroxy Tamoxifen, CAS: 1394929-55-5, stock: 2.6g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₂₅NO₂.
(E)-Tamoxifen, CAS: 13002-65-8, stock: 8.5g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₆H₂₉NO.
(E)-Tamoxifen-13C2, 15N, CAS: /, stock: 9.4g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄¹³C₂H₂₉¹⁵NO.
(E)-Toremifene, CAS: 89778-29-0, stock: 5.6g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₆H₂₈ClNO.
(E,Z)-1-Bromo-2-[4-[2-(dimethylamino)ethoxy]phenyl]-1,2-diphenylethene, CAS: 19076-79-0, stock: 3.7g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₂₄BrNO.
(E,Z)-Tamoxifen N-β-D-Glucuronide (>92%), CAS: /, stock: 7.3g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₂H₃₇NO₇.
(E,Z)-Tamoxifen-d5 N-β-D-Glucuronide (~90%), CAS: /, stock: 1g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₂H₃₃D₅NO₇.
(E/Z)-1-(4-Hydroxyphenyl)-1-[4-(trimethylacetoxy)phenyl]-2-phenylbut-1-ene, CAS: 364635-60-9, stock: 2.6g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₇H₂₈O₃.
(E/Z)-1-[4-(2-Chloroethoxy)phenyl]-1-(4-hydroxyphenyl)-2-phenyl-1-butene, CAS: 119757-57-2, stock: 4.9g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₂₃ClO₂.
(E/Z)-1-[4-(2-Chloroethoxy)phenyl]-2-(4-hydroxyphenyl)-1-phenyl-1-butene, CAS: 1276031-01-6, stock: 4.8g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₂₃ClO₂.
(E/Z)-1-[4-(2-Chloroethoxyphenyl]-1,2-diphenyl-1-butene, CAS: 97818-83-2, stock: 4.4g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₂₃ClO.
(E/Z)-1-[4-(2-Chloroethoxyphenyl]-1,2-diphenyl-1-butene-4,4,5,5,5-d5, CAS: 157738-49-3, stock: 2g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₁₈D₅ClO.
(E/Z)-4,4’-Dihydroxy Tamoxifen, CAS: /, stock: 6.6g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₆H₂₉NO₃.
(E/Z)-4,4’-Dihydroxy-N-desmethyl Tamoxifen, CAS: 1217247-19-2, stock: 2.6g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₂₇NO₃.
(E/Z)-4,4’-Dihydroxy-N-desmethyl Tamoxifen Hydrochloride, CAS: /, stock: 4.1g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₂₈ClNO₃.
(E/Z)-4,4’-Dihydroxy-N-desmethyl Tamoxifen-d3, CAS: 1246832-93-8, stock: 3.4g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₂₄D₃NO₃.
(E/Z)-4-Hydroxy Tamoxifen, CAS: 68392-35-8, stock: 3.9g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₆H₂₉NO₂.
(E/Z)-N,N-Didesmethyl-4-hydroxy Tamoxifen, CAS: 1217237-98-3, stock: 1g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₂₅NO₂.
(E/Z)-N,N-Didesmethyl-4-hydroxy Tamoxifen 2’-Azide, CAS: 1331643-32-3, stock: 5.6g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₂₃N₃O₂.
(E/Z)-N,N-Didesmethyl-4-hydroxy Tamoxifen-d5, CAS: /, stock: 8.5g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₂₀D₅NO₂.
(E/Z)-Tamoxifen, CAS: 7728-73-6, stock: 2.2g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₆H₂₉NO.
(E/Z)-Tamoxifen-d5, CAS: 157698-32-3, stock: 7.1g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₆H₂₄D₅NO.
(S)-(-)-1-Methyl-2-pyrrolidinemethanol, CAS: 34381-71-0, stock: 5.3g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₁₃NO.
(Z)-1-[4-(2-Chloroethoxyphenyl]-1,2-diphenyl-1-butene, CAS: 97818-83-2, stock: 6.6g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₂₃ClO.
(Z)-1-[4-(2-Chloroethoxyphenyl]-1,2-diphenyl-1-butene-4,4,5,5,5-d5, CAS: 157738-49-3, stock: 9.6g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₁₈D₅ClO.
(Z)-4-Hydroxy Tamoxifen, CAS: 68047-06-3, stock: 7.5g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₆H₂₉NO₂.
(Z)-4-Hydroxy Tamoxifen O-β-D-Glucuronide (~90%), CAS: 128255-45-8, stock: 8g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₂H₃₇NO₈.
(Z)-4-Hydroxy Tamoxifen O-β-D-Glucuronide Methyl Ester Triacetate, CAS: /, stock: 1.7g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₉H₄₅NO₁₁.
(Z)-4-Hydroxy Tamoxifen-d5, CAS: 164365-20-2, stock: 3.1g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₆H₂₄D₅NO₂.
(Z)-4-Hydroxy-N-desmethyl Tamoxifen (contains up to 10% E isomer), CAS: 112093-28-4, stock: 2.5g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₂₇NO₂.
(Z)-α-Hydroxy Tamoxifen, CAS: 97170-41-7, stock: 3.5g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₆H₂₉NO₂.
1,1,1-Trifluoromethanesulfonic Acid (E)-4-[1-[4-[2-(Dimethylamino)ethoxy]phenyl]-2-phenyl-1-buten-1-yl]phenyl Ester, CAS: 1370699-80-1, stock: 9.9g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₇H₂₈F₃NO₄S.
1,3-Benzodioxol-5-yl[4-(2-chloroethoxy)phenyl]methanone, CAS: 259149-65-0, stock: 6.1g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₁₃ClO₄.
1,3-Dichloropropane, CAS: 142-28-9, stock: 9.2g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃H₆Cl₂.
1-(4-Methoxyphenyl)-2-phenyl-1-butanone, CAS: 78423-10-6, stock: 7.3g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₈O₂.
1-Phenyl-2-[4-[(tetrahydro-2H-pyran-2-yl)oxy]phenyl]-1-butanone, CAS: 82413-31-8, stock: 7.2g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₂₄O₃.
1-Pivaloyl-4,4’,4’’-(1-ethyl-1-ethenyl-2-ylidene)tris-phenol, CAS: 1797136-60-7, stock: 2.2g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₇H₂₈O₄.
1-[2-[4-[1-(4-Methoxyphenyl)-2-phenylethenyl]phenoxy]ethyl]-pyrrolidine, CAS: 13542-64-8, stock: 7.7g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₇H₂₉NO₂.
1-[4-(2-Chloroethoxy)phenyl]-2-ethyl-2-phenylethanone, CAS: 103628-22-4, stock: 6.4g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₁₉ClO₂.
1-[4-[2-Dimethylamino)ethoxy]phenyl]-2-phenyl-1-butanone Hydrochloride, CAS: 94911-67-8, stock: 8.8g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₆ClNO₂.
1-[4-[2-Dimethylamino)ethoxy]phenyl]-2-phenyl-1-butanone-d6 Hydrochloride, CAS: /, stock: 6.2g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₀D₆ClNO₂.
2,2-Dimethylpropanoic Acid 1,1’-[[1-Ethyl-2-(4-hydroxyphenyl)-1,2-ethenediyl]di-4,1-phenylene] Ester, CAS: 1133415-48-1, stock: 7.8g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₂H₃₆O₅.
2-(4-((4-(2-(Dimethylamino)ethoxy)phenyl)(phenyl)methyl)phenyl)-4,4-dimethyloxazolidin-2-ol, CAS: /, stock: 7.5g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₈H₃₄N₂O₃.
2-(4-((4-(4,4-Dimethyl-4,5-dihydrooxazol-2-yl)phenyl)(phenyl)methyl)phenoxy)-N,N-dimethylethanamine, CAS: /, stock: 9.7g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₈H₃₂N₂O₂.
2-(4-Bromophenoxy)-N,N-dimethylethylamine, CAS: 09/07/2474, stock: 1.1g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₄BrNO.
2-(4-Bromophenoxy)-N,N-dimethylethylamine-d6, CAS: 1794787-00-0, stock: 8.1g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₈D₆BrNO.
2-(4-Hydroxyphenyl)-1-phenyl-1-butanone, CAS: 82413-28-3, stock: 5.9g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₁₆O₂.
2-(Methyl-2-(4-(4-(2-(trimethylammonium)ethoxy)benzoyl)phenoxy)propanoate Inner Salt, CAS: /, stock: 6.2g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₂₉NO₄.
2-[4-(1,2-Diphenyl-1-propenyl)phenoxy]-N,N-dimethylethanamine (E/Z Mixture), CAS: 197251-11-9, stock: 3g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₂₇NO.
2-[4-(1,2-Diphenyl-1-propenyl)phenoxy]-N,N-dimethylethanamine-d6 (E/Z Mixture), CAS: /, stock: 8g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₂₁D₆NO.
2-[4-(2-Bromo-1,2-diphenylethenyl)phenoxy]-N-methyl-ethanamine, CAS: 265321-58-2, stock: 4.7g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₂₂BrNO.
2-[4-[(1-(1,3-Benzodioxol-5-yl)-2-phenyl-1-buten-1-yl]phenoxy]-N,N-dimethylethanamine Hydrochloride (E/Z Mixture), CAS: /, stock: 9.6g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₆H₂₈ClNO₃.
3,3-Dichloro-1,1,1-trifluoroacetone, CAS: 126266-75-9, stock: 5g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃HCl₂F₃O.
3-Chloro-N-methylpropan-1-amine Hydrochloride, CAS: 97145-88-5, stock: 4.8g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄H₁₀ClN•(HCl).
4-(1-(4-(2-Chloroethoxy)phenyl)-2-phenylbut-1-en-1-yl)-2-methoxyphenol(E/Z Mixture), CAS: /, stock: 2.6g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₂₅ClO₃.
4-(1-(4-Methoxyphenyl)-2-phenylvinyl)phenol, CAS: /, stock: 2g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₁₈O₂.
4-Benzyloxy β-Hydroxy Tamoxifen, CAS: 176671-78-6, stock: 1.6g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₃H₃₅NO₃.
4-Formyl-2-methoxyphenylboronic Acid, CAS: 1028479-47-1, stock: 6.4g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₉BO₄.
4-Hydroxy Tamoxifen N-β-D-Glucuronide(E/Z-Mixture), CAS: /, stock: 6.6g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₂H₃₇NO₈.
4-Hydroxy-β-Carboxy Tamoxifen N-β-D-Glucuronide, CAS: /, stock: 4.1g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₃H₃₇NO₁₀.
4-Hydroxy-β-Carboxy Tamoxifen O-Glucuronide, CAS: /, stock: 5.6g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₃H₃₇NO₁₀.
4-Hydroxy-Tamoxifen Acyl-glucuronide, CAS: /, stock: 3.7g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₃H₃₇NO₁₀.
4-Hydroxymethoxy Clomiphene, CAS: 204123-74-0, stock: 2.6g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₂₆ClNO₃.
4-Methylbenzenesulfonic Acid 2-[(4-Hydroxyphenyl)phenylmethylene]hydrazide, CAS: 147169-63-9, stock: 2.5g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₁₈N₂O₃S.
4-Methylbenzenesulfonic Acid 2-[[4-[[(1,1-Dimethylethyl)dimethylsilyl]oxy]phenyl]phenylmethylene]hydrazide, CAS: 147169-61-7, stock: 8.7g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₆H₃₂N₂O₃SSi.
4-Pivaloyloxy Toremifene, CAS: 177748-20-8, stock: 5.2g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₁H₃₆ClNO₃.
4-[4-[2-(Dimethylamino)ethoxy]diphenylmethyl] Tamoxifen Dihydrochloride(Tamoxifen EP Impurity H), CAS: /, stock: 6.3g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄₃H₅₀Cl₂N₂O₂.
4’-Hydroxy Tamoxifen (contains up to 10% E isomer), CAS: 82413-23-8, stock: 6.6g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₆H₂₉NO₂.
4’-Hydroxy Tamoxifen-d6 (contains up to 10% E isomer), CAS: 1346606-80-1, stock: 9.7g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₆H₂₃D₆NO₂.
5-[1-[4-(2-Chloroethoxy)phenyl]-2-phenyl-1-buten-1-yl]-1,3-benzodioxole (E/Z Mixture), CAS: 259149-68-3, stock: 5.6g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₂₃ClO₃.
Bromoethane, CAS: 74-96-4, stock: 6.4g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂H₅Br.
Bromoethane-13C2, CAS: 34189-75-8, stock: 7.9g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: ¹³C₂H₅Br.
Bromoethane-d3, CAS: 7439-86-3, stock: 6.4g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂H₂D₃Br.
cis-β-Hydroxy Tamoxifen, CAS: 97151-04-7, stock: 8.4g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₆H₂₉NO₂.
Droloxifene Citrate, CAS: 97752-20-0, stock: 10g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₂H₃₇NO₉.
E/Z Tamoxifen Alcohol, CAS: /, stock: 4.6g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₂₄O₂.
Hydroxymethoxy-N-desmethyl Toremifene, CAS: /, stock: 8.1g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₆H₂₈ClNO₃.
Idoxifene, CAS: 116057-75-1, stock: 4.4g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₈H₃₀INO.
Ivacaftor Acyl-Glucuronide, CAS: /, stock: 4g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₀H₃₄N₂O₁₀.
α-[4-(2-Dimethylaminoethoxy)phenyl]stilbene, CAS: 19957-51-8, stock: 3.7g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₂₅NO.
α-[4-(2-Dimethylaminoethoxy)phenyl]stilbene-d6, CAS: /, stock: 2.5g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₁₉D₆NO.
β-Hydroxy Tamoxifen, CAS: 97151-03-6, stock: 8.7g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₆H₂₉NO₂.
Lithium Acetylide-ethylenediamine (1:1), CAS: 6867-30-7, stock: 8.4g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄H₉LiN₂.
Lonafarnib, CAS: 193275-84-2, stock: 3.3g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₇H₃₁Br₂ClN₄O₂.
Lonafarnib-d9, CAS: /, stock: 4.3g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₇H₂₂D₉Br₂ClN₄O₂.
MKT-077, CAS: 147366-41-4, stock: 1.4g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₂₂N₃OS₂⁺ • Ci.
N,N-Didesmethyl Tamoxifen, CAS: 80234-20-4, stock: 2.7g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₂₅NO.
N-Boc-N-desmethyl-4-hydroxy Tamoxifen (E/Z Mixture), CAS: 1189368-74-8, stock: 6.8g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₀H₃₅NO₄.
N-Boc-N-desmethyl-4-hydroxy Tamoxifen 2,3,4,6-Tetra-O-acetyl-β-D-glucuronide Methyl Ester (E/Z Mixture), CAS: /, stock: 5.6g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄₃H₅₁NO₁₃.
N-Demethyl-3,4-dihydroxytamoxifen Hydrochloride(Z,E mixture), CAS: 2125720-11-6, stock: 5.5g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₂₈ClNO₃.
N-Demethyl-3,4-dihydroxytamoxifen-d3 Hydrochloride(Z,E mixture), CAS: /, stock: 3.7g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₂₈D₃ClNO₃.
N-Demethyl-3-methoxy-4-hydroxytamoxifen Hydrochloride (E,Z mixture), CAS: 2125720-13-8, stock: 8.5g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₆H₃₀ClNO₃.
N-Demethyl-3-methoxy-4-hydroxytamoxifen-d3 Hydrochloride (Z,E mixture), CAS: /, stock: 7.6g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₆H₂₇D₃ClNO₃.
N-Desmethyl (E)-α-Hydroxy Tamoxifen, CAS: 162070-61-3, stock: 1.3g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₂₇NO₂.
N-Desmethyl Droloxifene (contains up to 5% Z isomer), CAS: 83647-33-0, stock: 5.2g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₂₇NO₂.
N-Desmethyl Droloxifene-d5, CAS: 1185241-63-7, stock: 3.7g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₂₂D₅NO₂.
N-Desmethyl Tamoxifen Hydrochloride, CAS: 15917-65-4, stock: 4.5g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₂₈ClNO.
N-Desmethyl Tamoxifen Methanethiosulfonate, CAS: 1025678-19-6, stock: 1.1g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₈H₃₃NO₃S₂.
N-Desmethyl Tamoxifen Methanethiosulfonate Hydrobromide, CAS: /, stock: 7.6g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₈H₃₄BrNO₃S₂.
N-Desmethyl Tamoxifen-d5, CAS: 164365-16-6, stock: 2.2g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₂₂D₅NO.
N-Desmethyl-3-hydroxy Tamoxifen O-β-D-Glucuronide, CAS: 206440-83-7, stock: 3.4g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₁H₃₅NO₈.
N-Desmethyl-4-hydroxy Tamoxifen (approx. 1:1 E/Z Mixture), CAS: 110025-28-0, stock: 8g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₂₇NO₂.
N-Desmethyl-4-hydroxy Tamoxifen β-D-Glucuronide (E/Z Mixture), CAS: 152764-52-8, stock: 7.9g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₁H₃₅NO₈.
N-Desmethyl-4-hydroxy Tamoxifen Tri-O-acetyl-β-D-glucuronic Acid Methyl Ester (E/Z Mixture), CAS: /, stock: 2.5g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₈H₄₃NO₁₁.
N-Desmethyl-4-hydroxy Tamoxifen-d5 (1:1 E/Z Mixture), CAS: 1584173-54-5, stock: 6.4g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₂₂D₅NO₂.
N-Desmethyl-4-hydroxy Tamoxifen-d5 β-D-Glucuronide(E/Z Mixture), CAS: /, stock: 4.9g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₁H₃₀D₅NO₈.
N-Desmethyl-4-hydroxy Tamoxifen-d5 Tri-O-acetyl-β-D-glucuronic Acid Methyl Ester (E/Z Mixture), CAS: /, stock: 4.3g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₈H₃₈D₅NO₁₁.
N-Desmethyl-4’-hydroxy Tamoxifen (E/Z Mixture), CAS: /, stock: 9.6g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₂₇NO₂.
N-Desmethyl-4’-hydroxy Tamoxifen, CAS: 170171-12-7, stock: 6.1g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₂₇NO₂.
N-Desmethyl-4’-hydroxy Tamoxifen-d3 (E/Z Mixture), CAS: 1795139-22-8, stock: 3.3g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₂₄D₃NO₂.
N-Methyl-N-(2-acetoxyacetyl) Tamoxifen (E/Z Mixture), CAS: 1076198-47-4, stock: 3g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₉H₃₁NO₄.
N-Methyl-N-(2-hydroxyethyl) Tamoxifen, CAS: 77214-91-6, stock: 5.1g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₇H₃₁NO₂.
N-Methyl-N-(2-hydroxyethyl)tamoxifen, CAS: 77214-91-6, stock: 5.7g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₇H₃₁NO₂.
Nafoxidine Hydrochloride, CAS: 1847-63-8, stock: 8.7g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₉H₃₂ClNO₂.
Nafoxidine-d5 Hydrochloride, CAS: 1794766-71-4, stock: 2.2g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₉H₂₇D₅BrNO₂.
N’-((4-(2-(Dimethylamino)ethoxy)phenyl)(phenyl)methylene)-4-methylbenzenesulfonohydrazide, CAS: /, stock: 7.6g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₂₇N₃O₃S.
Nitromifene, CAS: 10448-84-7, stock: 1.2g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₇H₂₈N₂O₄.
Nitromifene Citrate (E/Z mixture), CAS: 5863-35-4, stock: 2g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₃H₃₆N₂O₁₁.
Panomifene, CAS: 77599-17-8, stock: 8.6g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₂₄F₃NO₂.
Ridaifen-B, CAS: 886465-70-9, stock: 8.2g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₄H₄₂N₂O₂.
Tamoxifen, CAS: 10540-29-1, stock: 9.8g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₆H₂₉NO.
Tamoxifen (1.0 mg/mL in Methanol), CAS: 10540-29-1, stock: 3.8g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₆H₂₉NO.
Tamoxifen Citrate, CAS: 54965-24-1, stock: 2.9g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₆H₂₉NO•C₆H₈O₇.
Tamoxifen Dimer, CAS: 1346606-51-6, stock: 8.9g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄₉H₄₉NO₂.
Tamoxifen N-Oxide, CAS: 75504-34-6, stock: 3.4g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₆H₂₉NO₂.
Tamoxifen-13C6, CAS: 1346606-38-9, stock: 3.6g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀¹³C₆H₂₉NO.
Tamoxifen-d5, CAS: 157698-32-3, stock: 9.8g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₆H₂₄D₅NO.
Toremifene, CAS: 89778-26-7, stock: 6.3g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₆H₂₈ClNO.
Toremifene Citrate, CAS: 89778-27-8, stock: 8g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₂H₃₆ClNO₈.
Toremifene N-Oxide, CAS: 163130-29-8, stock: 7.9g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₆H₂₈ClNO₂.
Toremifene N-Oxide-d6, CAS: /, stock: 8g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₆H₂₂D₆ClNO₂.
Toremifene-d6 Citrate, CAS: 1246833-71-5, stock: 9.5g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₂H₃₀D₆ClNO₈.
trans-(E)-1-Bromo-2-[4-[2-(dimethylamino)ethoxy]phenyl]-1,2-diphenylethene, CAS: 19118-19-5, stock: 6.7g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₂₄BrNO.
TTC-352, CAS: 1607819-68-0, stock: 1.5g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₁₃FO₃S.
TTC-352-d4, CAS: /, stock: 1.9g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₉D₄FO₃S.
Z-[4-(1,2-Diphenyl-1-butenyl)phenoxy]acetic Acid, CAS: 97818-93-4, stock: 2.3g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₂₂O₃.
[4-[2-(Dimethylamino)ethoxy]phenyl](4-hydroxyphenyl)methanone, CAS: 173163-13-8, stock: 4.9g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₉NO₃.
[4-[2-(Dimethylamino)ethoxy]phenyl](4-hydroxyphenyl)methanone-d6, CAS: /, stock: 9.7g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₃D₆NO₃.
(1R,3R)-1-(1,3-Benzodioxol-5-yl)-2,3,4,9-tetrahydro-N-methyl-1H-pyrido[3,4-b]indole-3-carboxamide, CAS: 951661-82-8, stock: 3.3g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₁₉N₃O₃.
(1R,3R)-1-(1,3-benzodioxol-5-yl)-2-(2-chloroacetyl)-2,3,4,9-tetrahydro-1H-Pyrido[3,4-b]indole-3-carboxylic acid, CAS: 2058231-08-4, stock: 1.3g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₁₇ClN₂O₅.
(1R,3R)-1-(1,3-Benzodioxol-5-yl)-2-(2-chloroacetyl)-2,3,4,9-tetrahydro-N-methyl-1H-pyrido[3,4-b]indole-3-carboxamide, CAS: 951661-81-7, stock: 7.2g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₂₀ClN₃O₄.
(1R,3R)-1-(1,3-Benzodioxol-5-yl)-2-(dichloroacetyl)-2,3,4,9-tetrahydro-1H-b-carboline-3-carboxylic Acid, CAS: /, stock: 2.5g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₁₆Cl₂N₂O₅.
(1R,3R)-1-(Benzo[d][1,3]dioxol-5-yl)-2,9-bis(2-chloroacetyl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylic Acid, CAS: /, stock: 2.1g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₁₈Cl₂N₂O₆.
(1R,3R)-Methyl-1,2,3,4-tetrahydro-1-(3,4-methylenedioxyphenyl)-9H-pyrido[3,4-b]indole-3-carboxylate, CAS: 171596-41-1, stock: 2.8g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₁₈N₂O₄.
(1R,3R)-Methyl-1,2,3,4-tetrahydro-2-chloroacetyl-1-(3,4-methylenedioxyphenyl)-9H-pyrido[3,4-b]indole-3-carboxylate (Chloropretadalafil), CAS: 171489-59-1, stock: 5.9g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₁₉ClN₂O₅.
(1R,3S)-1-(1,3-Benzodioxol-5-yl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylic Acid Methyl Ester, CAS: 171596-44-4, stock: 9.3g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₁₈N₂O₄.
(1R,3S)-1-(1,3-Benzodioxol-5-yl)-2-(2-chloroacetyl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylic Acid Methyl Ester, CAS: 629652-44-4, stock: 2.6g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₁₉ClN₂O₅.
(1R,3R)-1-(1,3-Benzodioxol-5-yl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxamide, CAS: 1370438-57-5, stock: 3g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₁₇N₃O₃.
(1R,3R)-1-(1,3-Benzodioxol-5-yl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylic Acid Hydrochloride, CAS: 474668-76-3, stock: 5.6g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₁₆N₂O₄ . HCl.
(1R,3R)-2-Aacetyl-1-(1,3-benzodioxol-5-yl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylic Acid, CAS: 1598416-07-9, stock: 6.1g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₁₈N₂O₅.
(1S,3R)-1-(1,3-Benzodioxol-5-yl)-2,3,4,9-tetrahydro-N-methyl-1H-pyrido[3,4-b]indole-3-carboxamide, CAS: 951661-85-1, stock: 7.4g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₁₉N₃O₃.
(1S,3R)-1-(1,3-Benzodioxol-5-yl)-2,3,4,9-tetrahydro-N-methyl-1H-pyrido[3,4-b]indole-3-carboxamide-d3, CAS: /, stock: 7g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₁₆D₃N₃O₃.
(1S,3R)-1-(1,3-Benzodioxol-5-yl)-2-(2-chloroacetyl)-2,3,4,9-tetrahydro-N-methyl-1H-pyrido[3,4-b]indole-3-carboxamide, CAS: 951661-84-0, stock: 5.7g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₂₀ClN₃O₄.
(1S,3R)-1-Benzo[1,3]dioxol-5-yl-2-(2-chloro-acetyl)-2,3,4,9-tetrahydro-1H-b-carboline-3-carboxylic Acid Methyl Ester, CAS: 629652-40-0, stock: 10g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₁₉ClN₂O₅.
(1S,3R)-Methyl-1,2,3,4-tetrahydro-1-(3,4-methylenedioxyphenyl)-9H-pyrido[3,4-b]indole-3-carboxylate, CAS: 171596-42-2, stock: 9g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₁₈N₂O₄.
(1S,3S)-1-(1,3-Benzodioxol-5-yl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylic Acid Methyl Ester, CAS: 171596-43-3, stock: 5.5g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₁₈N₂O₄.
(1S,3S)-1-(1,3-Benzodioxol-5-yl)-2-(2-chloroacetyl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylic Acid Methyl Ester, CAS: 629652-42-2, stock: 2.3g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₁₉ClN₂O₅.
(2R)-2-Amino-3-(1-(1-(3-((R)-2-amino-2-carboxyethyl)-1H-inden-1-yl)ethyl)-1H-indol-3-yl)propanoic Acid, CAS: /, stock: 6.9g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₂₆N₄O₄.
(6bR,12R)-12-(Benzo[d][1,3]dioxol-5-yl)-12a-hydroxy-8-methyl-8,9,12,12a-tetrahydropyrazino[1’,2’:1,2]pyrrolo[3,4-c]quinoline-6,7,10(5H,6aH,6bH)-trione, CAS: /, stock: 1.2g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₁₉N₃O₆.
(6R)-6-(Benzo[d][1,3]dioxol-5-yl)-7-(2-chloroacetyl)-2-methyl-2,3,12,12a-tetrahydropyrazino[1’,2’:1,6]pyrido[3,4-b]indole-1,4(6H,7H)-dione, CAS: /, stock: 7.7g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₂₀ClN₃O₅.
(6R)-6-(Benzo[d][1,3]dioxol-5-yl)-N-ethyl-2-methyl-1,4-dioxo-1,2,3,4,12,12a-hexahydropyrazino[1’,2’:1,6]pyrido[3,4-b]indole-7(6H)-carboxamide, CAS: /, stock: 6.4g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₂₄N₄O₅.
(6R,12aS)-N-Desmethyl ent-Tadalafil, CAS: 929100-66-3, stock: 7.4g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₁₇N₃O₄.
(N-Phenylpropenyl) Desmethyltadalafil, CAS: /, stock: 6.2g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₀H₂₄N₄O₄.
2-Hydroxyethyl Nortadalafil, CAS: 385769-94-8, stock: 6.7g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₂₁N₃O₅.
2-Hydroxyethyl Nortadalafil-d4, CAS: /, stock: 1.4g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₁₇D₄N₃O₅.
2-Hydroxypropyl Nortadalafil (Mixture of Diastereomers), CAS: 1353020-85-5, stock: 3.1g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₂₃N₃O₅.
2-Hydroxypropyl-d6 Nortadalafil, CAS: /, stock: 6.9g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₁₇D₆N₃O₅.
2-Triethylmethyl Tadalafil, CAS: /, stock: 5.8g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₇H₂₉N₃O₄.
2’-Oxo Tadalafil, CAS: 1346602-17-2, stock: 6.1g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₁₇N₃O₅.
7-(2-Fluorophenyl)-1,2,3,4-tetrahydro-1-oxo-pyrrolo[1,2-a]pyrazine-4-acetic Acid, CAS: 1170575-17-3, stock: 4.4g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₃FN₂O₃.
Acetaminotadalafil, CAS: 1446144-71-3, stock: 6.2g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₂₀N₄O₅.
Amino Tadalafil, CAS: 385769-84-6, stock: 1.1g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₁₈N₄O₄.
Chloropretadalafil-13C2, CAS: /, stock: 4.5g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀¹³C₂H₁₉ClN₂O₅.
Chloropropanoylpretadalafil, CAS: 395665-87-9, stock: 8.2g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₂₁ClN₂O₅.
cis-ent-Tadalafil, CAS: 171596-28-4, stock: 5.7g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₁₉N₃O₄.
cis-ent-Tadalafil-d3, CAS: 1329799-70-3, stock: 8g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₁₆D₃N₃O₄.
cis-Tadalafil, CAS: 171596-27-3, stock: 1.4g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₁₉N₃O₄.
cis-Tadalafil-d3, CAS: 1329799-70-3, stock: 2.5g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₁₆D₃N₃O₄.
Desmethylene Tadalafil, CAS: 171489-03-5, stock: 8.4g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₁₉N₃O₄.
Dipropylaminopretadalafil, CAS: /, stock: 9.3g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₈H₃₃N₃O₅.
ent-Tadalafil, CAS: 629652-72-8, stock: 7.9g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₁₉N₃O₄.
ent-Tadalafil-d3, CAS: 1329568-92-4, stock: 2g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₁₆D₃N₃O₄.
Hydroxypropyl Nortadalafil, CAS: /, stock: 2.9g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₂₃N₃O₅.
L-Tryptophan Methyl Ester, CAS: 4299-70-1, stock: 6.5g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₄N₂O₂.
N-Butyl Nortadalafil, CAS: 171596-31-9, stock: 6.4g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₂₅N₃O₄.
N-Butyl Nortadalafil-d9, CAS: /, stock: 5.4g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₁₆D₉N₃O₄.
N-Desmethyl Tadalafil, CAS: 171596-36-4, stock: 4.3g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₁₇N₃O₄.
N-Desmethyl-N-cyclopentyl cis-ent-Tadalafil, CAS: 171488-19-0, stock: 8.8g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₆H₂₅N₃O₄.
N-Desmethyl-N-cyclopentyl cis-ent-Tadalafil-D4, CAS: /, stock: 8.9g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₆H₂₁D₄N₃O₄.
N-Desmethyl-N-cyclopentyl Tadalafil, CAS: 171596-32-0, stock: 3.4g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₆H₂₅N₃O₄.
N-Desmethyl-N-cyclopentyl Tadalafil-D4, CAS: /, stock: 5.5g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₆H₂₁D₄N₃O₄.
N-methyl-Tadalafil, CAS: 477970-21-1, stock: 4.4g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₂₁N₃O₄.
N-Octyl cis-ent-Nortadalafil, CAS: /, stock: 4g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₉H₃₃N₃O₄.
N-Octyl cis-Nortadalafil, CAS: /, stock: 9.3g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₉H₃₃N₃O₄.
N-Octyl Nortadalafil, CAS: 1173706-35-8, stock: 1.1g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₉H₃₃N₃O₄.
N-Octyl Nortadalafil-d17, CAS: /, stock: 5.1g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₉H₁₆D₁₇N₃O₄.
Tadalafil, CAS: 171596-29-5, stock: 4.1g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₁₉N₃O₄.
Tadalafil Hydroxypiperidone, CAS: /, stock: 2.7g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₁₉N₃O₆.
Tadalafil Ketolactam (>90%), CAS: 1346605-38-6, stock: 7.7g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₁₉N₃O₆.
Tadalafil Nindolyl Lactose, CAS: /, stock: 5g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₄H₃₉N₃O₁₄.
Tadalafil open ring acid, CAS: 2058231-15-3, stock: 8g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₂₁N₃O₅.
Tadalafil open ring methyl ester, CAS: /, stock: 7.5g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₂₃N₃O₅.
Tadalafil Oxidation Impurity, CAS: /, stock: 3.1g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₁₇N₃O₅.
Tadalafil-13C2,d3, CAS: /, stock: 3.2g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀¹³C₂H₁₆D₃N₃O₄.
Tadalafil-d3, CAS: 960226-55-5, stock: 6g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₁₆D₃N₃O₄.
trans-Bisphrehomotadalafil, CAS: 1803592-02-0, stock: 2.8g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄₆H₄₃N₅O₁₀.
(E/Z)-FK-506 26,28-Allylic Ester Rearrangement Impurity, CAS: 131944-48-4, stock: 8.2g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄₄H₆₉NO₁₂.
22-Hydroxy 33-tert-Butyldimethylsilyloxy-FK 506, CAS: /, stock: 5.2g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅₀H₈₅NO₁₂Si.
23-Hydroxy-33-O-tert-butyldimethylsilyloxy-27-O-trimethylsilyl-iso-FK-506, CAS: /, stock: 6.9g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅₃H₉₁NO₁₂Si₂.
24,32-Bis-O-(tert-butyldimethylsilyl)-FK-506, CAS: 133941-75-0, stock: 1.5g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅₆H₉₇NO₁₂Si₂.
24,32-Bis-O-(tert-butyldimethylsilyl)-FK-506-13C, D2 (Major), CAS: 1356352-20-9, stock: 9.3g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅₅¹³CH₉₅D₂NO₁₂Si₂.
24,33-Bis-O-(tert-butyldimethylsilyl)-37,38-dehydro-37,38-dihydroxy-FK-506 (mixture of diastereomers), CAS: 1356932-17-6, stock: 6.9g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅₆H₉₉NO₁₄Si₂.
33-tert-Butyldimethylsilyloxy-FK 506, CAS: 104987-25-9, stock: 6.1g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅₀H₈₃NO₁₂Si.
8-Epitacrolimus, CAS: 129212-35-7, stock: 7.3g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄₄H₆₉NO₁₂.
Ascomycin, CAS: 104987-12-4, stock: 2.3g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄₃H₆₉NO₁₂.
Dihydro FK-506, CAS: 104987-30-6, stock: 9.1g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄₄H₇₁NO₁₂.
FK-506 (Tacrolimus), CAS: 104987-11-3, stock: 8.6g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄₄H₆₉NO₁₂.
FK-506 3’-Methyl Ether, CAS: 124554-16-1, stock: 3.2g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄₅H₇₁NO₁₂.
FK-506-13C,D2 (Major) (Tacrolimus)(>85%), CAS: 1356841-89-8, stock: 5.3g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄₃¹³CH₆₇D₂NO₁₂.
Iso-FK-506 (iso-Tacrolimus), CAS: 134590-88-8, stock: 9.2g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄₄H₆₉NO₁₂.
Δ23-FK-506, CAS: 104987-16-8, stock: 7.9g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄₄H₆₇NO₁₁.
Methanediamine, CAS: 2372-88-5, stock: 2.2g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: CH₆N₂.
Tacrolimus Hydrate, CAS: 109581-93-3, stock: 4g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄₄H₇₁NO₁₃.
Tacrolimus Methyl Acryl Aldehyde, CAS: 109466-74-2, stock: 8.8g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₈O₃.
Tacrolimus Related Compound A, CAS: 135635-46-0, stock: 9.9g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄₃H₆₉NO₁₂.
(αR)-N-Methyl-α-(methylamino)-benzenepropanamide, CAS: 193150-11-7, stock: 5.2g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₆N₂O.
Methyl[(1R)-2-(methylamino)-2-oxo-1-(phenylmethyl)ethyl]-carbamic Acid 1,1-Dimethylethyl Ester, CAS: 193085-18-6, stock: 2.3g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₂₄N₂O₃.
N-Methyl-3-(2-naphthalenyl)-D-alanyl-N,Nα-dimethyl-D-phenylalaninamide, CAS: 186840-95-9, stock: 7.5g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₂₉N₃O₂.
N-[(1,1-Dimethylethoxy)carbonyl]-N-methyl-3-(2-naphthalenyl)-D-alanyl-N,Nα-dimethyl-D-phenylalaninamide, CAS: 193085-19-7, stock: 9.3g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₀H₃₇N₃O₄.
N-Boc Tabimorelin, CAS: 193085-20-0, stock: 5.1g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₇H₄₈N₄O₅.
Tabimorelin, CAS: 193079-69-5, stock: 4g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₂H₄₀N₄O₃.
Tabimorelin Hemifumarate, CAS: 242143-80-2, stock: 6g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₂H₄₀N₄O₃.1/₂C₄H₄O₄.
9-Amino-1,2,3,4-tetrahydroacridin-1-ol Maleate, CAS: 118909-22-1, stock: 3.7g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₈N₂O5.
9-Amino-1,2,3,4-tetrahydroacridin-1-ol-d3, CAS: 1219806-47-9, stock: 4.1g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₁D₃N₂O.
9-Amino-1,2,3,4-tetrahydroacridin-1-ol-d3 Maleate, CAS: 1219806-48-0, stock: 1g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₅D₃N₂O₅.
1-Boc-5-fluorooxindole, CAS: 1332461-14-9, stock: 6.7g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₄FNO₃.
2-[2-(Diethylamino)ethyl]-1H-isoindole-1,3(2H)-dione, CAS: /, stock: 7.3g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₄D₄N₂O₂.
4-[[[2-(Diethylamino)ethyl]amino]carbonyl]-3,5-dimethyl-1H-pyrrole-2-Carboxylic Acid, CAS: 1506692-68-7, stock: 8g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₂₃N₃O₃.
4-Benzyl 2-methyl 3,5-dimethyl-1H-pyrrole-2,4-dicarboxylate, CAS: 1438020-52-0, stock: 6.1g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₁₇NO₄.
5-(5-Fluoro-2-oxo-1,2-dihydro-indol-3-ylidenemethyl)-2,4-dimethyl-1H-pyrrole-3-carboxylic Acid, CAS: 452105-33-8, stock: 4.6g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₁₃FN₂O₃.
5-(Methoxycarbonyl)-2,4-dimethyl-1H-pyrrole-3-carboxylic Acid, CAS: 78331-73-4, stock: 3g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₁₁NO₄.
5-[(Z)-(5-Fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide, CAS: 1186651-51-3, stock: 3g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₁₄FN₃O₂.
JI-101, CAS: 900573-88-8, stock: 3g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₂₀BrN₅O₂.
Methyl 4-((2-(Diethylamino)ethyl)carbamoyl)-3,5-dimethyl-1H-pyrrole-2-carboxylate, CAS: 1462291-00-4, stock: 2.5g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₂₅N₃O₃.
N,N-Diethylethylenediamine-d4 Hydrochloride, CAS: /, stock: 2.8g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₁₂D₄N₂ • 2(HCl).
N,N-Didesethyl Sunitinib Hydrochloride, CAS: 1217216-61-9, stock: 3.7g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₂₀ClFN₄O₂.
N,N-Didesethyl Sunitinib-d4 Hydrochloride, CAS: 1346606-30-1, stock: 1.5g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₁₆D₄ClFN₄O₂.
N,N-Dimethyl Sunitinib, CAS: 326914-17-4, stock: 9.2g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₃FN₄O₂.
N-Boc-N,N-didesethyl Sunitinib, CAS: 1227960-76-0, stock: 5.3g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₂₇FN₄O₄.
N-Boc-N-desethyl Sunitinib, CAS: 1246833-23-7, stock: 8.2g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₃₁FN₄O₄.
N-Boc-N-desethyl Sunitinib-d5, CAS: 1246832-84-7, stock: 6g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₂₆D₅FN₄O₄.
N-Desethyl Sunitinib, CAS: 356068-97-8, stock: 4.6g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₃FN₄O₂.
N-Desethyl Sunitinib Hemimalate, CAS: 1474111-36-8, stock: 3.6g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₃FN₄O₂•1/2C₄H₆O₅.
N-Desethyl Sunitinib Maleate, CAS: /, stock: 5g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₂₇FN₄O₆.
N-Desethyl Sunitinib-d4 Maleate, CAS: /, stock: 9.6g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₂₃D₄FN₄O₆.
N-Desethyl Sunitinib-d5, CAS: 1217247-62-5, stock: 4g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₁₈D₅FN₄O₂.
N-[2-(Ethylamino)ethyl]-5-formyl-2,4-dimethyl-1H-pyrrole-3-carboxamide, CAS: 356068-98-9, stock: 7.6g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₉N₃O₂.
Sunitinib, CAS: 557795-19-4, stock: 5.1g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₂₇FN₄O₂.
Sunitinib 9’N-Methyl, CAS: /, stock: 8.8g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₂₉FN₄O₂.
Sunitinib Malate, CAS: 341031-54-7, stock: 8.3g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₆H₃₃FN₄O₇.
Sunitinib N-Glucuronide, CAS: /, stock: 9.4g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₈H₃₅FN₄O₈.
Sunitinib N-Oxide, CAS: 356068-99-0, stock: 9.7g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₂₇FN₄O₃.
Sunitinib N-Oxide-d10, CAS: /, stock: 1.5g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₁₇D₁₀FN₄O₃.
Sunitinib-d10, CAS: 1126721-82-1, stock: 2.2g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₁₇D₁₀FN₄O₂.
Sunitinib-d4, CAS: 1126721-79-6, stock: 4.2g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₂₃D₄FN₄O₂.
1-(3-(2-(Dimethylamino)ethyl)-1-((5-((N-methylsulfamoyl)methyl)-1H-indol-3-yl)methyl)-1H-indol-5-yl)-N-methylmethanesulfonamide, CAS: /, stock: 9.5g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₃₃N₅O₄S₂.
1-(3-(2-(Dimethylamino)ethyl)-1-((5-((N-methylsulfamoyl)methyl)-1H-indol-3-yl)methyl)-1H-indol-5-yl)-N-methylmethanesulfonamide Formate Salt, CAS: /, stock: 9.5g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₃₃N₅O₄S₂ • HCOOH.
1-(3-(2-(Dimethylamino)ethyl-2-((5-((N-methylsulfamoyl)methyl)-1H-indol-3-yl)methyl)-1H-indo-5-yl)-N-methylmethanesulfonamide, CAS: /, stock: 3.2g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₃₃N₅O₄S₂.
1-(3-(Hydroxymethyl)-2-(trimethylsilyl)-1H-indol-5-yl)-N-methylmethanesulfonamide, CAS: /, stock: 4.5g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₂₂N₂O₃SSi.
2-(Ethyl Formate) Sumatriptan, CAS: /, stock: 5.9g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₂₃N₃O₄S.
2-[3-(2-Dimethylaminoethyl)-1H-indol-2-yl-methyl]-Sumatriptan, CAS: /, stock: 9.7g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₇H₃₇N₅O₂S.
2-[[3-[2-(Dimethylamino)ethyl]-1H-indol-5-yl]methyl] Sumatriptan, CAS: 545338-89-4, stock: 6g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₇H₃₇N₅O₂S.
2-[[3-[2-(Dimethylamino)ethyl]-1H-indol-5-yl]methyl] Sumatriptan Succinate-d6, CAS: /, stock: 9.6g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₇H₃₁D₆N₅O₂S.
3-(2-Aminoethyl)-N-methyl-1H-indole-5-methanesulfonamide (Didesmethyl Sumatriptan), CAS: 88919-22-6, stock: 3.4g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₇N₃O₂S.
3-(Cyanomethyl)-N-methyl-1H-indole-5-methanesulfonamide, CAS: 88918-76-7, stock: 5.5g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₃N₃O₂S.
3-(Hydroxymethyl)-N-methyl-1H-indole-5-methanesulfonamide, CAS: 179636-97-6, stock: 7.2g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₄N₂O₃S.
3a-Hydroxy-1,1-dimethyl-5{[(methylamino)sulfonyl]methyl}-1,2,3,3a,8,8a-hexahydropyrrolo[2,3-b]indol-1-ium Trifluoroacetate-d6, CAS: /, stock: 2.4g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₁₆D₆F₃N₃O₅S.
4-Amino-3-iodo-N-methylbenzenemethanesulfonamide, CAS: 151140-66-8, stock: 6.7g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₁₁IN₂O₂S.
4-Amino-N-methyl-α-toluenesulfonamide, CAS: 109903-35-7, stock: 1.6g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₁₂N₂O₂S.
4-Hydrazino-N-methyl Benzene Methanesulfonamide Hydrochloride Salt, CAS: 88933-16-8, stock: 2.1g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₁₄ClN₃O₂S.
4-[2-(4-Chlorobutylidene)hydrazinyl]-N-methylbenzenemethanesulfonamide, CAS: 88918-68-7, stock: 6.7g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₈ClN₃O₂S.
5-Hydroxymethyl-N,N-dimethyltryptamine, CAS: 334981-08-7, stock: 7.6g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₈N₂O.
5-Hydroxymethyl-N,N-dimethyltryptamine-d6, CAS: 1346603-68-6, stock: 2.2g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₂D₆N₂O.
GR 49336, CAS: 103628-44-0, stock: 2.6g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₄N₂O₄S.
GR 49336-d3, CAS: /, stock: 1.6g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₁D₃N₂O₄S.
α,β-Dioxo-N-N-dimethyltryptamine 5-Carboxylic Acid Methyl Ester, CAS: 1052181-84-6, stock: 9.7g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₄N₂O₄.
N-Desmethyl Sumatriptan Hemisuccinate, CAS: /, stock: 7.3g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₀H₄₄N₆O₈S₂.
N-Hydroxymethyl Sumatriptan, CAS: 1797905-62-4, stock: 3.7g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₂₃N₃O₃S.
N-Methyl-1-(2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indol-6-yl)methanesulfonamide Succinate, CAS: /, stock: 4.8g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₂₃N₃O₆S.
N-Methyl-1-(2-(triethylsilyl)-3-(((triethylsilyl)oxy)methyl)-1H-indol-5-yl)methanesulfonamide, CAS: /, stock: 2.2g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₄₂N₂O₃SSi₂.
N-Methyl-1-(2-methyl-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indol-6-yl)methanesulfonamide Succinate, CAS: /, stock: 2.5g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₂₅N₃O₆S.
Sumatriptan, CAS: 103628-46-2, stock: 5.3g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₂₁N₃O₂S.
Sumatriptan Hydroxy-Oxindole Impurity (Sumatriptan Impurity 1), CAS: /, stock: 6.6g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₂₁N₃O₄S.
Sumatriptan Hydroxy-Oxindole Impurity Hydrochloride (Sumatriptan Impurity 1), CAS: /, stock: 2.9g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₂₂ClN₃O₄S.
Sumatriptan N-Oxide, CAS: 212069-94-8, stock: 3.8g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₂₁N₃O₃S.
Sumatriptan Succinate, CAS: 103628-48-4, stock: 2.8g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₂₇N₃O₆S.
Sumatriptan-d6, CAS: 1020764-38-8, stock: 3.4g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₅D₆N₃O₂S.
Sumatriptan-d6 N-Oxide, CAS: 1346599-50-5, stock: 3.7g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₅D₆N₃O₃S.
Sumatriptan-d6 Succinate, CAS: 1215621-31-0, stock: 5.6g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₂₁D₆N₃O₆S.
t-Butyl 3-(Bromomethyl)-5-((N-(tert-butoxycarbonyl)-N-methylsulfamoyl)methyl)-1H-indole-1-carboxylate, CAS: /, stock: 8.6g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₂₉BrN₂O₆S.
t-Butyl 5-((N-(t-Butoxycarbonyl)-N-methylsulfamoyl)methyl)-3-(hydroxymethyl)-1H-indole-1-carboxylate, CAS: /, stock: 7.6g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₃₀N₂O₇S.
tert-Butyl 5-((N-(tert-Butoxycarbonyl)-N-methylsulfamoyl)methyl)-3-((5-((N-(tert-butoxycarbonyl)-N-methylsulfamoyl)methyl)-3-(2-(dimethylamino)ethyl)-1H-indol-1-yl)methyl)-1H-indole-1-carboxylate, CAS: /, stock: 2.6g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄₀H₅₇N₅O₁₀S₂.
(R)-Sulindac, CAS: 190967-68-1, stock: 9g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₁₇FO₃S.
(R)-Sulindac Methyl Ester, CAS: 929081-61-8, stock: 7.4g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₁₉FO₃S.
(S)-Sulindac, CAS: 149116-77-8, stock: 6.9g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₁₇FO₃S.
(Z)-Sulindac Sulfone, CAS: 59973-80-7, stock: 5.4g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₁₇FO₄S.
5-Fluoro-2-methyl-1-(4-methylsulfinylbenzylidene)indene Acyl-β-D-Glucopyranuronic Acid 2-Propenyl Ester, CAS: /, stock: 3.9g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₉H₂₉FO₉S.
6-Bromo-1-hexanol, CAS: 4286-55-9, stock: 5g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₁₃BrO.
Sulindac, CAS: 38194-50-2, stock: 8.3g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₁₇FO₃S.
Sulindac Acyl-β-D-Glucuronide, CAS: 60018-36-2, stock: 1.5g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₆H₂₅FO₉S.
Sulindac Sulfide, CAS: 49627-27-2, stock: 4.2g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₁₇FO₂S.
Sulindac Sulfide Acyl-β-D-Glucuronide, CAS: 59973-78-3, stock: 9.3g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₆H₂₅FO₈S.
Sulindac Sulfide Methyl Ester, CAS: 106647-49-8, stock: 3.3g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₁₉FO₂S.
Sulindac Sulfide-d6 (Major), CAS: /, stock: 9.4g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₁₁D₆FO₂S.
Sulindac Sulfone, CAS: 59864-04-9, stock: 3.5g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₁₇FO₄S.
Sulindac Sulfone Acyl-β-D-Glucuronide, CAS: 60018-37-3, stock: 5.6g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₆H₂₅FO₁₀S.
Sulindac Sulfone Methyl Ester, CAS: 141741-24-4, stock: 3.7g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₁₉FO₄S.
Sulindac Sulfone-d6, CAS: /, stock: 1.8g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₁₁D₆FO₄S.
Sulindac-d6, CAS: /, stock: 5.5g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₁₁D₆FO₃S.
Sulindac-d6 Methyl Ester, CAS: /, stock: 10g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₁₃D₆FO₃S.
Ethyl 2-Methoxy-5-sulfamoylbenzoate, CAS: 33045-53-3, stock: 1.8g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₃NO₅S.
1-(6-aminohexyl)guanidine sulfuric acid, CAS: 1401846-54-5, stock: 6.2g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₁₈N₄.H₂O₄S.
1-Ethyl-4-hydrazinylpiperidine Dihydrochloride, CAS: 99669-99-5, stock: 6g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₁₇N₃ •2HCl.
1H-Benzimidazole-5-carboxylic Acid Methyl Ester Sulfate, CAS: 131020-58-1, stock: 1.1g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₁₀N₂O₆S.
2,2,2-Trichloroethyl Chlorosulfate, CAS: 764-09-0, stock: 8.7g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂H₂Cl₄O₃S.
2-Amino-5-chloro-3-nitro-6-picoline, CAS: 56960-82-8, stock: 5.4g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₆ClN₃O₂.
2-Aminoethyl Sulfate, CAS: 926-39-6, stock: 6.3g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂H₇NO₄S.
2-Methylbenzenesulfonic Acid Dihydrate, CAS: 68066-37-5, stock: 5.1g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₈O₃S . 2(H ₂O).
4-(5-chlorothiophen-2-yl)-1H-imidazol-2-amine sulfuric acid, CAS: 1423034-39-2, stock: 6.9g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₆N₃SCl.H₂O₄S.
4-Bromobutan-1-amine Hydrobromide, CAS: 24566-81-2, stock: 3.9g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄H₁₁Br₂N.
4-Methylpiperazine-1-carboximidamide Sulfuric Acid, CAS: 84727-42-4, stock: 1.8g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₁₄N₄.H₂O₄S.
5-Hydroxymethyl-2-furancarboxylic Acid-13C6, CAS: /, stock: 1.2g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: ¹³C₆H₆O₄.
Ammonium Dichromate, CAS: 05/09/7789, stock: 1.3g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: (NH₄)₂Cr₂O₇.
Ammonium Persulfate, CAS: 7727-54-0, stock: 8.4g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: H₈N₂O₈S₂.
Ammonium Sulfate (2:1), CAS: 7783-20-2, stock: 4.7g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: 2(NH₃) • 1/2(H ₂O₄S).
Arbekacin Sulfate (Technical Grade), CAS: 104931-87-5, stock: 7.6g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₄₄N₆O₁₀ • xH ₂SO₄.
bis(1-(3-methoxypropyl)guanidine) sulfuric acid, CAS: 1315366-59-6, stock: 9.8g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: ₂[C₅H₁₃N₃O].H₂O₄S.
Bis(1-[(4-methoxyphenyl)methyl]-1-methylguanidine) Sulfuric Acid, CAS: 1461708-20-2, stock: 7.1g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: 2[C₁₀H₁₅N₃O] • H₂O₄S.
bis(2-cyclopentylguanidine) sulfuric acid, CAS: 1315368-20-7, stock: 4.4g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: ₂[C₆H₁₃N₃].H₂O₄S.
bis(2-[3-(morpholin-4-yl)propyl]guanidine) sulfuric acid, CAS: 14279-76-6, stock: 1.7g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: ₂[C₈H₁₈N₄O].H₂O₄S.
bis(4-(2-methoxyphenyl)piperazine-1-carboximidamide) sulfuric acid, CAS: 1354949-56-6, stock: 4.6g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: ₂[C₁₂H₁₈N₄O].H₂O₄S.
bis(4-(4-methoxyphenyl)piperazine-1-carboximidamide) sulfuric acid, CAS: 1384428-70-9, stock: 5.6g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: ₂[C₁₂H₁₈N₄O].H₂O₄S.
Bis(6-methyl-1,2-dihydropyridin-2-one) Sulfuric Acid, CAS: 1443981-41-6, stock: 8.5g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: 2[C₆H₇NO] • H₂O₄S.
Butyl Potassium Sulfate, CAS: 18687-54-2, stock: 6.6g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄H₉KO₄S.
Butyl Potassium Sulfate-D9, CAS: /, stock: 4.1g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄D₉KO₄S.
Butyl Sodium Sulfate, CAS: 1000-67-5, stock: 7.2g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄H₉NaO₄S.
Butyl Sodium Sulfate-D9, CAS: /, stock: 4.9g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄D₉NaO₄S.
Chloromethoxysulfonyl Chloride, CAS: 49715-04-0, stock: 9.4g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: CH₂Cl₂O₃S.
Chlorosulfonic Acid, CAS: 7790-94-5, stock: 9.9g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: ClHO₃S.
Chlorosulfuric Acid Methyl Ester, CAS: 812-01-1, stock: 6.1g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: CH₃ClO₃S.
Chlorsulfonyl Isocyanate, CAS: 1189-71-5, stock: 3.5g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: CClNO₃S.
Copper(II) Sulfate Pentahydrate, CAS: 7758-99-8, stock: 7.7g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: CuSO₄•5[H₂O].
Daidzein 4’-Sulfate Disodium Salt, CAS: /, stock: 6.7g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₈Na₂O₇S.
Dimethyl Sulfate, CAS: 77-78-1, stock: 9.2g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂H₆O₄S.
Dimethyl Sulfate-d6, CAS: 15199-43-6, stock: 8.5g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂D₆O₄S.
Ferrous Sulfate Heptahydrate, CAS: 7782-63-0, stock: 2.3g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: FeO₄S•7H₂O.
Formamidine Sulfuric Acid, CAS: 1758-73-2, stock: 4.4g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: CH₄N₂O₂S.
(E)-3-(4-((2-Hydroxy-3-(methoxycarbonyl)phenyl)diazenyl)benzamido)propanoic Acid, CAS: /, stock: 6.5g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₁₇N₃O₆.
Genistein 7-(Tri-O-acetyl-β-D-glucuronic Acid Methyl Ester) 4’-Sulfate, CAS: /, stock: 7.5g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₈H₂₆O₁₇S.
Genistein 7-β-D-Glucuronide 4’-Sulfate Disodium Salt, CAS: /, stock: 7.2g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₁₆Na₂O₁₄S.
2-[[4-(2-Pyridylsulfamoyl)phenyl]azo]hydroxybenzene4-[[4-(2-Pyridylsulfamoyl)phenyl]azo]hydroxybenzene(Mixture of Regioisomers), CAS: /, stock: 8.2g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₄N₄O₃S.
Isopropyl chlorosulfonate, CAS: 36610-67-0, stock: 5.7g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃H₇ClO₃S.
3-Bromo 5-Acetamido-salicylic Acid Methyl Ester, CAS: /, stock: 9.3g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₀BrNO₄.
Magnesium Sulfate Heptahydrate, CAS: 10034-99-8, stock: 8g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: MgSO₄•7[H₂O].
3-Nitrosalicylic Acid-d3, CAS: /, stock: 2.6g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₂D₃NO₅.
Manganese Sulfate Monohydrate, CAS: 10034-96-5, stock: 6.5g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: MnO₄S•H₂O.
Methylene bis-(Chlorosulfate), CAS: 92975-18-3, stock: 2.8g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: CH₂Cl₂O₆S₂.
4-Bromo-N-(2-pyridyl)benzenesulfonamide, CAS: 3609-89-0, stock: 4.1g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₉BrN₂O₂S.
Methylsulfuric Acid Potassium Salt, CAS: 562-54-9, stock: 6.2g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: CH₃O₄SK.
Metol, CAS: 55-55-0, stock: 5.6g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₂₀N₂O₆S.
4-Bromo-N-(methoxymethyl)-N-(pyridin-2-yl)benzenesulfonamide, CAS: /, stock: 3.9g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₃BrN₂O₃S.
4-Deshydroxy-2-hydroxy Sulfasalazine Methyl Ester, CAS: /, stock: 4.9g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₁₆N₄O₅S.
Monobutyl Sulfate, CAS: 15507-13-8, stock: 2g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄H₁₀O₄S.
Monobutyl Sulfate-D9, CAS: /, stock: 4.6g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄HD₉O₄S.
4-Nitroso-N-2-pyridinylbenzenesulfonamide, CAS: 1202816-93-0, stock: 6.7g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₉N₃O₃S.
Monosultap, CAS: 29547-00-0, stock: 7.3g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅H₁₂NNaO₆S₄.
N-Acetyl-N-9H-fluoren-2-yl-hydroxylamine-O-sulfonic Acid Potassium Salt, CAS: 74925-71-6, stock: 6.9g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₂KNO₅S.
Oxyquinoline Sulfate Monohydrate, CAS: 134-31-6, stock: 6.4g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₉NO₅S•H₂O.
N1,N4-Diacetylsulfanilamide-d4, CAS: /, stock: 4.9g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₈D₄N₂O₄S.
Piperazine Sulfuric Acid, CAS: 4554-26-1, stock: 7.7g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄H₁₀N₂.H₂O₄S.
Polymyxin B Sulfate, CAS: 1405-20-5, stock: 6.4g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: N/A.
Sulfacetamide, CAS: 144-80-9, stock: 5.1g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₁₀N₂O₃S.
5-Nitrosalicylic-d3 Acid, CAS: /, stock: 9.5g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₂D₃NO₅.
Polyquaternium 11 (20% in H2O), CAS: 53633-54-8, stock: 4.5g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₃₅N₂O₃⁺•C₂H₅O₄S⁻•(C₂H₄)x•(C₃H₆)y.
Sulfacetamide Sodium Salt Monohydrate, CAS: 6209-17-2, stock: 5.1g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₉N₂NaO₃•H₂O.
Sulfacetamide-d4, CAS: /, stock: 6.4g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₆D₄N₂O₃S.
Potassium Disulfate, CAS: 7790-62-7, stock: 4.4g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: K₂O₇S₂.
Potassium Sulphate, CAS: 7778-80-5, stock: 1.4g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: K₂O₄S.
Selenosulfuric Acid Dipotassium Salt, Technical Grade, CAS: 15571-89-8, stock: 7g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: K₂O₃SSe.
Silver Sulfate, CAS: 10294-26-5, stock: 8.6g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: Ag₂O₄S.
Sodium 2-(2-(Dodecyloxy)ethoxy)ethyl Sulfate, CAS: 3088-31-1, stock: 7.6g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₃₃NaO₆S.
Sodium Acetate, CAS: 127-09-3, stock: 7.6g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂H₃NaO₂.
Sodium Acetate-1,2-13C2, CAS: 56374-56-2, stock: 9.2g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: ¹³C₂H₃NaO₂.
Sodium Acetate-18O2, CAS: 66012-98-4, stock: 7.1g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂H₃Na¹⁸O₂.
Sodium Acetate-d3, CAS: 39230-37-0, stock: 9.3g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂D₃NaO₂.
Benzyl 2-(Benzyloxy)-3-bromobenzoate, CAS: /, stock: 1.2g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₁₇BrO₃.
Sodium Dodecyl Sulfate, CAS: 151-21-3, stock: 7.1g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₂₅NaO₄S.
Sodium Dodecyl Sulphate, CAS: 151-21-3, stock: 4g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₂₅O₄SNa.
Sodium Ethyl Sulfate, CAS: 546-74-7, stock: 5.9g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂H₅NaO₄S.
Mesalazine-3-carboxylic Acid, CAS: 859964-08-2, stock: 7g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₇NO₅.
Sodium Ethyl-d5 Sulfate, CAS: 1329611-05-3, stock: 3.2g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂D₅NaO₄S.
Sodium Persulfate, CAS: 7775-27-1, stock: 2.4g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: Na₂O₈S₂.
Sodium Sulfate, CAS: 7757-82-6, stock: 5.8g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: Na₂O₄S.
Sodium Thiosulfate, CAS: 7772-98-7, stock: 9.6g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: Na₂O₃S₂.
Methyl 5-(Acetylamino)-2-hydroxybenzoate, CAS: 81887-68-5, stock: 5.8g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₁NO₄.
Sodium Thiosulfate Pentahydrate, CAS: 10102-17-7, stock: 9.7g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: Na₂O₃S₂•5[H₂O].
Strontium Sulfate, CAS: 06/02/7759, stock: 7.5g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: H₂O₄SSr.
N-(2-Bromo-4-(N-(methoxymethyl)-N-(pyridin-2-yl)sulfamoyl)phenyl)-N-(methoxymethyl)acetamide, CAS: /, stock: 7.4g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₂₀BrN₃O₅S.
N-(2-Bromo-4-(N-(methoxymethyl)-N-(pyridin-2-yl)sulfamoyl)phenyl)acetamide, CAS: /, stock: 7.8g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₆BrN₃O₄S.
Sulfamoyl Chloride, CAS: 7778-42-9, stock: 2g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: ClH₂NO₂S.
Sulfur (>80%), CAS: 7704-34-9, stock: 5.1g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: S.
N-(2-Bromo-5-(N-(pyridin-2-yl)sulfamoyl)phenyl)acetamide, CAS: /, stock: 9.5g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₂BrN₃O₃S.
Sulfur (>98%), CAS: 7704-34-9, stock: 3.1g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: S.
Sulfur-34 (>99%), CAS: 13965-97-4, stock: 9.8g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: ³⁴S.
Sulfuric Acid, Fuming, CAS: 8014-95-7, stock: 7.4g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: H₂O₄S . O₃S.
N-Acetyl Sulfapyridine, CAS: 19077-98-6, stock: 9.7g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₃N₃O₃S.
Sulfuric Acid-d2, CAS: 13813-19-9, stock: 1.3g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: D₂O₄S.
Thallium Sulfate, CAS: 7446-18-6, stock: 4.3g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: O₄STl₂.
N-Acetyl Sulfapyridine-d4, CAS: /, stock: 9.5g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₉D₄N₃O₃S.
N-Acetyl Sulfapyridine-d4 (Major), CAS: 1189732-52-2, stock: 4.1g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₉D₄N₃O₃S.
Vicamid 182, CAS: 5839-65-6, stock: 4.5g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₄₄N₂O₂.
Neopentyl 4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)benzenesulfonate, CAS: /, stock: 7.8g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₂₇BO₅S.
Zinc Sulfate, CAS: 7733-02-0, stock: 9.7g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: O₄SZn.
Diethylcarbamoyl Chloride, CAS: 88-10-8, stock: 7.4g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅H₁₀ClNO.
Disulfiram, CAS: 97-77-8, stock: 1.9g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₂₀N₂S₄.
Disulfiram-d20, CAS: 1216403-88-1, stock: 8.9g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀D₂₀N₂S₄.
Methyl Diethyldithiocarbamate, CAS: 686-07-7, stock: 5g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₁₃NS₂.
Methyl Diethyldithiocarbamate-d3, CAS: 1246816-30-7, stock: 9.5g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₁₀D₃NS₂.
S-Methyl-N,N-diethylthiocarbamate Sulfone, CAS: 155514-79-7, stock: 8.1g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₁₃NO₃S.
S-Methyl-N,N-diethylthiocarbamate Sulfoxide, CAS: 140703-15-7, stock: 7.9g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₁₃NO₂S.
Sulfiram, CAS: 95-05-6, stock: 5.9g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₂₀N₂S₃.
Sulfiram-d10, CAS: 1346603-19-7, stock: 7.5g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₀D₁₀N₂S₃.
Tryptophol, CAS: 526-55-6, stock: 4.7g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₁NO.
Tryptophol-d4, CAS: 75238-45-8, stock: 8.4g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₇D₄NO.
N-Acetylsulfathiazole (~90%), CAS: 127-76-4, stock: 9.9g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₁N₃O₃S₂.
N-Acetylsulfathiazole-d4 (Major), CAS: 1020718-91-5, stock: 9.7g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₇D₄N₃O₃S₂.
Succinylsulfathiazole, CAS: 116-43-8, stock: 6.3g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₃N₃O₅S₂.
4-Acetamidobenzenesulfonic Acid, CAS: 121-62-0, stock: 6.4g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₉NO₄S.
Sulfathiazole, CAS: 72-14-0, stock: 5.3g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₉N₃O₂S₂.
4-Amino-2,6-dimethoxypyrimidine, CAS: 3289-50-7, stock: 1.7g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₉N₃O₂.
Sulfadimethoxine, CAS: 122-11-2, stock: 2.3g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₄N₄O₄S.
Sulfathiazole-d4, CAS: 1020719-89-4, stock: 2.6g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₅D₄N₃O₂S₂.
Sulfadimethoxine D4 N4-Acetate, CAS: /, stock: 5.6g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₂D₄N₄O₅S.
Sulfadimethoxine N4-Acetate, CAS: 555-25-9, stock: 4.5g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₆N₄O₅S.
Sulfadimethoxine Sodium Salt, CAS: 1037-50-9, stock: 8.7g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₃N₄NaO₄S.
Sulfadimethoxine-d4, CAS: 1020719-80-5, stock: 5.7g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₀D₄N₄O₄S.
Sulfadimethoxine-d6, CAS: 73068-02-7, stock: 3.8g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₈D₆N₄O₄S.
Sulfanilic Acid, CAS: 121-57-3, stock: 5.3g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₇NO₃S.
4-Hydroxy Sulfadiazine, CAS: 20778-16-9, stock: 1.9g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₉N₃O₃S.
N-Acetyl Sulfadiazine, CAS: 127-74-2, stock: 5.7g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₂N₄O₃S.
N-Acetyl Sulfadiazine-13C6, CAS: 1217089-17-2, stock: 3.9g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆¹³C₆H₁₂N₄O₃S.
N-Acetyl Sulfadiazine-d4 (Major), CAS: 1219149-66-2, stock: 8.9g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₈D₄N₄O₃S.
Sulfadiazine, CAS: 68-35-9, stock: 8.4g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₀N₄O₂S.
Sulfadiazine Silver Salt, CAS: 22199-08-2, stock: 4g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₉AgN₄O₂S.
Sulfadiazine Sodium Salt, CAS: 547-32-0, stock: 5.5g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₉N₄NaO₂S.
Sulfadiazine-13C6, CAS: 1189426-16-1, stock: 5.2g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄¹³C₆H₁₀N₄O₂S.
Sulfadiazine-d4, CAS: 1020719-78-1, stock: 1.5g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₆D₄N₄O₂S.
Sulfamoxole, CAS: 729-99-7, stock: 7.4g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₃N₃O₃S.
Actinamine Dihydrochloride, CAS: 52049-70-4, stock: 1.4g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₂₀Cl₂N₂O₄.
Spectinomycin Dihydrochloride, CAS: 21736-83-4, stock: 9g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₂₄N₂O₇•2(HCl).
Spectinomycin Dihydrochloride Pentahydrate, CAS: 22189-32-8, stock: 5.7g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₃₆Cl₂N₂O₁₂.
Spectinomycin Hydrochloride, CAS: 22193-75-5, stock: 9.6g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₂₄N₂O₇ • ( HCl).
Spectinomycin Sulfate Tetrahydrate, CAS: 64058-48-6, stock: 9.6g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₂₄N₂O₇•H₂SO₄•4(H₂O).
Spectinomycin-D6, CAS: /, stock: 5.8g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₈D₆N₂O₇.
Trospectomycin Dihydrochloride, CAS: 85951-37-7, stock: 6.1g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₃₂Cl₂N₂O₇.
1,1,1-Kestopentaose, CAS: 59432-60-9, stock: 5.8g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₀H₅₂O₂₆.
1,6,6’-Tri-O-tritylsucrose Pentaacetate, CAS: 35867-26-6, stock: 8.6g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇₉H₇₄O₁₆.
1,6,6’-Tri-O-tritylsucrose-d6 Pentaacetate, CAS: /, stock: 5.6g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇₉H₆₈D₆O₁₆.
1-Kestose, CAS: 470-69-9, stock: 7.3g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₃₂O₁₆.
1’,6,6’-Tri-O-tritylsucrose, CAS: 35674-14-7, stock: 3.5g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆₉H₆₄O₁₁.
1’,6,6’-Tri-O-tritylsucrose-d6, CAS: /, stock: 9.4g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆₉H₅₈D₆O₁₁.
1’,6,6’-Trichloro Sucrose, CAS: 40631-75-2, stock: 1.6g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₉Cl₃O₈.
2,3,3’,4’,6-Penta-O-acetylsucrose, CAS: 35867-25-5, stock: 4.7g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₃₂O₁₆.
2,3,3’,4’,6-Penta-O-acetylsucrose-d6, CAS: /, stock: 4.9g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₂₆D₆O₁₆.
2,3,4,3’,4’-Penta-O-acetylsucrose, CAS: 34382-02-0, stock: 2.9g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₃₂O₁₆.
2,3,4,3’,4’-Penta-O-acetylsucrose-d6, CAS: /, stock: 3.4g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₂₆D₆O₁₆.
6-Acetylglucose, CAS: 7286-45-5, stock: 3.5g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₁₄O₇.
6-Carboxysucrose, CAS: 133634-68-1, stock: 2g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₂₀O₁₂.
6-Octanoyl Sucrose, CAS: 13039-39-9, stock: 7.4g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₃₆O₁₂.
6A,6B,6C,6D,6E,6F,6G,6H-Octadeoxy-6A,6B,6C,6D,6E,6F,6G,6H-octaiodo-γ-cyclodextrin, CAS: 168296-33-1, stock: 5.9g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄₈H₇₂I₈O₃₂.
Adenine Hemisulfate, CAS: 321-30-2, stock: 2.5g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅H₅N₅ •1/2H₂SO₄.
D-(+)-Raffinose, CAS: 512-69-6, stock: 4.1g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₃₂O₁₆.
D-CPP-ene, CAS: 117414-74-1, stock: 2.3g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₁₅N₂O₅P.
Iron Saccharate, CAS: 8047-67-4, stock: 6.7g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: [Na₂Fe₅O₈(OH) • 3H ₂O]n •(C₁₂H₂₂O₁₁)m.
α-D-Glucopyranoside-β-D-fructofuranosyl Octadecanoate, CAS: 37318-31-3, stock: 2g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₀H₅₆O₁₂.
L-Sorbose, CAS: 87-79-6, stock: 7.2g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₁₂O₆.
L-Sorbose-4-13C, CAS: 478506-34-2, stock: 3.3g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: ¹³CC₅H₁₂O₆.
L-Sorbose-5-13C, CAS: 478506-36-4, stock: 1.9g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: ¹³CC₅H₁₂O₆.
L-Sorbose-6-13C, CAS: 478506-38-6, stock: 8.9g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: ¹³CC₅H₁₂O₆.
Octa-O-acetyl D-(+)-Surcose, CAS: 126-14-7, stock: 7.1g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₈H₃₈O₁₉.
Palatinose Hydrate, CAS: /, stock: 6g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₂₂O₁₁ (H₂O).
Phenyl α-D-Glucopyranoside, CAS: 4630-62-0, stock: 9.1g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₆O₆.
Silver Sucrose Octasulfate, CAS: /, stock: 1.6g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₄Ag₈O₃₅S₈.
Sucralfate, CAS: 54182-58-0, stock: 6.2g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₅₄Al₁₆O₇₅S₈.
Sucralose, CAS: 56038-13-2, stock: 2.9g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₉Cl₃O₈.
Sucralose-d6 Pentaacetate, CAS: /, stock: 6.3g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₂₃D₆Cl₃O₁₃.
Sucrose, CAS: 57-50-1, stock: 8.2g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₂₂O₁₁.
Sucrose 1,6,6’-Tricarboxylate Trimethyl Ester, CAS: 289711-92-8, stock: 8.8g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₂₂O₁₄.
Sucrose 1’,6’-Dicarboxylic Acid, CAS: /, stock: 6.5g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₈O₁₃.
Sucrose 1’-Carboxylic Acid, CAS: 150787-99-8, stock: 2.4g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₂₀O₁₂.
Sucrose 4,6-Methyl Orthoester, CAS: 116015-72-6, stock: 3.9g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₂₆O₁₂.
Sucrose 6,1’,6’-Tricarboxylic Acid, CAS: /, stock: 3g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₆O₁₄.
Sucrose 6,1’-Dicarboxylic Acid, CAS: 155533-83-8, stock: 8g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₈O₁₃.
Sucrose 6,6’-Dicarboxylic Acid, CAS: 133634-70-5, stock: 4.9g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₈O₁₃.
Sucrose 6’-Acetate, Technical grade 80%, CAS: 936001-72-8, stock: 1.6g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₂₄O₁₂.
Sucrose 6’-Carboxylic Acid, CAS: 133634-69-2, stock: 6.1g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₂₀O₁₂.
Sucrose Heptasulfate Potassium Salt (>95% purity), CAS: 386229-69-2, stock: 8.1g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₅K₇O₃₂S₇.
Sucrose Heptasulfate, Potassium Salt, Technical Grade, CAS: 386229-69-2, stock: 9.4g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₅K₇O₃₂S₇.
Sucrose Hexasulfate, Potassium Salt, Technical Grade, CAS: 386229-70-5, stock: 7.6g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₆K₆O₂₉S₆.
Sucrose Monocaprate (~90%), CAS: 31835-06-0, stock: 6.8g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₄₀O₁₂.
Sucrose Monolaurate, CAS: 25339-99-5, stock: 7.7g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₄₄O₁₂.
Sucrose Octasulfate Potassium Salt, CAS: 73264-44-5, stock: 9.5g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₄K₈O₃₅S₈.
Sucrose Octasulfate TEA Salt, CAS: /, stock: 5.6g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₂₂O₃₅S₈ • C ₆H₁₅N.
Sucrose Octasulfate, Ammonium Salt, CAS: 74135-13-0, stock: 4.7g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₄₆N₈O₃₅S₈.
Sucrose Octasulfate, Sodium Salt, CAS: 74135-10-7, stock: 4.5g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₄Na₈O₃₅S₈.
Sucrose Octasulfate-d6 Potassium Salt, CAS: /, stock: 2.3g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₈D₆K₈O₃₅S₈.
Sucrose Palmitate, CAS: 26446-38-8, stock: 8.1g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₈H₅₂O₁₂.
Sucrose Stearate - 70% monostearate, CAS: 25168-73-4, stock: 5.7g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₀H₅₆O₁₂.
Sucrose-1,1,6,6,6’,6’-d6, CAS: 955943-30-3, stock: 2.5g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₆D₆O₁₁.
Sucrose-1-13Cfru, CAS: 154368-11-3, stock: 8g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: ¹³CC₁₁H₂₂O₁₁.
Sucrose-1-13Cglu, CAS: /, stock: 4.1g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: ¹³CC₁₁H₂₂O₁₁.
Sucrose-1-13Cglu-13Cfru, CAS: /, stock: 6.8g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: ¹³C₂C₁₀H₂₂O₁₁.
Sucrose-13C6-fru, CAS: /, stock: 9.1g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: ¹³C₆C₆H₂₂O₁₁.
Sucrose-13C6-glu, CAS: /, stock: 5.4g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: ¹³C₆C₆H₂₂O₁₁.
Sucrose-13C6-glu-13C6-fru, CAS: /, stock: 1.6g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: ¹³C₁₂H₂₂O₁₁.
Sucrose-D2, CAS: /, stock: 5.3g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂D₂H₂₀O₁₁.
Theanderose, CAS: 21291-36-1, stock: 7.5g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₃₂O₁₆.
6-Deoxy-6-((2-carboxyethyl)disulfide)-heptakis(6-deoxy-6-(2- carboxyethyl)thio)-γ-cyclodextrin Sodium Salt, CAS: /, stock: 5.8g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇₂H₁₀₄Na₈O₄₈S₉.
6A,6B,6C,6D,6E,6F,6G,6H-octakis-S-(2-carboxyethyl)-6A,6B,6C,6D,6E,6F,6G,6H-octathio-γ-Cyclodextrin, CAS: 343306-71-8, stock: 2.1g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇₂H₁₁₂O₄₈S₈.
Dihydroxy Sugammadex Sodium, CAS: /, stock: 9.8g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆₆H₉₈Na₆O₄₆S₆.
Dimethyl Amino Sugammadex, CAS: /, stock: 4.2g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇₁H₁₀₆NNa₇O₄₆S₇.
Mono-andhyro Sugammadex Sodium, CAS: /, stock: 8.3g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆₉H₉₉Na₇O₄₆S₇.
Mono-sulfoxide Sugammadex Sodium (Epimer A), CAS: /, stock: 7.3g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇₂H₁₀₅Na₇O₄₉S₈.
Mono-sulfoxide Sugammadex Sodium (Epimer B), CAS: /, stock: 8g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇₂H₁₀₅Na₇O₄₉S₈.
Monobromo Sugammadex Sodium, CAS: /, stock: 3.3g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆₉H₁₀₀BrNa₇O₄₆S₇.
Monochloro Sugammadex Sodium, CAS: /, stock: 8.5g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆₉H₁₀₇ClO₄₆S₇ •xNa.
Monohydroxy Sugammadex Sodium, CAS: /, stock: 2.4g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆₉H₁₀₈O₄₇S₇ •xNa.
Monoiodo Sugammadex Sodium, CAS: /, stock: 7.5g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆₉H₁₀₀INa₇O₄₆S₇.
Monothio Sugammadex Sodium, CAS: /, stock: 3.4g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆₉H₁₀₁Na₇O₄₆S₈.
Octakis-(6-bromo-6-deoxy)-γ-cyclodextrin-d24, CAS: /, stock: 1.3g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄₈H₄₈D₂₄Br₈O₃₂.
Sugammadex Disulfide Dimer, CAS: /, stock: 1.8g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃₈H₂₀₀Na₁₄O₉₂S₁₆.
Sugammadex Impurity A, CAS: /, stock: 5.9g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇₂H₁₀₄Na₈O₄₉S₈.
Sugammadex Impurity B, CAS: /, stock: 1.2g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇₂H₁₀₄Na₈O₅₀S₈.
Sugammadex Monosulfide Dimer, CAS: /, stock: 4.6g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃₈H₂₀₀Na₁₄O₉₂S₁₅.
Sugammadex Sodium, CAS: 343306-79-6, stock: 2.9g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇₂H₁₀₄Na₈O₄₈S₈.
Sugammadex Sodium-deuterated, CAS: /, stock: 9g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇₂H₁₀₄Na₈O₄₈S₈.
4-Aminoazobenzene, CAS: 60-09-3, stock: 4.5g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₁N₃.
Sudan Black, CAS: 4197-25-5, stock: 7.1g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₉H₂₄N₆.
Sudan Blue II;Oil Blue 35, CAS: 17354-14-2, stock: 8.6g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₂₆N₂O₂.
Sudan I, CAS: 842-07-9, stock: 7.9g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₁₂N₂O.
Sudan I-d5, CAS: 752211-63-5, stock: 4.5g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₇D₅N₂O.
Sudan II, CAS: 3118-97-6, stock: 4.2g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₁₆N₂O.
Sudan III, CAS: 85-86-9, stock: 8g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₁₆N₄O.
Sudan III-d6, CAS: 1014689-17-8, stock: 5.5g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₁₀D₆N₄O.
Sudan IV (>80%), CAS: 85-83-6, stock: 7.5g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₂₀N₄O.
Sudan IV-d6, CAS: 1014689-18-9, stock: 6g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₁₄D₆N₄O.
Sudan Orange G, CAS: 2051-85-6 , stock: 3.9g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₀N₂O₂.
Sudan Orange G, CAS: 2051-85-6, stock: 7.8g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₀N₂O₂.
Sudan Red 7B, CAS: 6368-72-5, stock: 2g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₂₁N₅.
Sudan Yellow 146, CAS: 4314-14-1, stock: 6g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₁₄N₄O.
1-Benzyl-4-phenylamino-4-(hydroxymethyl)piperidine, CAS: 61086-04-2, stock: 4.3g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₂₄N₂O.
1-Benzyl-4-phenylamino-4-(methoxymethyl)piperidine, CAS: 61380-02-7, stock: 7.7g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₆N₂O.
1-Benzyl-4-phenylamino-4-(methoxymethyl)piperidine-d3, CAS: 1204688-14-1, stock: 1.1g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₃D₃N₂O.
1-Benzyl-4-[N-(1-propanoyl)-N-phenylamino]-4-methoxymethylpiperidine, CAS: 61086-12-2, stock: 5.4g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₃₀N₂O₂.
1-Benzyl-4-[N-(1-propanoyl)-N-phenylamino]-4-methoxymethylpiperidine-d3, CAS: 1204688-15-2, stock: 6.2g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₂₇D₃N₂O₂.
2-Thiopheneethanol Methanesulfonate, CAS: 61380-07-2, stock: 1g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₁₀O₃S₂.
4-(Methoxymethyl)-N-phenyl-1-[2-(2-thienyl)ethyl]-4-piperidinamine, CAS: 72996-73-7, stock: 8.7g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₂₆N₂OS.
4-(Phenylamino)-1-[2-(2-thienyl)theyl]-4-piperidinemethanol, CAS: 164790-59-4, stock: 4.8g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₂₄N₂OS.
N-[4-(Methoxymethyl)-1-[2-(2-thienyl)ethyl]-4-piperidinyl]-N-phenyl-acetamide, CAS: 2250243-42-4, stock: 1.3g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₂₈N₂O₂S.
N-[4-(Methoxymethyl)-1-[2-(2-thienyl)ethyl]-4-piperidinyl]-N-phenyl-butanamide, CAS: 2250243-57-1, stock: 4g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₃₂N₂O₂S.
N-[4-(Methoxymethyl)-1-[2-(3-thienyl)ethyl]-4-piperidinyl]-N-phenyl-propanamide, CAS: 79146-60-4, stock: 8.8g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₃₀N₂O₂S.
N-[4-[(1-Oxopropoxy)methyl]-1-[2-(2-thienyl)ethyl]-4-piperidinyl]-N-phenyl-propanamide, CAS: 119997-43-2, stock: 4.3g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₃₂N₂O₃S.
N-[cis-4-(methoxymethyl)-1-oxido-1-[2-(2-thienyl)ethyl]-4-piperidinyl]-N-phenyl-propanamide, CAS: 2250242-55-6, stock: 2.1g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₃₀N₂O₃S.
N-[trans-4-(methoxymethyl)-1-oxido-1-[2-(2-thienyl)ethyl]-4-piperidinyl]-N-phenyl-propanamide, CAS: /, stock: 9.4g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₃₀N₂O₃S.
Noralfentanil, CAS: 61086-18-8, stock: 6.6g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₂₄N₂O₂.
Noralfentanil-d3 Hydrochloride, CAS: /, stock: 9.8g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₂₂D₃ClN₂O₂.
(-)-Tabersonine, CAS: 4429-63-4, stock: 1.2g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₂₄N₂O₂.
(-)-Tabersonine Hydrochloride, CAS: 29479-00-3, stock: 6.4g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₂₄N₂O₂ · HCl.
(20’RS)-15’,20’-Dihydro Vinorelbine Ditartarate (Mixture of Diastereomers), CAS: /, stock: 6.9g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅₃H₆₈N₄O₂₀.
(4-((3-Acetamidopropyl)(tert-butoxycarbonyl)amino)butyl)(3-((tert-butoxycarbonyl)amino)propyl)carbamic Acid-d3 tert-Butyl Ester, CAS: /, stock: 5.3g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₇H₄₉D₃N₄O₇.
(4-((3-Acetamidopropyl)amino)butyl)carbamic Acid tert-Butyl Ester, CAS: /, stock: 2.6g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₂₉N₃O₃.
(4-((3-Acetamidopropyl)amino)butyl)carbamic Acid tert-Butyl Ester-d6, CAS: /, stock: 4g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₂₃D₆N₃O₃.
(4-((tert-Butoxycarbonyl)amino)butyl)(3-((tert-butoxycarbonyl)amino)propyl)amine-d6, CAS: /, stock: 1.8g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₂₉D₆N₃O₄.
(±)-Pseudovincadifformine, CAS: 73837-57-7, stock: 6.4g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₂₆N₂O₂.
(±)-Vincadifformine, CAS: 18374-17-9, stock: 3.6g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₂₆N₂O₂.
(R)-tert-Butyl (1-Cyanopropan-2-yl)carbamate, CAS: 170367-68-7, stock: 8g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₁₆N₂O₂.
(S)-tert-Butyl (1-Cyanopropan-2-yl)carbamate, CAS: 172695-22-6, stock: 1.3g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₁₆N₂O₂.
1-Naphthylacetyl Spermine, CAS: 122306-11-0, stock: 1.8g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₃₅N₄O.
1-Naphthylacetyl Spermine Trihydrochloride, CAS: 1049731-36-3, stock: 6.1g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₃₇Cl₃N₄O.
18-O-Desmethyl Vinorelbine, CAS: 868596-47-8, stock: 1.2g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄₄H₅₂N₄O₈.
2-[Boc(2-Bocaminoethyl)amino]ethanol, CAS: 200283-08-5, stock: 2.3g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₂₈N₂O₅.
23-O-Desmethyl Vinorelbine L-Tartrate, CAS: /, stock: 7.2g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄₄H₅₂N₄O₈ • C₄H₆O₆.
2’,3’-O-(1-Methylethylidene)-5’-thio-adenosine 5’-Acetate, CAS: 84365-04-8, stock: 1.5g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₉N₅O₄S.
3,3’-Diaminodipropylamine, CAS: 56-18-8, stock: 3.6g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₁₇N₃.
4,4’-[(Phenylmethyl)imino]bisbutanenitrile, CAS: 78217-67-1, stock: 1.9g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₉N₃.
4-Methylcyclohexylamine, CAS: 6321-23-9, stock: 7.5g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₁₅N.
4-[(tert-Butoxycarbonyl)amino]butyraldehyde, CAS: 84766-90-5, stock: 3.1g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₁₇NO₃.
5’-S-(3-Aminopropyl)-5’-thio-adenosine Sulfate, CAS: 99019-00-8, stock: 6.1g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₂₀N₆O₃S • H ₂SO₄.
5’-S-[3-(1,3-Dihydro-1,3-dioxo-2H-isoindol-2-yl)propyl]-2’,3’-O-(1-methylethylidene)-5’-thio-adenosine, CAS: 263715-50-0, stock: 3.2g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₂₆N₆O₅S.
9-Fluorenylmethyl Chlorocarbonate, CAS: 28920-43-6, stock: 6.9g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₁ClO₂.
anti- Spermidine synthase antibody, CAS: /, stock: 2.8g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
Bovine PAOX (Peroxisomal N(1)-acetyl-spermine/spermidine oxidase) ELISA Kit (96T), CAS: /, stock: 6.6g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
CGP 48664A, CAS: 138794-73-7, stock: 4.3g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₆Cl₂N₆.
Conophylline, CAS: 142741-24-0, stock: 4.9g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄₄H₅₀N₄O₁₀.
Decarboxylated S-Adenosylmethionine Sulfate Salt, CAS: 67380-81-8, stock: 4g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₂₄N₆O₇S₂ • H ₂SO₄.
Decarboxylated S-Adenosylmethionine-d3 Sulfate Salt, CAS: /, stock: 2.5g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₂₀D₃N₆O₃S •2H₂SO₄.
Desacetyl Vindoline, CAS: 3633-92-9, stock: 1.1g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₃₀N₂O₅.
Dicyclohexylamine, CAS: 101-83-7, stock: 4.1g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₂₃N.
Human Spermidine synthase ELISA Kit (96T), CAS: /, stock: 3.9g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
(S)-2-Benzyl-N,N-dimethylaziridine-1-sulfonamide, CAS: 902146-43-4, stock: 8.3g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₆N₂O₂S.
Human SRM (Spermidine synthase) ELISA Kit (96T), CAS: /, stock: 5g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
Mouse Paox (Peroxisomal N(1)-acetyl-spermine/spermidine oxidase) ELISA Kit (96T), CAS: /, stock: 3.9g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
5’-Sulfamoyladenosine, CAS: 25030-31-3, stock: 2.9g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₄N₆O₆S.
Mouse Srm (Spermidine synthase) ELISA Kit (96T), CAS: /, stock: 8.3g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
N,N’-Trimethylenediphthalimide-d6, CAS: /, stock: 7.2g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₈D₆N₂O₄.
N-(2-Bromoethyl)ethane-1,2-diamine Dihydrobromide, CAS: 23545-41-7, stock: 4.5g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄H₁₃Br₃N₂.
N-(3-Aminopropyl)cyclohexylamine, CAS: 3312-60-5, stock: 9.3g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₂₀N₂.
Bupirimate, 90%, CAS: 41483-43-6, stock: 7.4g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₂₄N₄O₃S.
N-(4-Azidobutyl)-1,3-propanediamine Dihydrochloride Salt, CAS: /, stock: 4.8g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₁₉Cl₂N₅.
N-Acetyl-1,3-propanediamine, CAS: 4078-13-1, stock: 1.5g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅H₁₂N₂O.
Cyclamic Acid Sodium Salt, CAS: 139-05-9, stock: 3.4g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₁₂NNaO₃S.
Cyclamic Acid-d11, CAS: 1215770-73-2, stock: 3.8g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₂D₁₁NO₃S.
N-Acetyl-1,3-propanediamine-d6, CAS: /, stock: 7.5g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅H₆D₆N₂O.
Cyclamic Acid-d11 Sodium Salt, CAS: /, stock: 7.9g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆HD₁₁NNaO₃S.
N-Boc-1,3-propanediamine-d6, CAS: /, stock: 8.7g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₁₂D₆N₂O₂.
N-Boc-2-aminoacetonitrile, CAS: 85363-04-8, stock: 6.7g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₁₂N₂O₂.
Des-[4,5-O-(1-methylethylidene)] Topiramate, CAS: 205249-06-5, stock: 2.9g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₁₇NO₆S.
Ethoxysulfuron (~90%), CAS: 126801-58-9, stock: 1.6g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₈N₄O₇S.
N-[4-(3-Acetyltetrahydro-1(2H)-pyrimidinyl)butyl]-acetamide, CAS: 85681-32-9, stock: 9.5g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₂₃N₃O₂.
N-[4-(Tetrahydro-1(2H)-pyrimidinyl)butyl]-acetamide, CAS: 85681-29-4, stock: 3.8g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₂₁N₃O.
Hydroxylamine-O-sulfonic Acid, CAS: 2950-43-8, stock: 5.5g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: H₃NO₄S.
Isopropylaminosulfoni-d7 Acid, CAS: 131842-75-6, stock: 9.5g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃HD₇ClNO₂S.
N1,N11-Diethylnorspermine, CAS: 121749-39-1, stock: 5.4g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₃₂N₄.
N1,N4-Bis-Boc-spermidine, CAS: 85503-20-4, stock: 4.6g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₃₅N₃O₄.
Isopropylaminosulfonic Acid, CAS: 26118-67-2, stock: 3g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃H₈ClNO₂S.
Metoclopramide N4-Sulfonate, CAS: 27260-42-0, stock: 6.7g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₂₂ClN₃O₅S.
N1,N8-Diacetylspermidine, CAS: 82414-35-5, stock: 6.7g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₂₃N₃O₂.
N1,N8-Diacetylspermidine-d6 (Major), CAS: /, stock: 3.4g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₇D₆N₃O₂.
MLN 4924, CAS: 905579-51-3, stock: 8.7g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₂₅N₅O₄S.
MLN 4924 2-Sulfonamide, CAS: 1391052-49-5, stock: 4.9g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₂₆N₆O₆S₂.
N1-(4-Aminobutyl)-N1-(phenylmethyl)-1,4-butanediamine Trihydrochloride, CAS: /, stock: 5.5g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₂₇N₃ •3HCl.
N1-Acetylspermidine Dihydrochloride, CAS: 34450-16-3, stock: 1.3g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₂₃Cl₂N₃O.
N-Cyclohexylsulfamic Acid(Cyclamic Acid), CAS: 100-88-9, stock: 9.6g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₁₃NO₃S.
N-Desisopropyl Delavirdine N-Sulfate-d8, CAS: /, stock: 7.6g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₁₄D₈N₆O₆S₂.
N1-Acetylspermidine-d3 Dihydrochloride, CAS: /, stock: 4.9g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₂₀D₃Cl₂N₃O.
N1-Acetylspermidine-d6 Dihydrochloride, CAS: /, stock: 1.9g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₁₇D₆Cl₂N₃O.
Oxcarbazepine N-Sulfate, CAS: 1159977-54-4, stock: 2.9g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₂N₂O₅S.
Pentyl sulfamate, CAS: 637772-35-1, stock: 4.1g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅H₁₃NO₃S.
Rasagiline Sulfate, CAS: /, stock: 9.7g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₃NO₃S.
N1-Caffeoylspermidine, CAS: 69563-41-3, stock: 4.5g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₂₅N₃O₃.
Rasagiline-13C3 Sulfate, CAS: /, stock: 8.8g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉¹³C₃H₁₃NO₃S.
S4, CAS: 1330061-67-0, stock: 4.9g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₇N₃O₄S.
N1-Coumaroylspermidine, CAS: 70185-59-0, stock: 6.3g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₂₅N₃O₂.
N1-Feruloylspermidine, CAS: 70185-60-3, stock: 1.3g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₂₇N₃O₃.
Sitagliptin N-Sulfate Sodium Salt, CAS: /, stock: 4.3g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₁₅F₆NaN₅O₄S.
Sodium cis-2-methylcyclohexylsulfamate, CAS: 56120-29-7, stock: 4.9g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₁₄NNaO₃S.
N8-Acetylspermidine Dihydrochloride, CAS: 34450-15-2, stock: 7.6g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₂₃Cl₂N₃O.
N8-Acetylspermidine-d3 Dihydrochloride, CAS: /, stock: 6.4g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₂₀D₃Cl₂N₃O.
STX64, CAS: 288628-05-7, stock: 3.4g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₅NO₅S.
Sulfamide, CAS: 7803-58-9, stock: 2.3g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: H₄N₂O₂S.
N8-Caffeoylspermidine, CAS: 95687-22-2, stock: 2.9g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₂₅N₃O₃.
N8-Coumaroylspermidine, CAS: 67005-74-7, stock: 5.8g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₂₅N₃O₂.
p-Coumaroylspermine, CAS: 130210-35-4, stock: 3.3g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₃₂N₄O₂.
Propane-1,3-diylbis((3-acetamidopropyl)carbamic Acid) di-tert-Butyl Ester, CAS: /, stock: 4g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₄₄N₄O₆.
Propane-1,3-diylbis((3-acetamidopropyl)carbamic Acid) di-tert-Butyl Ester-d6, CAS: /, stock: 6.7g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₃₈D₆N₄O₆.
Spermidine, CAS: 124-20-9, stock: 7.9g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₁₉N₃.
Spermidine Phosphate, CAS: 49721-50-8, stock: 6.2g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: 2(C₇H₁₉N₃) • 3( H₃PO₄).
Spermidine Phosphate Salt Hexahydrate, CAS: 23273-82-7, stock: 3.2g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₁₉N₃ • 3/2(H ₃O₄P) • 3(H ₂O).
Spermidine trihydrochloride, CAS: 334-50-9, stock: 5.5g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₂₂Cl₃N₃.
Spermidine-d6 Trihydrochloride, CAS: /, stock: 7.2g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₁₆D₆Cl₃N₃.
sym-Homo Spermidine Trihydrochloride, CAS: 189340-78-1, stock: 2g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₂₄Cl₃N₃.
sym-Homo Spermidine-d4 Trihydrochloride (Major), CAS: 856869-03-9, stock: 3.9g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₂₀D₄Cl₃N₃.
tetra-Boc-spermine-5-carboxylic Acid, CAS: 119798-08-2, stock: 2.1g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₁H₅₈N₄O₁₀.
Thermospermine Tetrahydrochloride, CAS: /, stock: 6.3g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₃₀Cl₄N₄.
trans-4-Methylcyclohexylamine, CAS: 2523-55-9, stock: 8g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₁₅N.
Vinamidine-d3-hydroxide Sulfate, CAS: /, stock: 8.1g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄₆H₅₃D₃N₄O₁₁ . x( H₂O₄S).
Vinamidine-hydroxide Sulfate, CAS: /, stock: 1.5g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄₆H₅₆N₄O₁₁ . x( H₂O₄S).
Vindoline, CAS: 2182-14-1, stock: 5.3g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₃₂N₂O₆.
Vindoline-d3, CAS: /, stock: 6.6g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₂₉D₃N₂O₆.
Vinflunine Ditartrate, CAS: 194468-36-5, stock: 5.4g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅₃H₆₆F₂N₄O₂₀.
Vinorelbine N’b-Oxide, CAS: 74075-34-6, stock: 2.6g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄₅H₅₄N₄O₉.
(E)-N-[2-(3,4-Dihydro-7-methoxy-1(2H)-naphthalenylidene)ethyl]acetamide(Agomelatine Impurity), CAS: 178677-39-9, stock: 3.2g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₉NO₂.
3,4-Dihydro-3,4-dihydroxyagomelatine, CAS: 1385018-56-3, stock: 3g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₉NO₄.
3,4-Dihydro-3,4-dihydroxyagomelatine-d3, CAS: /, stock: 8.5g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₆D₃NO₄.
3,4-Dihydroagomelatine, CAS: 1352139-51-5, stock: 8.2g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₉NO₂.
3-Hydroxyagomelatine, CAS: 166526-99-4, stock: 9.8g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₇NO₃.
3-Hydroxyagomelatine-d3, CAS: /, stock: 4.3g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₄D₃NO₃.
7-Desmethyl-3-hydroxyagomelatine, CAS: 166527-00-0, stock: 7.5g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₅NO₃.
7-Desmethyl-3-hydroxyagomelatine-d3, CAS: /, stock: 1g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₂D₃NO₃.
7-Desmethylagomelatine, CAS: 152302-45-9, stock: 3.3g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₅NO₂.
7-Methoxy-1-naphthaleneacetamide, CAS: 138113-07-2, stock: 8g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₃NO₂.
7-Methoxy-1-naphthaleneethanamine Hydrochloride, CAS: 139525-77-2, stock: 9.4g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₅NO • HCi.
7-Methoxy-1-naphthaleneethanol, CAS: 99416-99-6, stock: 9g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₄O₂.
7-Methoxy-1-naphthalenol, CAS: 67247-13-6, stock: 8.9g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₀O₂.
7-Methoxy-1-naphthalenol Acetate, CAS: 150712-58-6, stock: 2.4g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₂O₃.
7-Methoxy-N-[2-(7-methoxy-1-naphthalenyl)ethyl]-1-naphthaleneethanamine, CAS: 1385018-57-4, stock: 2.6g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₆H₂₇NO₂.
Agomelatine, CAS: 138112-76-2, stock: 8g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₇NO₂.
Agomelatine Dimer Acetamide, CAS: 1385018-58-5, stock: 9.3g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₈H₂₉NO₃.
Agomelatine Dimer Urea, CAS: 185421-27-6, stock: 8.2g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₇H₂₈N₂O₃.
Agomelatine-d4, CAS: 1079389-44-8, stock: 6.8g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₃D₄NO₂.
((1R,4S)-4-(2-Amino-6-chloro-9H-purin-9-yl)cyclopent-2-en-1-yl)methyl Formate, CAS: /, stock: 3.8g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₂ClN₅O₂.
Agomelatine-d6, CAS: 1079389-42-6, stock: 8.1g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₁D₆NO₂.
Desacetyl-7-desmethyl Agomelatine Hydrobromide, CAS: 144705-51-1, stock: 2.2g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₄BrNO.
((1S,4R)-4-(2-Amino-6-(((1R,4S)-4-(hydroxymethyl)cyclopent-2-en-1-yl)amino)-9H-purin-9-yl)cyclopent-2-en-1-yl)methanol, CAS: /, stock: 7g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₂₂N₆O₂.
(1R)-(-)-2-Azabicyclo[2.2.1]hept-5-en-3-one, CAS: 79200-56-9, stock: 7.9g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₇NO.
N-Deacetyl-N-Formyl Agomelatine, CAS: 138113-05-0, stock: 5.4g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₅NO₂.
(1R,2S,4R)-4-Amino-2-hydroxy-cyclopentanemethanol Hydrochloride, CAS: 155750-92-8, stock: 3.8g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₁₃NO₂•HCl.
(1R,3S)-3-[2-Amino-6-(cyclopropylamino)-9H-purin-9-yl]cyclopentanemethanol, CAS: 208762-35-0, stock: 7g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₂₀N₆O.
(1R,3S)-3-[2-Amino-6-(cyclopropylamino)-9H-purin-9-yl]cyclopentanemethanol-d4, CAS: /, stock: 6.1g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₆D₄N₆O.
(1R,4R)-4-[[(1,1-Dimethylethoxy)carbonyl]amino]-2-cyclopentene-1-carboxylic Acid Methyl Ester, CAS: 168958-19-8, stock: 6.9g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₉NO₄.
(1R,4S)-4-(2-Amino-6-chloro-9H-purin-9-yl)-2-cyclopentene-1-methanol, CAS: 216481-88-8, stock: 4.7g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₂ClN₅O.
(1R,4S)-4-Amino-2-cyclopentene-1-carboxylic Acid Methyl Ester Hydrochloride, CAS: 426226-35-9, stock: 8.7g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₁₁NO₂ • HCl.
(1R,4R)-rel-4-[2-Amino-6-(cyclopropylamino)-9H-purin-9-yl]-2-cyclopentene-1-methanol, CAS: 783292-37-5, stock: 2.5g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₈N₆O.
(1R,4R)-rel-4-[2-Amino-6-(cyclopropylamino)-9H-purin-9-yl]-2-cyclopentene-1-methanol Hydrochloride, CAS: 267668-71-3, stock: 2.5g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₉ClN₆O.
(1R,4S)-3-Oxo-2-azabicyclo[2.2.1]hept-5-ene-2-carboxylic acid 1,1-Dimethylethyl Ester, CAS: 151792-53-9, stock: 2.7g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₅NO₃.
(1R,4S)-4-[(1,1-Dimethylethoxy)methyl]-2-cyclopenten, CAS: /, stock: 8g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₉NO.
(1R-4S)-N-[4-Chloro-5-(formylamino)-6-[[4-(hydroxymethyl)-2-cyclopenten-1-yl]amino]-2-pyrimidinyl]acetamide, CAS: 136522-32-2, stock: 5.6g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₆ClN₅O₃.
(1S,4R)-4-(2-Amino-6-chloro-9H-purin-9-yl)-2-cyclopentene-1-carboxylate, CAS: 1246819-78-2, stock: 5.9g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₀ClN₅O₂.
(1S,4R)-4-(2-Amino-6-chloro-9H-purin-9-yl)-2-cyclopentene-1-methanol Hydrochloride, CAS: 172015-79-1, stock: 6g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₃Cl₂N₅O.
(1S,4R)-4-Amino-2-cyclopentene-1-methanol, CAS: 136522-35-5, stock: 3.4g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₁₁NO.
(1S,4R)-4-Amino-2-cyclopentene-1-methanol (-)-Dibenzoyl-L-tartaric Acid, CAS: /, stock: 3.5g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₁₁NO • C₁₈H₁₄O₈.
(1S,4R)-4-Amino-2-cyclopentene-1-methanol Hydrochloride, CAS: 168960-19-8, stock: 8.3g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₁₁NO.HCl.
(1S,4R)-4-[(2,5-Diamino-6-chloro-4-pyrimidinyl)amino]-2-cyclopentene-1-methanol, CAS: 141271-11-6, stock: 3.3g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₄ClN₅O.
(1S,4R)-cis-4-Amino-2-cyclopentene-1-methanol D-Tartrate, CAS: 229177-52-0, stock: 7.9g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₇NO₇.
2,5-Diamino-4,6-dichloropyrimidine, CAS: 55583-59-0, stock: 10g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄H₄Cl₂N₄.
2,2,2-Trifluoro-N-[(1R,4S)-4-(hydroxymethyl)-2-cyclopenten-1-yl]-acetamide, CAS: /, stock: 9.3g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₁₀F₃NO₂.
2-t-Butylamino Abacavir, CAS: /, stock: 9.6g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₂₆N₆O.
2’-(R)-Hydroxy-2’,3’-dihydroabacavir Dihydrochloride, CAS: /, stock: 9g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₂₀N₆O₂•2HCl.
4-(2,5-Diamino-6-chloropyrimidin-4-ylamino)cyclopent-2-enyl]methanol), CAS: 141271-12-7, stock: 8.7g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₄ClN₅O.
5’-O-t-Butyl 2-t-Butylamino Abacavir, CAS: /, stock: 3.6g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₃₄N₆O.
6-Chloro-9-[(1R,4S)-4-[(1,1-dimethylethoxy)methyl]-2-cyclopenten-1-yl]-9H-purin-2-amine, CAS: /, stock: 8.9g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₂₀ClN₅O.
6-Chloro-N4-[(1R,4S)-4-[(1,1-dimethylethoxy)methyl]-2-cyclopenten-1-yl]-2,4,5-pyrimidinetriamine, CAS: /, stock: 8.3g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₂₂ClN₅O.
Abacavir, CAS: 136470-78-5, stock: 4.7g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₈N₆O.
Abacavir (1.0 mg/mL in Methanol), CAS: 136470-78-5, stock: 1.2g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₈N₆O.
Abacavir 5’-(2,3,4-Tri-O-isobytyryl)-β-D-glucuronic Acid Methyl Ester, CAS: /, stock: 5.2g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₃H₄₆N₆O₁₀.
Abacavir 5’-4-Chloro-6-methylpyrimidine-2,5-diamine, CAS: 1443421-69-9, stock: 4.9g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₂₁ClN₁₀O.
Abacavir 5’-β-D-Glucuronide Sodium Salt, CAS: /, stock: 9.3g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₅N₆NaO₇.
Abacavir 5’-Phosphate, CAS: 136470-77-4, stock: 6.9g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₉N₆O₄P.
Abacavir Carboxylate, CAS: 384380-52-3, stock: 6.9g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₆N₆O₂.
Abacavir Sulfate, CAS: 188062-50-2, stock: 8.6g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₈H₃₈N₁₂O₆S.
Abacavir Sulphate, CAS: 136777-48-5, stock: 2.7g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₈H₃₈N₁₂O₆S.
Abacavir Triphosphate TEA Salt, CAS: /, stock: 7.3g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₂₁N₆O₁₀P₃ • xC ₆H₁₅N.
Abacavir-1-O-pyrimidine Derivative, CAS: /, stock: 5.7g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₁₇Cl₂N₉O₃.
Abacavir-d4, CAS: 1217731-56-0, stock: 4.6g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₄D₄N₆O.
Abacavir-d4 5’-4-Chloro-6-methylpyrimidine-2,5-diamine, CAS: /, stock: 7.7g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₁₇D₄ClN₁₀O.
Carbovir Monophosphate, CAS: 144490-73-3, stock: 8.3g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₄N₅O₅P.
Carbovir Triphosphate Triethylamine Salt, CAS: 1391048-07-9, stock: 7.3g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₆N₅O₁₁P₃•xC₆H₁₅N.
Carbovir-13C,d2 Monophosphate, CAS: /, stock: 4g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀¹³CH₁₂D₂N₅O₅P.
Carbovir-13C,d2 Triphosphate Triethylamine Salt, CAS: /, stock: 5.7g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀¹³CH₁₄D₂N₅O₁₁P₃•xC₆H₁₅N.
cis-rac-4-(2-Amino-6-chloro-9H-purin-9-yl)-2-cyclopentene-1-methanol Hydrochloride, CAS: 267668-74-6, stock: 7.5g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₂ClN₅O•HCl.
Descyclopropyl Abacavir, CAS: 124752-25-6, stock: 9.3g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₄N₆O.
ent-Abacavir, CAS: 136470-79-6, stock: 4.1g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₈N₆O.
Methyl (1R,4S)-4-Amino-2-cyclopentene-1-carboxylate (2S,3S)-2,3-Dihydroxybutanedioic Acid, CAS: 419563-23-8, stock: 6.9g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₁₁NO₂ • C ₄H₆O₆.
N-(2-Amino-4,6-dichloro-5-pyrimidinyl)formamide, CAS: 171887-03-9, stock: 2.3g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅H₄Cl₂N₄O.
N-[(1R,4S)-4-(Hydroxymethyl)-2-cyclopenten-1-yl]-carbamic Acid 1,1-Dimethylethyl Ester, CAS: 168960-18-7, stock: 1.6g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₉NO₃.
N-[(1R,4S)-4-[(1,1-Dimethylethoxy)methyl]-2-cyclopenten-1-yl]-2,2,2-trifluoro-acetamide, CAS: /, stock: 1.7g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₈F₃NO₂.
N-[(1S,4R)-4-(hydroxymethyl)-2-cyclopenten-1-yl]-carbamic Acid 1,1-Dimethylethyl Ester, CAS: 153011-43-9, stock: 7.2g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₉NO₃.
N-[2-Amino-4-chloro-6-[[(1S,4R)-4-(hydroxymethyl)-2-cyclopenten-1-yl]amino]-5-pyrimidinyl]formamide, CAS: 229177-44-0, stock: 9.8g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₄ClN₅O₂.
N-[4,6-Dichloro-5-(formylamino)-2-pyrimidinyl]acetamide, CAS: 136470-91-2, stock: 8.8g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₆Cl₂N₄O₂.
N6-Cyclopropyl-9-[(1R,4S)-4-[(1,1-dimethylethoxy)methyl]-2-cyclopenten-1-yl]-9H-purine-2,6-diamine, CAS: 1443421-68-8, stock: 5.7g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₂₆N₆O.
N6-Cyclopropyl-9-[(1R,4S)-4-[(1,1-dimethylethoxy)methyl]-2-cyclopenten-1-yl]-9H-purine-2,6-diamine-d4, CAS: /, stock: 1.2g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₂₂D₄N₆O.
N6-Cyclopropyl-9H-purine-2,6-diamine Methanolate, CAS: /, stock: 9.3g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₁₄N₆O.
N6-Cyclopropyl-9H-purine-2,6-diamine-d4 Methanolate, CAS: /, stock: 8.7g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₁₀D₄N₆O.
rac 2-Azabicyclo[2.2.1]hept-5-en-3-one, CAS: 49805-30-3, stock: 1.9g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₇NO.
rac-Abacavir Sulfate, CAS: /, stock: 9.7g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₈H₃₈N₁₂O₆S.
trans-4-(2-Amino-6-chloro-9H-purin-9-yl)-2-cyclopentene-1-methanol, CAS: 172721-00-5, stock: 2.5g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₂ClN₅O.
trans-Abacavir Dihydrochloride, CAS: /, stock: 7.8g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₂₀Cl₂N₆O.
trans-Abacavir-d4 Hydrochloride, CAS: 1346605-40-0, stock: 1.6g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₅D₄ClN₆O.
(4-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)butanoyl)phosphonic Acid, CAS: /, stock: 8g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₂₀NO₆P.
2-Pyrrolidinylphosphonic Acid, CAS: 73858-59-0, stock: 8.4g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄H₁₀NO₃P.
Alendronate Acid, CAS: 66376-36-1, stock: 2.5g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄H₁₃NO₇P₂.
Alendronic Acid Monosodium Salt Trihydrate, CAS: 121268-17-5, stock: 9.1g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄H₁₈NNaO₁₀P₂.
Alendronic Acid-d6 (Major), CAS: 1035437-39-8, stock: 1.1g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄H₇D₆NO₇P₂.
Alendronic Acid-d6 Sodium Salt Hydrate, CAS: /, stock: 8.5g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄H₆D₆NNaO₇P₂ xH₂O.
N-Fmoc 4-Amino-1-oxo-butane 1-Phosphonic Acid, CAS: /, stock: 1.5g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₂₀NO₆P.
N-Trifluoroacetyl Alendronic Acid, CAS: 1076199-48-8, stock: 2.8g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₁₂F₃NO₈P₂.
Tetramethyl N,N,O-Trimethyl Alendronate, CAS: /, stock: 2.4g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₂₇NO₇P₂.
Tetramethyl N,N,O-Trimethyl Alendronate-d6, CAS: /, stock: 7.7g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₂₁D₆NO₇P₂.
11β,17,21-Trihydroxy-16α-methylpregna-1,4-diene-3,20-dione 17,21-Dipropionate, CAS: 71868-53-6, stock: 6.3g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₈H₃₈O₇.
11β-Hydroxy-16α-methyl-17,20:20,21-bis(methylenedioxy)-pregn-1,4-dien-3-one, CAS: 110428-42-7, stock: 7.8g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₃₂O₆.
21-Dehydro Alclometasone, CAS: /, stock: 2g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₂₇ClO₅.
7α-Chloro-16α-methyl Prednisolone, CAS: 67452-97-5, stock: 8.9g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₂₉ClO₅.
Alclometasone 17,21-Dipropionate, CAS: 66734-13-2, stock: 3.1g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₈H₃₇ClO₇.
(3-((6-Bromohexyl)oxy)butyl)benzene, CAS: /, stock: 7.4g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₂₅BrO.
(8-Chloro-2,2-dimethyl-4H-benzo[d][1,3]dioxin-6-yl)methanol, CAS: /, stock: 2.3g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₃ClO₃.
(±)-4-O-Ethyl Albuterol, CAS: /, stock: 3.3g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₂₅NO₃.
(±)-4-O-Ethyl Albuterol-d5, CAS: /, stock: 3.2g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₂₀D₅NO₃.
(E)-4-(2-(t-Butylamino)-1-(tert-butylimino)ethyl)phenol Hydrobromide, CAS: /, stock: 5.5g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₂₆N₂O • HBr.
(R)-4-Benzyl Albuterol, CAS: 174607-68-2, stock: 4.9g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₇NO₃.
(R)-Albuterol Hydrochloride, CAS: 50293-90-8, stock: 8.1g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₂₂ClNO₃.
(R)-Albuterol-d9 Hydrochloride, CAS: /, stock: 6.9g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₃D₉ClNO₃.
(S)-Albuterol Hydrochloride, CAS: 50293-91-9, stock: 7.9g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₂₂ClNO₃.
(S)-Albuterol Tartrate, CAS: /, stock: 2.7g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₂₇NO₉.
(S)-Albuterol-d9 Hydrochloride, CAS: /, stock: 8.3g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₃D₉ClNO₃.
1,3-O-Isopropylidene (R)-Albuterol (2S,3S)-Di-O-toluoyl Tartrate Salt, CAS: 238762-33-9, stock: 9.6g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅₂H₆₈N₂O₁₄.
1-(3-(Ethoxymethyl)-4-hydroxyphenyl)ethanone, CAS: /, stock: 8.3g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₄O₃.
1-(RS)-1-[4-Hydroxy-3-(Hydroxymethylphenyl]-2-[(4-phenylbutyl)aminoethanol (Salmeterol EP Impurity A), CAS: 1798014-51-3, stock: 6.6g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₂₅NO₃.
1-(RS)-1-[4-Hydroxy-3-(Hydroxymethylphenyl]-2-[(4-phenylbutyl)aminoethanol-d3 (Salmeterol EP Impurity), CAS: /, stock: 4.4g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₂₂D₃NO₃.
2,2-Dibromo-1-(3-(ethoxymethyl)-4-hydroxyphenyl)ethanone, CAS: /, stock: 5.5g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₂Br₂O₃.
2,2’-Methylenebis(4-bromophenol), CAS: 78563-03-8, stock: 3.1g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₀Br₂O₂.
2-(2-((5-(2-(tert-Butylamino)-1-hydroxyethyl)-2-hydroxybenzyl)oxy)-2-oxoethyl)-2-hydroxysuccinic Acid, CAS: /, stock: 2.7g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₂₇NO₉.
2-(Acetyloxy)-3-[[2-(acetyloxy)-5-(2-oxiranyl)phenyl]methyl]-5-(2-oxiranyl)-benzenemethanol 1-Acetate, CAS: 438246-24-3, stock: 3.3g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₂₄O₅.
2-(Acetyloxy)-3-[[2-(acetyloxy)-5-bromophenyl]methyl]-5-bromo-benzenemethanol Acetate, CAS: /, stock: 4.4g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₁₈Br₂O₃.
2-(Acetyloxy)-3-[[2-(acetyloxy)-5-ethenylphenyl]methyl]-5-ethenyl-benzenemethanol Acetate, CAS: /, stock: 3.3g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₂₄O₃.
2-[(1,1-Dimethylethyl)amino]-1-(4-hydroxyphenyl)-ethanone Hydrobromide, CAS: /, stock: 3.9g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₇NO₂ • HBr.
2-[(1,1-Dimethylethyl)amino]-1-[3-(ethoxymethyl)-4-hydroxyphenyl]-ethanone Hydrobromide, CAS: /, stock: 2.4g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₂₃NO₃ • HBr.
3-Dehydroxy Salbutamol, CAS: 18910-68-4, stock: 6.7g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₂₁NO₂.
3-O-Xinafoyl Salmeterol, CAS: /, stock: 6.9g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₆H₄₃NO₆.
4-(2-(Benzyl(6-((4-phenylbutan-2-yl)oxy)hexyl)amino)-1-hydroxyethyl)-2-(hydroxymethyl)phenol, CAS: /, stock: 9.4g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₂H₄₃NO₄.
4-(2-(tert-butylamino)-1-ethoxyethyl)-2-(hydroxymethyl)phenol, CAS: 1221742-55-7, stock: 1.7g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₂₅NO₃.
4-(Acetyloxy)-5-[[2-(acetyloxy)-5-(2-bromo-1-hydroxyethyl)phenyl]methyl]-α1-(bromomethyl)-1,3-benzenedimethanol α3-Acetate, CAS: 438246-23-2, stock: 4.7g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₂₆Br₂O₅.
4-Benzyl Albuterol, CAS: 56796-66-8, stock: 9.3g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₇NO₃.
4-Hydroxy-α1-[[[6-(1-methyl-3-phenylpropoxy)hexyl]amino]methyl]-1,3-benzenedimethanol (Salmeterol Impurity), CAS: 108928-81-0, stock: 1.6g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₃₇NO₄.
4-Hydroxy-α1-[[[6-(2-phenylethoxy)hexyl]amino]methyl]-1,3-benzenedimethanol, CAS: 94749-02-7, stock: 9.7g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₃₃NO₄.
4-Hydroxy-α1-[[[6-(2-phenylethoxy)hexyl]amino]methyl]-1,3-benzenedimethanol-d3, CAS: /, stock: 4.9g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₃₀D₃NO₄.
4-Hydroxy-α1-[[[6-(3-phenylpropoxy)hexyl]amino]methyl]-1,3-benzenedimethanol, CAS: 94749-11-8, stock: 9.1g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₃₅NO₄.
4-Hydroxy-α1-[[[6-(3-phenylpropoxy)hexyl]amino]methyl]-1,3-benzenedimethanol-d3, CAS: /, stock: 7.2g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₃₂D₃NO₄.
4-tert-Butylaminoethyl-2-methylphenol, CAS: 132183-64-3, stock: 9.8g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₂₁NO.
5-((5-(2-(tert-Butylamino)-1-hydroxyethyl)-2-hydroxybenzyl)oxy)pentane-1,1,2,3,4,5-hexaol, CAS: /, stock: 1.3g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₃₁NO₉.
5-Chloro-4-hydroxy-1,3-benzenedimethanol, CAS: 22002-29-5, stock: 1.1g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₉ClO₃.
5-Hydroxy Albuterol, CAS: 182676-90-0, stock: 6.2g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₂₁NO₄.
5-Hydroxy Albuterol Hemisulfate Salt, CAS: /, stock: 9.9g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₂₁NO₄•1/2H₂SO₄.
5-Hydroxy Albuterol-d9 Hemisulfate Salt, CAS: /, stock: 9.5g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₂D₉NO₄•1/2H₂SO₄.
6-(4-Phenylbutoxy)-1-hexanamine, CAS: 97664-58-9, stock: 2.9g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₂₇NO.
Albuterol Dimer Ether, 75%, CAS: 147663-30-7, stock: 1.2g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₆H₄₀N₂O₅.
Albuterol Methyl Ether Hydrochloride Salt, CAS: /, stock: 2.5g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₂₃NO₃ . HCl.
Albuterol Sulfate, CAS: 51022-70-9, stock: 6.3g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₆H₄₄N₂O₁₀S.
Albuterol-d4, CAS: /, stock: 1.3g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₇D₄NO₃.
Deshydroxy Albuterol, CAS: 1823256-56-9, stock: 6.6g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₂₁NO₂.
Di-O-acetyl N-Benzyl Salbutamon, CAS: 77430-27-4, stock: 2.4g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₂₉NO₅.
α-Methoxy Albuterol, CAS: 870076-72-5, stock: 6.2g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₂₃NO₃.
α-[[(1,1-Dimethylethyl)amino]methyl]-4-hydroxy-3-[[4-hydroxy-3-(hydroxymethyl)phenyl]methyl]-benzenemethanol, CAS: 156339-89-8, stock: 3.1g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₇NO₄.
α-[[(1,1-Dimethylethyl)amino]methyl]-4-hydroxy-3-[[4-hydroxy-3-(hydroxymethyl)phenyl]methyl]-benzenemethanol-d9, CAS: /, stock: 9.5g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₁₈D₉NO₄.
m-Chloro Salbutamon Hydrochloride, CAS: /, stock: 5.8g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₉Cl₂NO₃.
Methyl 5-(2,2-Dihydroxyacetyl)-2-ethoxybenzoate, CAS: /, stock: 9.3g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₄O₆.
Methyl 5-(2-(Benzyl(6-((4-phenylbutan-2-yl)oxy)hexyl)amino)acetyl)-2-hydroxybenzoate, CAS: /, stock: 1.9g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₃H₄₁NO₅.
Methyl 5-(2-(tert-Butylimino)acetyl)-2-ethoxybenzoate, CAS: /, stock: 9g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₂₁NO₄.
N-Benzyl Albuterol, CAS: 24085-03-8, stock: 7.9g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₇NO₃.
N-Benzyl Albuterol-d9, CAS: /, stock: 1.8g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₁₈D₉NO₃.
N-Benzyl Salbutamol Acetonide, CAS: 1797114-57-8, stock: 9g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₃₁NO₃.
(17α)-7-Cyano-17-hydroxy-3-oxo-pregna-4,9(11)-diene-21-carboxylic acid γ-Lactone, CAS: 1197900-95-0, stock: 4.8g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₂₇NO₃.
(2’R,7R,8R,9S,10R,13S,14S)-10,13-Dimethyl-3,5’,18-trioxooctadecahydro-3’H-spiro[4,7-methanocyclopenta[a]phenanthrene-17,2’-furan]-5-carbonitrile, CAS: /, stock: 3.4g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₂₉NO₄.
N-Benzyl Salbutamol Acetonide Methyl Ether, CAS: 1797879-98-1, stock: 9.1g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₃₃NO₃.
(2’R,7R,8R,9S,10R,13S,14S)-18-Amino-10,13-dimethyl-3,5’-dioxo-2,3,4’,5,5’,6,7,8,9,10,11,12,13,14,15,16-hexadecahydro-1H,3’H-spiro[4,7-(metheno)cyclopenta[a]phenanthrene-17,2’-furan]-5-carbonitrile, CAS: /, stock: 2.1g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₃₀N₂O₃.
(7α,11α,12α,17α)-11,12-Epoxy-17-hydroxy-3-oxo-pregn-4-ene-7,21-dicarboxylic Acid Lactone, Methyl Ester, CAS: 192704-82-8, stock: 5.7g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₃₀O₆.
N-Benzyl-6-((4-phenylbutan-2-yl)oxy)hexan-1-amine, CAS: 108928-82-1, stock: 2.5g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₃₃NO.
(7α,17α)- 9,17-Dihydroxy-3-oxo-pregn-4-ene-7,21-dicarboxylic Acid Di-γ-lactone, CAS: 209253-67-8, stock: 6.8g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₂₈O₅.
1-Cycloocten-1-ol 1-Acetate, CAS: 14478-13-8, stock: 4.3g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₆O₂.
O-Ethyl Albuterol, CAS: 754926-25-5, stock: 6.5g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₂₅NO₃.
O-Methyl Albuterol, CAS: 18910-70-8, stock: 1.9g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₂₃NO₃.
1-Dehydro Aldosterone, CAS: 76959-24-5, stock: 2.3g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₂₆O₅.
Pirbuterol Dihydrochloride, CAS: 38029-10-6, stock: 6g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₂₂Cl₂N₂O₃.
Pirbuterol-d9 Dihydrochloride, CAS: 64856-15-1, stock: 8.8g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₃D₉Cl₂N₂O₃.
rac Albuterol, CAS: 18559-94-9, stock: 8.1g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₂₁NO₃.
rac Albuterol-d9, CAS: 1173021-73-2, stock: 2g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₂D₉NO₃.
Salbutamol Acetonide Methyl Ether, CAS: 1797136-74-3, stock: 4.6g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₂₇NO₃.
Salbutamol Impurity L Acetate Salt, CAS: /, stock: 4.2g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₂₀ClNO₃ • C ₂H₄O₂.
Salbutamol Impurity O Sulfate Salt, CAS: /, stock: 2.1g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₂₅NO₃(H₂SO₄).
17-(Ethoxymethyl) Androst-5-ene-3β,17β-diol, CAS: 855-49-2, stock: 4.3g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₃₆O₃.
Salbutamol Impurity P, CAS: /, stock: 5.5g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₃₁NO₆.
Salbutamon Hydrochloride, CAS: 41489-89-8, stock: 1.9g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₂₀ClNO₃.
Salbutamon-d9 Hydrochloride, CAS: 1346605-08-0, stock: 1.8g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₁D₉ClNO₃.
Salmeterol Xinafoate, CAS: 94749-08-3, stock: 7g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₆H₄₅NO₇.
17α-Ethoxymethyl 6-Dehydrotestosterone, CAS: /, stock: 1.8g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₃₂O₃.
Salmeterol-d3, CAS: 497063-94-2, stock: 7.4g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₃₄D₃NO₄.
Salmeterol-d4, CAS: 1204192-41-5, stock: 2.3g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₃₃D₄NO₄.
17β-Spiro[5-androsten-17,2’-oxiran]-3β-ol, CAS: 847-75-6, stock: 4.1g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₃₀O₂.
20,21-Dehydro Spironolactone, CAS: 132458-33-4, stock: 4.1g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₃₀O₄S.
21-Hydroxyeplerenone (α, β mixture), CAS: 334678-67-0, stock: 3.1g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₃₀O₇.
21β-Hydroxyeplerenone, CAS: 1633889-97-0, stock: 2.2g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₃₀O₇.
21β-Hydroxyeplerenone 3-Bis Ethyl Ketal, CAS: /, stock: 2.3g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₈H₄₀O₈.
3-(1H-Imidazol-1-ylmethyl)aniline, CAS: 120107-85-9, stock: 5.5g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₁N₃.
3-Acetyl-5-bromopyridine, CAS: 38940-62-4, stock: 5.3g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₆BrNO.
3-Bromo-1,2-dihydroacenapthylene, CAS: 5209-31-4, stock: 9g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₉Br.
3β,5-Dihydroxy-15β,16β-methylene-5β-androst-6-en-17-one, CAS: 82543-15-5, stock: 7.7g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₈O₃.
4-Bromo-spironolactone, CAS: /, stock: 7.4g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₃₁BrO₄S.
4-Chloro-2-iodobenzeneacetic Acid Methyl Ester, CAS: 936098-39-4, stock: 5.9g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₈ClIO₂.
4-Chloro-2-iodobenzeneethanol, CAS: 1067882-47-6, stock: 5.5g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₈ClIO.
5-(4,4,5,5-Tetramethyl-[1,3,2]dioxaborolan-2-yl)-7,8-dihydronaphthalene-2-carbonitrile, CAS: 952675-93-3, stock: 5g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₂₀BNO₂.
5-Chloro-1-Indanone, CAS: 42348-86-7, stock: 8.4g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₇ClO.
5-Iodopyrimidin-4-ol, CAS: 09/07/4349, stock: 4.6g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄H₃N₂OI.
6-Cyano-1-tetralone, CAS: 90401-84-6, stock: 4g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₉NO.
6-Hydroxy-20,21-epoxy Eplerenone 20-O-Ethyl Enol Ether, CAS: /, stock: 8.8g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₆H₃₄O₈.
6β,21-Dihydroxy-Eplerenone, CAS: 674781-15-8, stock: 1.8g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₃₀O₈.
6β-Hydroxy Eplerenone, CAS: 209253-80-5, stock: 9.7g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₃₀O₇.
7-(Desacetothioxy)-7-acetodithioperoxy-spironolactone, CAS: /, stock: 9g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₃₂O₄S₂.
7α-Acetylthio-17α-ethoxymethyl Testosterone, CAS: /, stock: 7.8g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₃₆O₄S.
Aldosterone 18-Oxime 21-Acetate, CAS: 74220-49-8, stock: 5.2g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₃₁NO₆.
Aldosterone 21-Acetate, CAS: 2827-21-6, stock: 1.3g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₃₀O₆.
Benzo[d]thiazole-6-carboxamide, CAS: 101084-51-9, stock: 2g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₆N₂OS.
Bovine ALD(Aldosterone) ELISA Kit (96T), CAS: /, stock: 4.5g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
Canrenoic Acid Potassium Salt, CAS: 2181-04-6, stock: 7.5g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₂₉KO₄.
Cyclooctanone, CAS: 502-49-8, stock: 9.5g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₁₄O.
Eplerenone, CAS: 107724-20-9, stock: 4.4g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₃₀O₆.
Eplerenone 3,20-Bis-ethyl Enol Ether, CAS: /, stock: 1.9g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₈H₃₈O₆.
Eplerenone 3-Ethylene Ketal, CAS: /, stock: 7.1g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₆H₃₄O₇.
Eplerenone 7-Carboxylic Acid, CAS: 209253-82-7, stock: 6g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₂₈O₆.
Eplerenone-d3, CAS: /, stock: 5.8g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₂₇D₃O₆.
Ethynylandrostenediol, CAS: 3604-60-2, stock: 3.9g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₃₀O₂.
Isonicotinyl Chloride Hydrochloride, CAS: 39178-35-3, stock: 3g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₅Cl₂NO.
Mespirenone, CAS: 87952-98-5, stock: 9.3g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₃₀O₄S.
MMTC, CAS: 1210-56-6, stock: 6.4g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₆N₂O.
Pyrimidin-4-ylboronic Acid (~80%), CAS: 852362-24-4, stock: 4.2g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄H₅BN₂O₂.
Spironolactone, CAS: 52-01-7, stock: 9.5g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₃₂O₄S.
Spironolactone-d3, CAS: /, stock: 7.4g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₂₉D₃O₄S.
Spironolactone-d7 (Major), CAS: /, stock: 5.2g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₂₅D₇O₄S.
Tetrahydro Aldosterone, CAS: 13489-75-3, stock: 9.5g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₃₂O₅.
Universal ALD(Aldosterone) ELISA Kit (96T), CAS: /, stock: 9.5g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
(16α)-3β-(Acetyloxy)-16,17-dihydroxy-pregna-5,14-dien-20-one, CAS: /, stock: 6.6g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₃₂O₅.
Algestone, CAS: 595-77-7, stock: 7g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₃₀O₄.
Algestone Acetonide, CAS: 06/09/4968, stock: 1.1g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₃₄O₄.
Algestone Acetonide-d6, CAS: /, stock: 8.1g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₂₈D₆O₄.
Algestone Acetophenide, CAS: 24356-94-3, stock: 8.1g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₉H₃₆O₄.
Δ14,15, 16α Hydroxy-pregnenolone 16-17 Acetophenide, CAS: /, stock: 6.8g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₉H₃₆O₄.
Δ14,15-Algestone Acetophenide (Mixture of Diastereomers), CAS: /, stock: 4.7g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₉H₃₄O₄.
2-(2-Amino-3-ethylphenyl)ethanol, CAS: 141949-10-2, stock: 8.1g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₅NO.
Alachlor, CAS: 15972-60-8, stock: 5.5g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₂₀ClNO₂.
Alachlor ESA, CAS: 142363-53-9, stock: 1.5g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₂₁NO₅S.
Alachlor ESA Sodium Salt, CAS: 140939-15-7, stock: 7.7g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₂₀NNaO₅S.
Alachlor ESA-d13 Sodium Salt, CAS: /, stock: 1.5g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₇D₁₃NNaO₅S.
Alachlor OA, CAS: 171262-17-2, stock: 2.4g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₉NO₄.
Alachlor OA-d13, CAS: /, stock: 9.6g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₆D₁₃NO₄.
Alachlor OXA-D5, CAS: /, stock: 5.3g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₆D₅NO₄.
Alachlor-13C4, CAS: /, stock: 6.7g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀¹³C₄H₂₀ClNO₂.
Alachlor-d13, CAS: 1015856-63-9, stock: 3.8g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₇D₁₃ClNO₂.
(2E)-N-[4-[(3-Chloro-4-fluorophenyl)amino]-7-[[(3R)-tetrahydro-3-furanyl]oxy]-6-quinazolinyl]-4-(dimethylamino)-2-butenamide, CAS: 945553-91-3, stock: 5.9g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₂₅ClFN₅O₃.
(2E)-N-[4-[(3-chloro-4-fluorophenyl)amino]-7-[[(3S)-tetrahydro-3-furanyl]oxy]-6-quinazolinyl]-4-hydroxy-2-butenamide, CAS: 2121530-37-6, stock: 3.7g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₂₀ClFN₄O₄.
(2Z)-Afatinib, CAS: 1680184-59-1, stock: 9.8g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₂₅ClFN₅O₃.
(2Z)-Afatinib-d6, CAS: /, stock: 6.1g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₁₉D₆ClFN₅O₃.
(E)-4-(Dimethylamino)but-2-enoyl Chloride-d6, CAS: /, stock: 2.3g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₄D₆ClNO.
(E)-N-(4-((3-Chloro-4-fluorophenyl)amino)-7-ethoxyquinazolin-6-yl)-4-(dimethylamino)but-2-enamide, CAS: /, stock: 1g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₂₃ClFN₅O₂.
(E)-N-(4-((3-Chloro-4-fluorophenyl)amino)-7-methoxyquinazolin-6-yl)-4-(dimethylamino)but-2-enamide, CAS: /, stock: 7.8g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₂₁ClFN₅O₂.
(S)-3-Chloro-N-(4-((3-chloro-4-fluorophenyl)amino)-7-((tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)-4-(dimethylamino)but-2-enamide, CAS: /, stock: 3.8g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₂₄Cl₂FN₅O₃.
(S)-N-(3-Chloro-4-fluorophenyl)-6-nitro-7-(tetrahydrofuran-3-yloxy)quinazolin-4-amine, CAS: 314771-88-5, stock: 1.1g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₁₄ClFN₄O₄.
(S)-N-(4-((3-Chloro-4-fluorophenyl)amino)-7-((tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)-4-hydroxybutanamide, CAS: /, stock: 9.1g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₂₂ClFN₄O₄.
(S,Z)-4-((4-((3-Chloro-4-fluorophenyl)amino)-7-((tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)amino)-4-oxobut-2-enoic Acid, CAS: /, stock: 7.5g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₁₈ClFN₄O₅.
3-Dechloro Afatinib, CAS: /, stock: 7.5g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₂₆FN₅O₃.
3-Dechloro-4-defluoro 4-Chloro-3-fluoro Afatinib, CAS: /, stock: 8.2g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₂₅ClFN₅O₃.
3-Dimethylamino-1-propyne, CAS: 7223-38-3, stock: 7.2g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅H₉N.
4-(3-Chloro-4-fluorophenylamino)-7-fluoro-6-nitroquninazoline, CAS: 162012-67-1, stock: 4.6g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₇ClF₂N₄O₂.
4-Chloro-7-fluoro-6-nitroquinazoline, CAS: 162012-70-6, stock: 9.1g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₃ClFN₃O₂.
4-Dimethylaminobut-2-ynoic Acid Hydrochloride, CAS: 118764-06-0, stock: 7.9g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₉NO₂ •HCl.
4-[(4-Chloro-3-fluorophenyl)amino]-6-nitroquinazolin-7-ol, CAS: /, stock: 3.3g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₈ClFN₄O₃.
Afatinib, CAS: 850140-72-6, stock: 4g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₂₅ClFN₅O₃.
Afatinib Dimaleate, CAS: 850140-73-7, stock: 8.7g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₂₅ClFN₅O₃•[C₄H₄O₄]₂.
Afatinib Dimer, CAS: /, stock: 8.2g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄₈H₅₀Cl₂F₂N₁₀O₆.
Afatinib Impurity AFT-8, CAS: /, stock: 6.1g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₂₇ClFN₅O₄.
Afatinib Maleic Acid Adduct, CAS: /, stock: 5.5g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₈H₂₉ClFN₅O₇.
Afatinib N-Oxide, CAS: /, stock: 6.8g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₂₅ClFN₅O₄.
Afatinib-d4, CAS: /, stock: 3.6g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₂₁D₄ClFN₅O₃.
Afatinib-d6, CAS: 1313874-96-2, stock: 4.5g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₁₉D₆ClFN₅O₃.
Afatinib-d6 Dimaleate, CAS: /, stock: 2.5g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₂H₂₇D₆ClFN₅O₁₁.
Afatinib-des(4-dimethylamino-2-en-1-oxo)butyl (Contained ~8.5% Ethanol), CAS: 314771-76-1, stock: 5.7g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₁₆ClFN₄O₂.
Des(N,N-Dimethylprop-2-enyl-1-Amine) Afatinib, CAS: /, stock: 3.5g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₁₆ClFN₄O₃.
Des-(4-dimethylamino-2-en-1-oxo)butylamino 6-(5-Amino-pyrrolidin-2-on-1-yl) Afatinib, CAS: /, stock: 3.9g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₂₁ClFN₅O₃.
Des-(4-dimethylamino-2-en-1-oxo)butylamino 6-(5-Hydroxy-pyrrolidin-2-on-1-yl) Afatinib, CAS: /, stock: 5.4g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₂₀ClFN₄O₄.
Des-(4-dimethylamino-2-en-1-oxo)butylamino 6-(pyrrolidin-2,5-dion-1-yl) Afatinib, CAS: /, stock: 2g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₁₈ClFN₄O₄.
Des-(4-dimethylamino-2-en-1-oxo)butylamino 6-(pyrrolidin-2,5-dion-1-yl) Afatinib Acetic Acid Salt, CAS: /, stock: 8.8g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₁₈ClFN₄O₄ + C₂H₄O₂.
Deschloro,desfluoro-N-des(4-dimethylamino-2-en-1-oxo)butyl Afatinib, CAS: /, stock: 9.1g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₁₈N₄O₂.
Deschloro-N-des(4-dimethylamino-2-en-1-oxo)butyl Afatinib, CAS: /, stock: 2.5g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₁₇FN₄O₂.
Desfluoro-N-des(4-dimethylamino-2-en-1-oxo)butyl Afatinib, CAS: /, stock: 5.4g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₁₇ClN₄O₂.
N-(3,4-Dichlorophenyl)-7-fluoro-6-nitroquinazolin-4-amine, CAS: /, stock: 2.5g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₇Cl₂FN₄O₂.
N-(3-Chloro-4-fluorophenyl)-7-methoxy-6-nitroquinazolin-4-amine, CAS: 179552-74-0, stock: 2.7g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₀ClFN₄O₃.
(2E,4E,6E,8E)-2,4,6,8-Decatetraenoic Acid, CAS: 876607-76-0, stock: 9.2g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₂O₂.
(4-(Chloromethyl)phenyl)methanesulfonyl Chloride, CAS: 1314928-78-3, stock: 4.5g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₈Cl₂O₂S.
(4-Formylphenyl)methanesulfonyl Chloride, CAS: 1196151-28-6, stock: 9.3g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₇ClO₃S.
2,4,6,8-Decatetraenoic Acid N-Hydroxysuccinimide, CAS: /, stock: 6.7g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₅NO₄.
4-Hydroxybenzenemethanesulfonyl Chloride, CAS: 1394917-69-1, stock: 9.1g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₇ClO₃S.
2’-Deoxy-7-[(6aS,8R,9R,9aR)-1,2,3,6a,8,9,9a,11-octahydro-9-hydroxy-4-methoxy-1,11-dioxocyclopenta[c]furo[3’,2’:4,5]furo[2,3-h][1]benzopyran-8-yl]guanosine 3’,5’-Dibutanoate, CAS: 918446-34-1, stock: 3.4g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₅H₃₈N₅O₁₃.
2’-Deoxyguanosine 3’,5’-Dibutanoate, CAS: 79971-08-7, stock: 5.4g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₂₅N₅O₆.
4-Methoxy-2-methyl-2,3-dihydrocyclopenta[c]furo[3’,2’:4,5]furo[2,3-h]chromene-1,11(6aH,9aH)-dione-d6, CAS: /, stock: 9.3g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₈D₆O₆.
9-Dihydro-8-(N7-guanyl)-9-hydroxyaflatoxin B1, CAS: 64585-66-6, stock: 9.1g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₇H₂₆N₅O₁₁.
AFB-Guanine Acetic Acid Salt, CAS: /, stock: 3g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₂₁N₅O₁₀.
AFB-Guanine-13C,15N2, CAS: /, stock: 3.6g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁¹³CH₁₇N₃¹⁵N₂O₈.
Aflatoxin M1 (0.5µg/ml in Acetonitrile), CAS: 6795-23-9, stock: 1.1g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₂O₇.
Aflatoxin Mix (in Methanol (varied conc.)), CAS: /, stock: 2.8g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: N/A.
Blasticidin A, CAS: 100513-53-9, stock: 1.1g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅₈H₁₀₇NO₂₃.
cis-2,3,3a,6a-Tetrahydro-furo[2,3-b]furan, CAS: 109789-21-1, stock: 6.7g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₈O₂.
Mouse Akr7a2 (Aflatoxin B1 aldehyde reductase member 2) ELISA Kit (96T), CAS: /, stock: 8.9g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
Mouse Akr7a2(Aflatoxin B1 aldehyde reductase member 2) ELISA Kit (96T), CAS: /, stock: 9.1g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
Myricetin 3-Rhamnoside, CAS: 17912-87-7, stock: 3.7g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₂₀O₁₂.
O-Methylsterigmatocystin, CAS: 17878-69-2, stock: 2.9g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₁₄O₆.
Rat Akr7a2 (Aflatoxin B1 aldehyde reductase member 2) ELISA Kit (96T), CAS: /, stock: 9.2g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
Rat Akr7a2(Aflatoxin B1 aldehyde reductase member 2) ELISA Kit (96T), CAS: /, stock: 6.7g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
Rat Akr7a3 (Aflatoxin B1 aldehyde reductase member 3) ELISA Kit (96T), CAS: /, stock: 8.6g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
2-Amino-4-(methylthio)aniline, CAS: 67469-02-7, stock: 2.8g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₁₀N₂S.
2-Nitro-4-(propylthio)aniline, CAS: 54393-89-4, stock: 6.8g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₁₂N₂O₂S.
2-Nitro-4-thiocyanato Aniline, CAS: 54029-45-7, stock: 3.6g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₅N₃O₂S.
2-Nitro-5-(propylthio)aniline, CAS: 57780-75-3, stock: 4.1g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₁₂N₂O₂S.
2-Nitroaniline, CAS: 88-74-4, stock: 6g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₆N₂O₂.
4-(Propylthio)-1,2-benzenediamine, CAS: 66608-52-4, stock: 6.7g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₁₄N₂S.
4-Nitroaniline, CAS: 100-01-6, stock: 9.1g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₆N₂O₂.
5-(S-Methyl) Albendazole, CAS: 80983-45-5, stock: 4.9g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₁N₃O₂S.
5-(S-Methyl) Albendazole-d3, CAS: /, stock: 1g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₈D₃N₃O₂S.
5-Methylsulfanyl-2-nitroaniline, CAS: 31431-10-4, stock: 5.5g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₈N₂O₂S.
Albendazole, CAS: 54965-21-8, stock: 6.5g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₅N₃O₂S.
Albendazole Sulfone, CAS: 75184-71-3, stock: 1.1g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₅N₃O₄S.
Albendazole Sulfone-d5, CAS: /, stock: 6.7g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₀D₅N₃O₄S.
Albendazole Sulfoxide, CAS: 54029-12-8, stock: 6.1g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₅N₃O₃S.
Albendazole Sulfoxide-d7, CAS: /, stock: 1.6g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₈D₇N₃O₃S.
Albendazole-d3 (Methoxy-d3), CAS: 1353867-92-1, stock: 6.1g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₂D₃N₃O₂S.
Albendazole-d7, CAS: 1287076-43-0, stock: 9.7g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₈D₇N₃O₂S.
Amino Albendazole, CAS: 80983-36-4, stock: 4.9g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₃N₃S.
Amino Albendazole Sulfone, CAS: 80983-34-2, stock: 4.6g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₃N₃O₂S.
Amino Albendazole-d5 Sulfone, CAS: /, stock: 7.7g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₈D₅N₃O₂S•HCl.
Carbendazim, CAS: 10605-21-7, stock: 5.6g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₉N₃O₂.
Carbonyl Bis(amino albendazole), CAS: /, stock: 5.4g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₂₄N₆OS₂.
Hydroxyalbendazole, CAS: 107966-05-2, stock: 1.5g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₅N₃O₃S.
Methyl (5-((2-methyl-4-oxopentan-2-yl)thio)-1H-benzo[d]imidazol-2-yl)carbamate, CAS: /, stock: 2.1g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₉N₃O₃S.
Methyl (6-Mercapto-1H-benzo[d]imidazol-2-yl)carbamate, CAS: 79213-76-6, stock: 6g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₉N₃O₂S.
Methyl 5-Hydroxy-2-benzimidazolecarbamate, CAS: 22769-68-2, stock: 2g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₉N₃O₃.
Methyl [5(6)-chlorobenzimidazole-2-yl]carbamate, CAS: 20367-38-8, stock: 4.7g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₈ClN₃O₂.
Methyl-N-(4,6-dichloro-1H-benzimidazol-2-yl)carbamate, CAS: 946498-41-5, stock: 5.8g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₇Cl₂N₃O₂.
Methyl-N-(5-[butylsulfanyl]-1-H-benzimidazol-2-yl)carbamate, CAS: 70484-51-4, stock: 4g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₇N₃O₂S.
Methyl-N-(5-[propan-2-yl)sulfanyl]-1H-benzimidazol-2-yl)carbamate, CAS: 108579-67-5, stock: 3.3g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₅N₃O₂S.
O-Desmethyl-O-ethyl Albendazole, CAS: 139751-05-6, stock: 3.2g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₇N₃O₂S.
O-Desmethyl-O-ethyl Albendazole-d5, CAS: /, stock: 8.4g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₂D₅N₃O₂S.
Alcaftadine, CAS: 147084-10-4, stock: 5.4g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₂₁N₃O.
Alcaftadine 3-Carboxylic Acid, CAS: 147083-93-0, stock: 3.3g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₂₁N₃O₂.
Alcaftadine 3-Carboxylic Acid-d3, CAS: 1795019-71-4, stock: 7.9g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₁₈D₃N₃O₂.
Alcaftadine-d3, CAS: 1794775-80-6, stock: 4.2g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₁₈D₃N₃O.
Alcaftadine-N-oxide, CAS: 952649-75-1, stock: 1.6g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₂₁N₃O₂.
Cyclosporin A, CAS: 59865-13-3, stock: 3.1g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆₂H₁₁₁N₁₁O₁₂.
Cyclosporin A Sulfate, CAS: 121673-00-5, stock: 5.7g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆₂H₁₁₁N₁₁O₁₅S.
Cyclosporin A-13C2,d4 (Major), CAS: /, stock: 9.9g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆₀¹³C₂H₁₀₇D₄N₁₁O₁₂.
Cyclosporin A-13C2,d4 Acetate, CAS: /, stock: 8.6g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆₂¹³C₂H₁₀₉D₄N₁₁O₁₃.
Cyclosporin A-d13, CAS: /, stock: 10g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆₂D₁₃H₉₈N₁₁O₁₂.
Cyclosporin A-d4 (Major), CAS: /, stock: 5.7g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆₂H₁₀₇D₄N₁₁O₁₂.
Cyclosporin AM 1 (>80%), CAS: 89270-28-0, stock: 8.4g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆₂H₁₁₁N₁₁O₁₃.
Cyclosporin AM 1-d3, CAS: /, stock: 6.7g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆₂D₃H₁₀₈N₁₁O₁₃.
Cyclosporin B, CAS: 63775-95-1, stock: 5.2g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆₁H₁₀₉N₁₁O₁₂.
Cyclosporin B-d4, CAS: /, stock: 6.9g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆₁H₁₀₅D₄N₁₁O₁₂.
Cyclosporin C, CAS: 59787-61-0, stock: 8.2g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆₂H₁₁₁N₁₁O₁₃.
Cyclosporin C-d4, CAS: /, stock: 7.1g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆₂H₁₀₇D₄N₁₁O₁₃.
Cyclosporin D, CAS: 63775-96-2, stock: 7.6g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆₃H₁₁₃N₁₁O₁₂.
Cyclosporin D-d4, CAS: /, stock: 6g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆₃H₁₀₉D₄N₁₁O₁₂.
Cyclosporin G, CAS: 74436-00-3, stock: 2.8g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆₃H₁₁₃N₁₁O₁₂.
Cyclosporin H, CAS: 83602-39-5, stock: 4.2g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆₂H₁₁₁N₁₁O₁₂.
Dehydro Cyclosporin A (~90%), CAS: /, stock: 9.9g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆₂H₁₀₉N₁₁O₁₁.
Dehydro Cyclosporin A-d4, CAS: /, stock: 8.2g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆₂H₁₀₅D₄N₁₁O₁₁.
Everolimus, Cyclosporine and Tacrolimus Mix Standard, CAS: /, stock: 2.6g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅₃H₈₃NO₁₄ • C₆₂H₁₁₁N₁₁O₁₂ • C₄₄H₆₉N.
4-Hydroxy Benzeneacetic Acid 2-(Dimethylamino)-2-oxoethyl Ester, CAS: 59721-16-3, stock: 1.6g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₅NO₄.
4-Hydroxy Benzeneacetic Acid 2-(Dimethylamino-d6)-2-oxoethyl Ester, CAS: 1346603-09-5, stock: 9g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₉D₆NO₄.
4-[[4-[(Aminoiminomethyl)amino]benzoyl]oxy]benzeneacetic Acid, CAS: 71079-08-8, stock: 8.6g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₁₅N₃O₄.
4-[[4-[(Aminoiminomethyl)amino]benzoyl]oxy]benzeneacetic Acid Phenylmethyl Ester Hydrobromide, CAS: /, stock: 1g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₂₂BrN₃O₄.
4-[[4-[(Aminoiminomethyl)amino]benzoyl]oxy]benzeneacetic Acid Phenylmethyl Ester-d4, CAS: /, stock: 6.1g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₁₇D₄N₃O₄.
Benzyl (4-Hydroxyphenyl)acetate, CAS: 27727-37-3, stock: 1g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₄O₃.
Camostat Mesylate, CAS: 59721-29-8, stock: 5.7g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₂₆N₄O₈S.
Camostat Mesylate-D4, CAS: /, stock: 8.7g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₂₂D₄N₄O₈S.
Camostat Mesylate-D6, CAS: /, stock: 2.1g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₂₀D₆N₄O₈S.
FOY 251, CAS: 71079-09-9, stock: 8g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₉N₃O₇S.
FOY 251 Benzyl Ester Hydrochloride, CAS: 71079-12-4, stock: 9.8g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₂₂ClN₃O₄.
2,3,4,5-Tetradehydro Alfuzosin Hydrochloride, CAS: 98902-29-5, stock: 6.8g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₂₄ClN₅O₄.
2,3,4,5-Tetradehydro Alfuzosin-d3 Hydrochloride, CAS: 1346605-39-7, stock: 1.8g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₂₁D₃ClN₅O₄.
2-Tetrahydrofuroic Acid, CAS: 16874-33-2, stock: 2.1g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅H₈O₃.
4-Amino-2-chloro-6,7-dimethoxyquinazoline, CAS: 23680-84-4, stock: 2.1g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₀ClN₃O₂.
4-Amino-6,7-dimethoxy-1,2-dihydroquinazolin-2-one, CAS: 664347-52-8, stock: 3.2g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₁N₃O₃.
6,7-Dimethoxy-N2,N2-dimethylquinazoline-2,4-diamine, CAS: 19216-53-6, stock: 2.8g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₆N₄O₂.
6,7-Dimethoxyquinazoline-2,4-dione, CAS: 28888-44-0, stock: 3.9g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₀N₂O₄.
Alfuzosin Hydrochloride, CAS: 81403-68-1, stock: 8.8g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₂₈ClN₅O₄.
Alfuzosin-d3 Hydrochloride, CAS: 1216383-97-9, stock: 8.8g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₂₅D₃ClN₅O₄.
N-(4-Amino-6,7-dimethoxyquinazol-2-yl)-N-(methyl-d3)-2-cyanoethylamine, CAS: 1185144-54-0, stock: 5.5g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₄D₃N₅O₂.
N-(4-Amino-6,7-dimethoxyquinazol-2-yl)-N-methyl-2-cyanoethylamine, CAS: 76362-28-2, stock: 9.3g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₇N₅O₂.
N-(4-Amino-6,7-dimethoxyquinazol-2-yl)-N-methylpropylenediamine Formamide Hydrochloride, CAS: 1796934-51-4, stock: 5.2g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₇N₅O₂.
N-(4-Amino-6,7-dimethoxyquinazol-2-yl)-N-methylpropylenediamine Hydrochloride, CAS: 81403-69-2, stock: 7.9g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₂₂ClN₅O₂.
N-Des-tetrahydrofuran N-(6,7-Dimethoxy-4,4a-dihydroquinazolin-4-amine) Alfuzosin, CAS: 928780-95-4, stock: 3.5g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₃₀N₈O₄.
N-Des-tetrahydrofuran N-(6,7-Dimethoxy-4,4a-dihydroquinazolin-4-amine) Alfuzosin-d3, CAS: /, stock: 5.9g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₂₇D₃N₈O₄.
N2-Methyl Alfuzosin, CAS: 98902-34-2, stock: 8.3g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₂₇N₅O₄.
N2-Methyl Alfuzosin Destetrahydrofuran-2-carbaldehyde Hydrochloride, CAS: /, stock: 8.1g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₂₁N₅O₂•x(HCl).
N2-Methyl Alfuzosin-d7 Hydrochloride, CAS: 1346601-27-1, stock: 3.5g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₂₁D₇ClN₅O₄.
15β-Hydroxy Cyproterone, CAS: 68791-71-9, stock: 9.4g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₂₇ClO₄.
15β-Hydroxy Cyproterone AcetateCURRENTLY UNAVAILABLE, CAS: 65423-26-9, stock: 1.6g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₂₉ClO₅.
17-Acetyloxy-pregna-1,4-diene-3,20-dione (~90%), CAS: 2668-74-8, stock: 6.9g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₃₀O₄.
1α-Chloromethyl-3,6,20-pregn-4-en-17-yl Acetate, CAS: /, stock: 3.2g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₃₁ClO₅.
3,17-Dihydroxy-pregna-3,5-dien-20-one Diacetate, CAS: 08/07/4954, stock: 7.5g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₃₄O₅.
6-Deschloro Cyproterone Acetate, CAS: 2701-50-0, stock: 9.6g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₃₀O₄.
6-Deschloro-4-chloro Cyproterone Acetate, CAS: 23814-68-8, stock: 1.4g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₂₉ClO₄.
6-Deschloro-6,7-epoxy Cyproterone Acetate, CAS: 15423-97-9, stock: 8g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₃₀O₅.
6-Deschloro-6-methoxy Cyproterone Acetate, CAS: /, stock: 8.3g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₃₂O₅.
6-Keto Cyproterone Acetate, CAS: 17184-05-3, stock: 7g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₃₀O₅.
6β-Chloro-7α-hydroxy-6,7-dihydro Cyproterone Acetate, CAS: 23814-84-8, stock: 6.7g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₃₁ClO₅.
Cyproterone, CAS: 2098-66-0, stock: 1.1g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₂₇ClO₃.
Cyproterone Acetate, CAS: 427-51-0, stock: 2.4g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₂₉ClO₄.
Cyproterone Acetate-13C2,d3, CAS: /, stock: 1.9g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂¹³C₂H₂₆D₃ClO₄.
(3R)-3,4-Bis((4-methylbenzoyl)oxy)pentane-1,1,5-triyl triacetate, CAS: /, stock: 4.1g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₇H₃₀O₁₀.
Cyproterone Acetate-d3 (Major), CAS: /, stock: 4.1g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₂₆D₃ClO₄.
Cyproterone-13C2,d8, CAS: /, stock: 1.7g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀¹³C₂H₁₉D₈ClO₃.
(3R,4S)-6-(4-Amino-2-oxo-1,3,5-triazin-1(2H)-yl)tetrahydro-2H-pyran-3,4-diyl Diacetate, CAS: /, stock: 6.8g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₆N₄O₆.
(3R,4S,6R)-6-(4-Amino-2-oxo-1,3,5-triazin-1(2H)-yl)tetrahydro-2H-pyran-3,4-diyl Bis(4-methylbenzoate), CAS: /, stock: 1.7g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₂₄N₄O₆.
Cyproterone-d4, CAS: /, stock: 7.2g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₂₃D₄ClO₃.
(4-N-(Benzhydryloxycarbonyl)cytosine)-1-acetic Acid, CAS: 186046-78-6, stock: 7.5g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₁₇N₃O₅.
1,3,5-Tri-O-acetyl-2-deoxy-D-ribose (Major), CAS: /, stock: 1.6g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₆O₇.
1-(2’-Deoxy-2’-fluoro-b-D-arabinofuranosyl)cytosine Hydrochloride, CAS: 56632-83-8, stock: 4.2g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₁₂FN₃O₄ • HCl.
2,4,5-Triamino-6-pyrimidinol-13C2,15N, CAS: /, stock: 8.3g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂¹³C₂H₇N₄¹⁵NO.
2,4-Diamino-6-hydroxypyrimidine, CAS: 56-06-4, stock: 1.5g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄H₆N₄O.
2,4-Diamino-6-hydroxypyrimidine-15N3, CAS: 1638736-04-5, stock: 7.7g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄H₆N¹⁵N₃O.
2,4-Diamino-6-hydroxypyrimidine-15N4, CAS: /, stock: 8.1g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄H₆¹⁵N₄O.
2,4-Dichloro-5-methylpyrimidine-15N2,13C, CAS: /, stock: 7.5g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄¹³CH₄Cl₂¹⁵N₂.
2,6-Diamino-4-hydroxy-5-nitrosopyrimidine-13C2,15N, CAS: /, stock: 6.1g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂¹³C₂H₅N₄¹⁵NO₂.
2-Amino-5-methyl-pyrimidin-4-ol, CAS: 15981-91-6, stock: 1.7g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅H₇N₃O.
2-Amino-6-chloro-4-pyrimidinol, CAS: 1194-21-4, stock: 8g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄H₄ClN₃O.
2-Deoxy-D-erythro-pentopyranose-tris(4-methylbenzoate), CAS: /, stock: 1.5g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₉H₂₈O₇.
2-Deoxy-D-α-ribopyranosyl-5-azacytosine, CAS: /, stock: 1.9g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₁₂N₄O₄.
2-Deoxy-D-β-ribopyranosyl-5-azacytosine, CAS: 157771-78-3, stock: 5.4g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₁₂N₄O₄.
2-Deoxy-D-β-ribopyranosyl-5-azacytosine-15N4, CAS: /, stock: 7.6g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₁₂¹⁵N₄O₄.
2-Deoxy-D-ribopyranosyl-5-azacytosine, CAS: /, stock: 3.1g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₁₂N₄O₄.
2-Deoxy-α-L-erythro-pentopyranose-tris(4-methylbenzoate), CAS: /, stock: 6.9g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₉H₂₈O₇.
2-Deoxy-β-D-erythro-pentopyranose-tris(4-methylbenzoate), CAS: /, stock: 2.2g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₉H₂₈O₇.
2’-Deoxy Cytidine, CAS: 951-77-9, stock: 5.4g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₁₃N₃O₄.
2’-Deoxy Cytidine-13C, 15N, CAS: /, stock: 8.7g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈¹³CH₁₃N¹⁵N₂O₄.
2’-Deoxy Cytidine-2’,2’-d2, CAS: 114218-03-0, stock: 5.2g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₁₁D₂N₃O₄.
2’-Deoxy Cytidine-5,6-d2, CAS: 1186526-91-9, stock: 9.8g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₁₁D₂N₃O₄.
2’-Deoxy Cytidine-5-d1, CAS: 25352-61-8, stock: 3.3g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₁₂DN₃O₄.
2’-Deoxy-2’-fluoro Cytidine, CAS: 10212-20-1, stock: 3g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₁₂FN₃O₄.
2’-Deoxy-N4-DMF-5’-O-DMT-pseudoisocytidine 3’-CE Phosphoramidite, CAS: 307314-31-4, stock: 1.7g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄₂H₅₃N₆O₇P.
2’-Deoxycytidine-1’-13C Monohydrate, CAS: 478510-83-7, stock: 6.3g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈¹³CH₁₅N₃O₅.
2’-Deoxycytidine-1’-d Monohydrate, CAS: /, stock: 4.6g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₁₄DN₃O₅.
2’-Deoxycytidine-2’-13C, CAS: /, stock: 9.9g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈¹³CH₁₃N₃O₄.
2’-Deoxycytidine-5’,5’’-d2 Monohydrate, CAS: 478511-25-0, stock: 6.9g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₁₃D₂N₃O₅.
2’-OMe-ibu-G Phosphoramidite, CAS: 150780-67-9, stock: 8g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄₅H₅₆N₇O₉P.
3,5-Dimethylcytosine, CAS: /, stock: 5.8g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₉N₃O.
4(3H)-Pyrimidinone, CAS: 4562-27-0, stock: 8g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄H₄N₂O.
4,6-Diamino-2-thiopyrimidine, CAS: 1004-39-3, stock: 5.2g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄H₆N₄S.
4-(Trifluoromethoxy)benzamidoxime, CAS: 56935-71-8, stock: 3.6g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₇F₃N₂O₂.
4-Amino-2-chloro-5-methylpyrimidine-15N2,13C, CAS: /, stock: 2.3g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄¹³CH₆ClN¹⁵N₂.
4-Amino-2-mercaptopyrimidine, CAS: 333-49-3, stock: 9.4g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄H₅N₃S.
4-Amino-2-pyridone, CAS: 38767-72-5, stock: 1.5g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅H₆N₂O.
5,6-Dimethylcytosine, CAS: 25589-26-8, stock: 1.6g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₉N₃O.
5-(Hydroxymethyl)cytosine, CAS: 1123-95-1, stock: 2.1g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅H₇N₃O₂.
5-(Hydroxymethyl)cytosine-d2,13C, CAS: /, stock: 5.2g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄¹³CH₅D₂N₃O₂.
5-Aza Cytosine, CAS: 931-86-2, stock: 4.5g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃H₄N₄O.
5-Aza Cytosine-15N4, CAS: 1189895-68-8, stock: 1.7g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃H₄¹⁵N₄O.
5-Aza-2’-deoxy-6-oxo Cytidine, CAS: 106966-55-6, stock: 5.8g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₁₂N₄O₅.
5-Bromocytosine, CAS: 2240-25-7, stock: 7.6g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄H₄N₃OBr.
5-Carboxycytosine, CAS: 3650-93-9, stock: 7.9g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅H₅N₃O₃.
5-Carboxycytosine-13C,15N2, CAS: /, stock: 6.5g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄¹³CH₅N¹⁵N₂O₃.
5-Fluoro Cytosine, CAS: 2022-85-7, stock: 1.9g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄H₄FN₃O.
5-Fluoro Cytosine O-β-D-Glucuronide, CAS: 150494-26-1, stock: 9.8g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₂FN₃O₇.
5-Fluoro Cytosine-13C,15N2, CAS: 1216616-31-7, stock: 4g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃¹³CH₄FN¹⁵N₂O.
5-Fluoro Cytosine-13C,15N2 O-β-D-Glucuronide, CAS: /, stock: 2.7g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉¹³CH₁₂FN¹⁵N₂O₇.
5-Fluoro Uracil, CAS: 51-21-8, stock: 9.2g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄H₃FN₂O₂.
5-Fluoro-O4-(2,4,6-trimethylphenyl)-2’-deoxyuridine, CAS: 141120-63-0, stock: 6.8g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₂₁FN₂O₅.
5-Fluoroisocytosine, CAS: 1683-86-9, stock: 5.6g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄H₄FN₃O.
5-Formylcytosine, CAS: 4425-59-6, stock: 5.9g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅H₅N₃O₂.
5-Formylcytosine-13C,15N2, CAS: /, stock: 1.5g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄¹³CH₅N¹⁵N₂O₂.
5-Hydroxycytosine, CAS: 13484-95-2, stock: 6.5g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄H₅N₃O₂.
5-Hydroxycytosine-13C, 15N2, CAS: 181516-92-7, stock: 8.8g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃¹³CH₅N¹⁵N₂O₂.
5-Hydroxymethlyl-2’-deoxycytidine Cyclic Carbamate, CAS: 1257247-41-8, stock: 6.7g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₃N₃O₆.
5-Iodocytidine, CAS: 1147-23-5, stock: 9.1g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₁₂IN₃O₅.
5-Methyl Cytosine Hydrochloride, CAS: 58366-64-6, stock: 4.7g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅H₈ClN₃O.
5-Methyl Cytosine-13C,15N2 Hydrochloride, CAS: 1246815-59-7, stock: 1.9g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄¹³CH₈ClN¹⁵N₂O.
5-Methyl-2’-deoxy Cytidine, CAS: 838-07-3, stock: 7.2g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₅N₃O₄.
5-Methyl-2’-deoxy Cytidine-13C,15N2, CAS: /, stock: 2.4g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉¹³CH₁₅N¹⁵N₂O₄.
5-Methyl-2’-deoxy Cytidine-d3, CAS: 1160707-78-7, stock: 7.4g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₂D₃N₃O₄.
5-Methylcytosine, CAS: 554-01-8, stock: 9.7g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅H₇N₃O.
5-O-Benzyl-2,3-O-isopropylidene-D-ribono-1,4-lactone, CAS: 85846-80-6, stock: 1.7g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₈O₅.
6-Amino-5-(sulfooxy)-2(1H)-pyrimidinone, CAS: 51392-11-1, stock: 1.7g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄H₇N₃O₅S.
6-Amino-5-iodopyrimidin-2(1H)-one, CAS: 1122-44-7, stock: 4.9g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄H₄N₃OI.
9-Methoxymethyl Guanine, CAS: 1202645-50-8, stock: 1.8g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₉N₅O₂.
Ancitabine, CAS: 31698-14-3, stock: 7.5g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₁₁N₃O₄.
Ancitabine Hydrochloride, CAS: 10212-25-6, stock: 4.4g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₁₁N₃O₄ • (HCl).
Bovine AICDA (Single-stranded DNA cytosine deaminase) ELISA Kit (96T), CAS: /, stock: 8.6g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
Bovine TRDMT1 (tRNA (cytosine-5-)-methyltransferase) ELISA Kit (96T), CAS: /, stock: 5.1g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
Bropirimine, CAS: 56741-95-8, stock: 5.6g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₈BrN₃O.
Cyclopentenylcytosine, CAS: 90597-22-1, stock: 1.5g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₃N₃O₄.
Cyclopentenylcytosine-5’-triphosphate Triethylamine Salt, CAS: /, stock: 6.9g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₆N₃O₁₃P₃•xC₆H₁₅N.
Cytarabine, CAS: 147-94-4, stock: 8.7g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₁₃N₃O₅.
Cytarabine 5’-Monophosphate, CAS: 08/11/7075, stock: 5.3g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₁₄N₃O₈P.
Cytarabine-13C3, CAS: /, stock: 7.5g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆¹³C₃H₁₃N₃O₅.
Cytarabine-13C3 5’-Monophosphate, CAS: /, stock: 5.9g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆¹³C₃H₁₄N₃O₈P.
Cytidine, CAS: 65-46-3, stock: 4.2g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₁₃N₃O₅.
Cytidine 5’-Monophosphate, CAS: 63-37-6, stock: 9.3g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₁₄N₃O₈P.
Cytidine 5’-Monophosphate Disodium Salt, CAS: 08/06/6757, stock: 5.4g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₁₂N₃Na₂O₈P.
Cytidine-1’,2’,3’,4’,5’-13C5, CAS: /, stock: 6.2g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄¹³C₅H₁₃N₃O₅.
Cytidine-1’-13C, CAS: 201996-57-8, stock: 1.5g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈¹³CN₃O₅.
Cytidine-1’-d, CAS: /, stock: 4.4g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₁₂DN₃O₅.
Cytidine-2’-13C, CAS: 478511-19-2, stock: 5.4g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈¹³CH₁₃N₃O₅.
Cytidine-5’,5’’-d2, CAS: /, stock: 8.5g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₁₁D₂N₃O₅.
Cytosine, CAS: 71-30-7, stock: 3.6g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄H₅N₃O.
Cytosine beta-D-Arabinofuranoside Hydrochloride, CAS: 69-74-9, stock: 4.9g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₁₃N₃O₅ • (HCl).
Cytosine-13C,15N2, CAS: /, stock: 8.8g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃¹³CH₅N¹⁵N₂O.
D-Ribose 1-Phosphate, Biscyclohexylammonium Salt, CAS: 58459-37-3, stock: 6.8g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₃₇N₂O₈P.
Deoxy Chlorocytarabine, CAS: 32659-31-7, stock: 5.9g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₁₂ClN₃O₄.
Dideoxycytidinene, CAS: 7481-88-1, stock: 7g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₁₁N₃O₃.
Diethyl 2-Hydroxy-3-methylbutanedioate-13C, CAS: /, stock: 8.7g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈¹³CH₁₆O₅.
DL-Cytarabine-13C3, CAS: /, stock: 7g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆¹³C₃H₁₃N₃O₅.
Enocitabine, CAS: 55726-47-1, stock: 2.2g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₁H₅₅N₃O₆.
(Fmoc-Cys-OSu)2, CAS: 112514-60-0, stock: 6g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄₄H₃₈N₄O₁₂S₂.
Ethyl Cytosine-5-carboxylate, CAS: 20187-46-6, stock: 2.8g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₉N₃O₃.
1,8-Bis(cystineyl)-3,6-dioxa-octane Dihydrochloride, CAS: 337515-04-5, stock: 8.7g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₂₆Cl₂N₂O₆S₂.
Boc-Cys(Acm)-OH, CAS: 19746-37-3, stock: 9.1g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₂₀N₂O₅S.
Boc-Cys(Mob)-OH, CAS: 18942-46-6, stock: 8g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₂₃NO₅S.
Boc-Cys(tBu)-OH, CAS: 56976-06-8, stock: 3.2g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₂₃NO₄S.
Fluoromalonaldehydic Acid, CAS: 58629-87-1, stock: 3.1g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃H₃FO₃.
Boc-L-Cys(pMeBzl)-OH, CAS: 61925-77-7, stock: 6.8g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₂₃NO₄S.
D-Cystine, CAS: 349-46-2, stock: 1.7g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₁₂N₂O₄S₂.
Guanine-13C5,15N5, CAS: 1207522-89-1, stock: 1.5g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: ¹³C₅H₅¹⁵N₅O.
D-Cystine Dimethyl Ester Dihydrochloride, CAS: 144000-36-2, stock: 8.7g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₁₆N₂O₄S₂ • 2(HCl).
Guanine-15N5, CAS: 168566-53-8, stock: 6.3g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅H₅¹⁵N₅O.
Guanine-4,5-13C2,7-15N, CAS: 1207525-05-0, stock: 5.8g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃¹³C₂H₅N₄¹⁵NO.
D-Selenocystine, CAS: 26932-45-6, stock: 5.4g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₁₂N₂O₄Se₂.
Di-Boc-L-homocystine, CAS: 130981-51-0, stock: 7.5g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₃₂N₂O₈S₂.
Guanine-4,8-13C2,7-15N, CAS: 1246814-70-9, stock: 5.7g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃¹³C₂H₅N₄¹⁵NO.
Hordenine, CAS: 539-15-1, stock: 6.3g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₅NO.
DL-Cystine, CAS: 923-32-0, stock: 4.3g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₁₂N₂O₄S₂.
Hordenine-d6, CAS: 1346598-66-0, stock: 1.8g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₉D₆NO.
Human DNMT1(DNA(cytosine-5)-methyltransferase 1) ELISA Kit (96T), CAS: /, stock: 5.8g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
Dl-homocystine, CAS: 462-10-2, stock: 8.5g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₁₆N₂O₄S₂.
Human TRDMT1 (tRNA (cytosine-5-)-methyltransferase) ELISA Kit (96T), CAS: /, stock: 1.9g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
Iso Cytosine, CAS: 108-53-2, stock: 1.8g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄H₅N₃O.
Iso Ganciclovir Diacetate, CAS: 90661-36-2, stock: 7.7g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₇N₅O₆.
Human SLC7A11 (Cystine/glutamate transporter) ELISA Kit (96T), CAS: /, stock: 4.8g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
Human SLC7A11(Cystine/glutamate transporter) ELISA Kit (96T), CAS: /, stock: 6.1g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
Isouramil, CAS: 3914-34-9, stock: 8.4g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄H₅N₃O₃.
α-Decitabine, CAS: 22432-95-7, stock: 3g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₁₂N₄O₄.
Mixture of 1,2,3,5-Tetra-O-acetyl-D-arabinofuranose and 1,2,3,4-Tetra-O-acetyl-D-arabinopyranose (α/β-mixture), CAS: 43225-70-3, stock: 7.4g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₈O₉.
Mouse Aicda (Single-stranded DNA cytosine deaminase) ELISA Kit (96T), CAS: /, stock: 7.7g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
Mouse Trdmt1 (tRNA (cytosine-5-)-methyltransferase) ELISA Kit (96T), CAS: /, stock: 1.4g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
N-4,5-Dimethyl Cytosine, CAS: /, stock: 7.6g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₁₁N₃O.
N4-Acetylcytosine, CAS: 14631-20-0, stock: 6.6g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₇N₃O₂.
N4-Hydroxycytosine, CAS: 20555-88-8, stock: 2.6g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄H₅N₃O₂.
Rat Trdmt1 (tRNA (cytosine-5-)-methyltransferase) ELISA Kit (96T), CAS: /, stock: 7.5g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
L-Cystine Bis(beta-naphthylamide) Dihydrochloride, CAS: 100900-22-9, stock: 2.3g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₆H₂₆N₄O₂S₂ • 2HCl.
L-Cystine Bis(T-butyl Ester) Dihydrochloride, CAS: 38261-78-8, stock: 1.7g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₃₀Cl₂N₂O₄S₂.
Sulfacytine, CAS: 17784-12-2, stock: 6.9g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₄N₄O₃S.
Sulfacytine-d5, CAS: /, stock: 6.3g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₉D₅N₄O₃S.
L-Cystine bis-Ethyl Ester Dihydrochloride, CAS: 22735-07-5, stock: 1.3g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₂₁ClN₂O₄S₂.
Thymine-15N2,13C, CAS: /, stock: 8.5g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄¹³CH₆¹⁵N₂O₂.
L-Cystine Bisamide Dihydrochloride, CAS: 22671-21-2, stock: 6.3g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₁₆Cl₂N₄O₂S₂.
L-Cystine Dihydrochloride, CAS: 30925-07-6, stock: 1.1g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₁₂N₂O₄S₂ • 2(HCl).
(+)-Cytisine, CAS: 55821-72-2, stock: 2.1g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₄N₂O.
L-Cystine Disodium Salt, CAS: 64704-23-0, stock: 3.6g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₁₀N₂Na₂O₄S₂.
1-Benzyl-5-(hydroxymethyl)piperidin-2-one, CAS: 744212-68-8, stock: 6.5g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₇NO₂.
3-(Pyridin-3’-yl)-cytisine, CAS: 948027-43-8, stock: 2.3g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₁₇N₃O.
